data_1xbd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xbd _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . 0.418 ' C ' ' SG ' ' A' ' 330' ' ' CYS . 3.5 p . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.53 173.73 11.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.658 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 268' ' ' SER . 0.9 OUTLIER -136.55 134.36 49.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.444 -179.16 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.1 OUTLIER -116.59 134.51 54.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 109.505 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.497 ' HB1' ' CE2' ' A' ' 267' ' ' TYR . . . -124.89 106.89 10.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.526 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.5 m -103.59 135.33 45.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.462 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -69.8 111.51 5.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.87 . . . . 0.0 109.469 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -82.75 -74.43 0.35 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.451 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . 0.479 ' HB3' ' CH2' ' A' ' 259' ' ' TRP . 3.1 mm-40 -106.62 138.06 43.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.436 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -125.16 128.73 48.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 109.502 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' TRP . . . . . 0.479 ' CH2' ' HB3' ' A' ' 257' ' ' GLU . 8.9 m-90 -120.01 -178.69 3.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.216 -0.928 . . . . 0.0 109.463 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 m -91.96 9.74 31.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.453 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.22 -39.26 0.93 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.431 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.92 154.8 43.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.47 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 263' ' ' PHE . 40.4 p90 -130.25 133.69 46.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.93 . . . . 0.0 109.457 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -89.11 160.81 16.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.485 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 1.6 t -136.88 159.23 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 109.422 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 253' ' ' ALA . 3.2 m -123.66 92.54 3.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.547 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' TYR . . . . . 0.578 ' CD2' ' HB3' ' A' ' 328' ' ' ALA . 45.2 m-85 -87.65 150.74 23.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.3 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 251' ' ' VAL . 11.2 p -160.13 148.67 17.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 109.678 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.502 HG11 ' N ' ' A' ' 270' ' ' SER . 89.1 t -129.54 143.03 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -0.879 . . . . 0.0 109.41 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' SER . . . . . 0.502 ' N ' HG11 ' A' ' 269' ' ' VAL . 0.8 OUTLIER -115.57 156.79 25.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.207 -0.933 . . . . 0.0 109.531 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 110.9 -62.85 0.28 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.25 171.38 14.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -1.12 . . . . 0.0 109.427 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 31.3 t -106.13 -26.91 11.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.501 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.64 78.0 6.22 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.578 ' CE3' HG21 ' A' ' 277' ' ' VAL . 6.4 p-90 -128.36 163.23 25.29 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.367 -0.833 . . . . 0.0 109.988 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 34.9 m -113.37 99.76 8.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.578 HG21 ' CE3' ' A' ' 275' ' ' TRP . 41.9 t -79.8 99.09 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.166 -0.959 . . . . 0.0 109.99 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 0.4 OUTLIER -87.14 133.17 33.66 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 302' ' ' ARG . 82.6 mt -116.98 132.61 56.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -0.978 . . . . 0.0 109.698 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -104.67 77.28 1.35 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.254 -0.904 . . . . 0.0 109.109 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.495 ' N ' HD21 ' A' ' 281' ' ' LEU . 4.1 mm? -59.41 131.96 52.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.425 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -86.75 147.38 25.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.28 -0.887 . . . . 0.0 109.514 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 66.08 -148.39 50.87 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 69.4 m -103.7 48.99 0.83 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -1.15 . . . . 0.0 109.461 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.459 ' OE1' HD11 ' A' ' 281' ' ' LEU . 64.4 mt-30 -69.56 150.51 47.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.863 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.431 ' O ' ' HG2' ' A' ' 318' ' ' MET . 23.0 p -139.04 146.96 41.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.459 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.444 ' CD1' HG21 ' A' ' 317' ' ' VAL . 32.0 mm -94.36 136.17 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.277 -0.889 . . . . 0.0 109.469 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.24 11.86 12.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.537 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.445 ' HB1' ' OG1' ' A' ' 316' ' ' THR . . . -168.18 153.51 6.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.94 . . . . 0.0 109.465 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.6 p -165.41 127.97 2.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.48 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.574 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 19.1 p90 -127.61 142.48 51.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.497 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.497 ' HB3' ' CB ' ' A' ' 313' ' ' PHE . 15.8 t-20 69.78 17.68 7.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.407 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.505 ' HB1' ' CB ' ' A' ' 313' ' ' PHE . . . 174.27 151.52 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -110.15 143.65 39.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.425 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 20.9 t -118.72 123.94 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.269 0.556 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 279' ' ' LEU . 7.6 mmt-85 -138.45 160.76 38.71 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.323 -0.861 . . . . 0.0 109.207 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.511 HG23 ' N ' ' A' ' 304' ' ' VAL . 21.1 m -142.85 161.16 38.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.956 . . . . 0.0 109.71 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.511 ' N ' HG23 ' A' ' 303' ' ' THR . 56.1 t -142.0 144.94 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.358 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 21.6 p -137.42 147.77 59.14 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.403 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.71 152.33 29.08 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.547 2.165 . . . . 0.0 110.446 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -113.77 -10.48 13.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.499 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 116.54 57.2 0.32 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 58.5 m -135.16 -59.9 0.77 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -1.174 . . . . 0.0 109.429 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -169.36 -146.04 4.88 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -129.31 13.97 6.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -1.145 . . . . 0.0 109.456 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 2.2 m -122.19 111.99 17.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 313' ' ' PHE . 4.6 p90 -135.37 165.81 24.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.412 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.574 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -128.43 161.25 22.19 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 32.5 m -134.38 158.17 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -1.154 . . . . 0.0 109.49 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' THR . . . . . 0.445 ' OG1' ' HB1' ' A' ' 289' ' ' ALA . 19.0 m -113.23 95.22 5.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.504 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.499 ' CG1' ' CZ ' ' A' ' 263' ' ' PHE . 53.7 t -85.75 147.9 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 286' ' ' THR . 67.0 mmm -106.09 128.13 53.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.507 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' A' ' 322' ' ' SER . 18.0 mmtp -45.22 -68.18 0.22 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 53.13 37.7 25.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 87.28 25.49 33.49 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' SER . . . . . 0.466 ' O ' ' HD2' ' A' ' 319' ' ' LYS . 0.2 OUTLIER -150.73 -178.64 6.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -1.167 . . . . 0.0 109.462 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 324' ' ' THR . 0.0 OUTLIER -164.2 -46.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.415 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' THR . . . . . 0.435 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -41.45 120.91 1.54 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.418 -0.801 . . . . 0.0 109.873 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.535 HG21 ' CE1' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -61.06 165.45 6.24 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.923 . . . . 0.0 109.463 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 325' ' ' THR . 33.6 Cg_endo -77.66 170.94 18.3 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.676 2.251 . . . . 0.0 110.775 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -106.32 119.48 39.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 109.089 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.578 ' HB3' ' CD2' ' A' ' 267' ' ' TYR . . . -93.89 147.99 22.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.204 -0.935 . . . . 0.0 109.946 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 41.1 p -142.11 126.71 17.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.478 -0.764 . . . . 0.0 109.23 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 330' ' ' CYS . 15.6 p -85.38 128.72 34.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.199 -0.938 . . . . 0.0 109.57 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 109.515 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . 0.51 ' N ' ' SG ' ' A' ' 330' ' ' CYS . 11.7 p . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.57 174.74 5.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.432 -0.793 . . . . 0.0 109.88 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . 0.422 ' HA ' HG23 ' A' ' 269' ' ' VAL . 0.8 OUTLIER -129.5 169.57 20.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.359 -179.196 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.0 115.17 5.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.227 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.522 ' HB3' ' CE2' ' A' ' 267' ' ' TYR . . . -126.95 150.88 49.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 109.505 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.95 160.74 16.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.423 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.433 ' HG2' HG22 ' A' ' 325' ' ' THR . 2.6 mtm180 -95.85 136.58 36.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -117.8 -66.57 1.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.497 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -107.77 117.61 34.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.491 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -107.2 136.34 47.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 0.0 109.45 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 2.6 m-90 -120.74 -173.83 2.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.928 . . . . 0.0 109.449 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.8 m -92.66 17.65 9.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.918 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.9 -43.57 0.3 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.436 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.25 158.03 43.35 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.186 -0.946 . . . . 0.0 109.438 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.573 ' CE1' HG21 ' A' ' 325' ' ' THR . 27.9 p90 -123.7 160.62 26.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.432 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -98.25 151.86 20.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -0.873 . . . . 0.0 109.388 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.487 ' CG1' ' CE1' ' A' ' 267' ' ' TYR . 1.7 t -133.99 139.2 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.458 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.99 96.39 6.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.222 -0.924 . . . . 0.0 109.471 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 253' ' ' ALA . 38.4 m-85 -95.74 100.74 12.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.46 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.26 152.34 34.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.662 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.51 HG11 ' N ' ' A' ' 270' ' ' SER . 59.9 t -140.64 142.86 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.352 -0.843 . . . . 0.0 109.495 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' SER . . . . . 0.51 ' N ' HG11 ' A' ' 269' ' ' VAL . 1.8 m -134.84 163.73 29.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 109.526 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' A' ' 272' ' ' SER . . . 104.64 -10.41 49.33 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 271' ' ' GLY . 0.5 OUTLIER 169.37 159.7 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -1.109 . . . . 0.0 109.321 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 48.5 t -105.34 -29.5 10.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.6 77.96 6.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 108.661 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.574 ' CZ3' HG22 ' A' ' 277' ' ' VAL . 10.7 p-90 -128.69 157.1 42.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.41 -0.806 . . . . 0.0 109.934 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 16.0 m -110.61 96.48 6.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.406 -0.809 . . . . 0.0 108.863 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.574 HG22 ' CZ3' ' A' ' 275' ' ' TRP . 40.2 t -79.76 104.15 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.919 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . 0.472 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 5.7 t-20 -93.47 138.96 31.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.369 -0.832 . . . . 0.0 108.783 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 327' ' ' ALA . 34.1 mt -122.61 132.3 54.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.174 -0.954 . . . . 0.0 109.568 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -110.1 83.2 1.72 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 109.271 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.531 ' N ' HD21 ' A' ' 281' ' ' LEU . 4.2 mm? -59.26 139.26 57.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.466 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -83.86 122.71 29.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.405 -0.809 . . . . 0.0 109.422 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 82.91 -149.21 26.49 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 58.8 m -100.47 34.11 2.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -1.104 . . . . 0.0 109.538 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.46 ' O ' HG21 ' A' ' 286' ' ' THR . 85.3 mt-30 -57.13 169.57 0.55 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.932 . . . . 0.0 109.522 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.46 HG21 ' O ' ' A' ' 285' ' ' GLN . 15.8 p -155.81 148.25 23.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.491 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.515 ' CD1' HG23 ' A' ' 317' ' ' VAL . 38.2 mm -83.25 153.46 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 109.398 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . 0.423 ' NE2' ' HE2' ' A' ' 318' ' ' MET . 3.6 tp-100 -118.52 -28.38 5.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.461 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.408 ' C ' ' OG ' ' A' ' 290' ' ' SER . . . -145.46 166.99 24.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.953 . . . . 0.0 109.459 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' SER . . . . . 0.408 ' OG ' ' C ' ' A' ' 289' ' ' ALA . 0.8 OUTLIER -169.99 137.26 1.58 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.567 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 28.0 p90 -136.4 150.62 48.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.476 ' HB3' ' CB ' ' A' ' 313' ' ' PHE . 0.6 OUTLIER 70.48 15.82 7.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 109.451 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.464 ' HB1' ' CB ' ' A' ' 313' ' ' PHE . . . 172.41 157.8 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.47 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -108.27 134.05 51.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.9 . . . . 0.0 109.501 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.427 ' O ' HG21 ' A' ' 296' ' ' THR . 59.9 t -112.75 118.92 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' THR . . . . . 0.427 HG21 ' O ' ' A' ' 295' ' ' VAL . 71.2 p . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.447 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.358 0.599 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 279' ' ' LEU . 18.4 mmt-85 -145.26 162.47 37.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.244 -0.91 . . . . 0.0 109.253 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 7.6 m -140.28 167.63 21.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.711 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.557 HG12 ' CE2' ' A' ' 313' ' ' PHE . 38.6 t -154.23 142.33 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.366 -0.834 . . . . 0.0 109.314 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 62.3 p -145.66 150.36 43.21 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 109.473 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.83 164.44 27.73 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.678 2.252 . . . . 0.0 110.39 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -119.29 -12.16 9.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.868 . . . . 0.0 109.443 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 114.49 42.89 0.79 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.51 -59.24 1.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -1.159 . . . . 0.0 109.467 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -156.8 162.82 31.89 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -90.18 -7.45 53.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -1.138 . . . . 0.0 109.505 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.423 ' O ' ' CG ' ' A' ' 292' ' ' ASN . 32.1 m -100.59 117.4 34.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.463 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.557 ' CE2' HG12 ' A' ' 304' ' ' VAL . 12.5 p90 -135.81 153.31 51.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 0.0 109.518 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.567 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -117.1 152.33 17.85 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.92 148.16 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -1.166 . . . . 0.0 109.503 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' THR . . . . . 0.447 ' O ' HG21 ' A' ' 287' ' ' ILE . 23.9 m -107.43 129.82 54.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.552 ' HB ' ' CZ ' ' A' ' 263' ' ' PHE . 40.3 t -114.88 149.51 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.939 . . . . 0.0 109.481 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' MET . . . . . 0.426 ' O ' ' C ' ' A' ' 319' ' ' LYS . 0.8 OUTLIER -103.68 128.39 51.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 109.399 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 322' ' ' SER . 10.1 mptt -43.79 -66.13 0.42 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.893 . . . . 0.0 109.538 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 319' ' ' LYS . 19.3 m-20 59.42 31.27 20.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.915 . . . . 0.0 109.436 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 111.36 -47.81 1.0 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 319' ' ' LYS . 0.0 OUTLIER -103.71 158.4 16.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.224 -1.163 . . . . 0.0 109.471 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 324' ' ' THR . 65.1 m -122.34 -32.46 3.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.429 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -41.51 119.82 1.32 Allowed 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.355 -0.841 . . . . 0.0 109.967 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.573 HG21 ' CE1' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -56.42 166.22 1.3 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.335 179.587 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . 0.492 ' HB3' ' CD2' ' A' ' 281' ' ' LEU . 32.9 Cg_endo -77.55 157.2 32.36 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.552 2.168 . . . . 0.0 110.721 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 279' ' ' LEU . . . -88.65 165.16 14.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.105 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 278' ' ' ASN . . . -138.18 152.36 48.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.045 -1.034 . . . . 0.0 109.763 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 278' ' ' ASN . 80.4 p -146.4 127.72 14.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.647 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 249' ' ' CYS . 1.6 t -91.1 138.29 31.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.421 -0.799 . . . . 0.0 108.969 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.903 . . . . 0.0 109.504 179.975 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . 0.418 ' C ' ' SG ' ' A' ' 330' ' ' CYS . 6.0 p . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.471 ' O ' HG21 ' A' ' 269' ' ' VAL . 52.6 p -149.06 173.23 13.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.96 . . . . 0.0 109.538 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 268' ' ' SER . 0.9 OUTLIER -135.87 120.19 25.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.528 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.55 118.62 37.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.888 . . . . 0.0 109.453 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.493 ' HB1' ' CE2' ' A' ' 267' ' ' TYR . . . -109.19 101.57 10.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 109.458 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.97 169.04 10.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.868 . . . . 0.0 109.415 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.481 ' NH1' ' CD2' ' A' ' 263' ' ' PHE . 0.0 OUTLIER -98.3 142.67 29.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 109.493 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -110.42 -55.21 2.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 109.413 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . 0.517 ' HB3' ' CZ2' ' A' ' 259' ' ' TRP . 52.1 mm-40 -144.04 144.42 31.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -122.63 122.58 39.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.45 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' TRP . . . . . 0.517 ' CZ2' ' HB3' ' A' ' 257' ' ' GLU . 6.1 m-90 -124.82 -176.64 3.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 73.2 m -93.37 2.11 56.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.914 . . . . 0.0 109.67 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.42 -24.62 7.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.426 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 317' ' ' VAL . 10.1 ptt180 -178.51 166.31 1.79 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.912 . . . . 0.0 109.451 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.576 ' CE2' HG21 ' A' ' 325' ' ' THR . 47.3 p90 -133.37 151.27 51.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.408 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -97.82 150.75 20.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.333 -0.854 . . . . 0.0 109.469 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.88 164.67 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.468 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 253' ' ' ALA . 0.9 OUTLIER -133.52 95.22 3.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' TYR . . . . . 0.565 ' HB2' ' CZ ' ' A' ' 313' ' ' PHE . 44.3 m-85 -91.13 140.85 29.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -0.854 . . . . 0.0 109.317 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 251' ' ' VAL . 0.8 OUTLIER -149.88 157.58 43.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.925 . . . . 0.0 109.602 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 250' ' ' SER . 98.5 t -144.3 145.85 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.202 -0.936 . . . . 0.0 109.46 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' SER . . . . . 0.465 ' N ' HG11 ' A' ' 269' ' ' VAL . 7.6 p -127.76 173.09 10.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.337 -0.852 . . . . 0.0 109.534 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 106.24 -55.11 0.55 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 274' ' ' ALA . 0.3 OUTLIER -154.53 104.79 2.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -1.145 . . . . 0.0 109.367 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 272' ' ' SER . 2.4 t -42.06 -26.74 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 0.0 109.87 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 272' ' ' SER . . . -79.37 78.3 5.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.068 -1.02 . . . . 0.0 108.665 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.572 ' CE3' HG21 ' A' ' 277' ' ' VAL . 7.8 p-90 -128.95 172.78 11.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.286 -0.884 . . . . 0.0 109.855 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.7 m -132.15 102.25 5.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.488 -0.757 . . . . 0.0 108.983 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.572 HG21 ' CE3' ' A' ' 275' ' ' TRP . 12.3 t -79.96 127.45 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.253 -0.905 . . . . 0.0 109.961 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 1.5 t30 -112.46 109.65 19.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.35 -0.844 . . . . 0.0 108.976 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 327' ' ' ALA . 22.2 mt -90.29 140.93 29.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 109.682 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -138.38 93.06 2.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.325 -0.86 . . . . 0.0 109.3 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.45 HD12 ' HB3' ' A' ' 285' ' ' GLN . 24.1 mt -59.83 170.2 1.22 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.94 . . . . 0.0 109.68 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -116.62 85.08 2.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.926 . . . . 0.0 109.439 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 129.52 -145.43 16.4 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.6 4.96 52.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -1.16 . . . . 0.0 109.588 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.45 ' HB3' HD12 ' A' ' 281' ' ' LEU . 57.6 mt-30 -47.06 154.5 0.35 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.458 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 30.8 p -145.61 174.67 10.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 109.532 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 29.2 mt -124.17 152.36 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 109.408 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -141.55 11.96 2.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.181 -0.949 . . . . 0.0 109.699 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -154.3 153.99 32.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.069 -1.019 . . . . 0.0 109.603 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 24.0 p -165.37 126.02 1.9 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.39 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.578 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 22.4 p90 -124.98 138.85 54.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.659 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.518 ' HB3' ' CB ' ' A' ' 313' ' ' PHE . 1.4 t-20 71.98 33.96 1.56 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.885 . . . . 0.0 109.508 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . 172.3 157.76 0.1 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.484 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -104.86 99.08 8.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.487 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 48.0 t -95.48 112.44 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.919 . . . . 0.0 109.469 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.966 . . . . 0.0 109.591 179.945 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -119.35 102.09 8.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.2 -0.938 . . . . 0.0 109.394 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 40.0 m -69.21 149.72 48.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.469 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.452 ' HB ' ' HB ' ' A' ' 277' ' ' VAL . 58.5 t -140.27 139.76 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.447 HG21 ' O ' ' A' ' 304' ' ' VAL . 30.0 p -145.17 155.83 54.56 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.47 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.08 140.63 18.03 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.626 2.217 . . . . 0.0 110.479 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -120.44 26.08 9.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 74.43 55.43 5.58 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.14 -60.4 0.77 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -1.133 . . . . 0.0 109.467 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -162.24 -179.77 37.07 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -103.15 -2.68 26.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -1.107 . . . . 0.0 109.571 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.45 ' O ' ' ND2' ' A' ' 292' ' ' ASN . 40.9 m -113.77 162.06 16.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 109.539 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.565 ' CZ ' ' HB2' ' A' ' 267' ' ' TYR . 3.0 p90 -176.99 155.65 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.381 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.578 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -125.54 166.84 18.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 16.9 m -136.89 167.45 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -1.155 . . . . 0.0 109.515 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 89.1 m -117.52 108.55 15.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.883 . . . . 0.0 109.483 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.57 ' HB ' ' CZ ' ' A' ' 263' ' ' PHE . 40.4 t -100.91 149.95 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.879 . . . . 0.0 109.347 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 7.2 mtp -99.84 135.19 41.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.92 . . . . 0.0 109.501 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 320' ' ' ASN . 17.9 mmtp -46.92 -69.4 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.533 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 319' ' ' LYS . 24.9 m-20 61.27 24.64 14.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.467 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 97.13 -28.27 14.7 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.79 148.57 25.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -1.121 . . . . 0.0 109.495 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 324' ' ' THR . 23.3 t -123.27 -37.19 2.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 109.456 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -41.89 117.51 0.96 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.472 -0.768 . . . . 0.0 109.826 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.576 HG21 ' CE2' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -52.86 164.35 0.7 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.92 . . . . 0.0 109.416 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . 0.466 ' HG2' ' OH ' ' A' ' 267' ' ' TYR . 33.3 Cg_endo -77.78 166.39 25.41 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.673 2.249 . . . . 0.0 110.69 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 279' ' ' LEU . . . -92.72 170.52 9.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.839 . . . . 0.0 109.135 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 278' ' ' ASN . . . -147.78 149.0 31.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.136 -0.978 . . . . 0.0 110.011 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' THR . . . . . 0.462 ' OG1' ' HB3' ' A' ' 278' ' ' ASN . 40.2 p -140.17 128.0 21.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 109.352 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . 0.418 ' SG ' ' C ' ' A' ' 249' ' ' CYS . 16.6 p -82.43 171.63 13.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 109.517 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.455 179.934 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 22.5 p . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.461 ' O ' HG21 ' A' ' 269' ' ' VAL . 60.5 p -151.06 174.59 13.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.933 . . . . 0.0 109.6 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . 0.457 HG12 HG23 ' A' ' 277' ' ' VAL . 0.8 OUTLIER -132.17 171.49 17.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.462 -0.774 . . . . 0.0 109.608 -179.168 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.98 119.24 3.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.349 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.568 ' HB3' ' CE1' ' A' ' 267' ' ' TYR . . . -111.56 149.16 31.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 109.491 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 23.8 m -151.07 130.37 12.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.481 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.414 ' HG2' HG22 ' A' ' 325' ' ' THR . 2.7 mtm-85 -77.88 137.95 38.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.446 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -107.49 -69.14 0.86 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.449 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -107.71 136.09 48.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.504 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -111.2 129.25 56.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.411 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -124.7 172.31 9.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 109.453 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 57.2 m -88.99 4.34 48.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.895 . . . . 0.0 109.63 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -119.09 -26.5 5.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.169 -0.957 . . . . 0.0 109.48 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 317' ' ' VAL . 16.0 ptt180 -173.41 162.42 4.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.45 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.576 ' CE1' HG21 ' A' ' 325' ' ' THR . 34.0 p90 -124.75 144.75 50.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.886 . . . . 0.0 109.508 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -85.47 157.93 20.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.44 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . 0.525 ' CG1' ' CE2' ' A' ' 267' ' ' TYR . 1.9 t -136.12 152.23 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 0.0 109.505 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 253' ' ' ALA . 10.1 m -126.78 91.26 3.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.428 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' TYR . . . . . 0.568 ' CE1' ' HB3' ' A' ' 253' ' ' ALA . 58.8 m-85 -91.34 144.29 25.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.404 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.447 ' O ' HG11 ' A' ' 251' ' ' VAL . 24.9 p -159.93 158.26 30.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.211 -0.93 . . . . 0.0 109.585 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.514 HG11 ' N ' ' A' ' 270' ' ' SER . 74.2 t -134.87 141.47 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.302 -0.873 . . . . 0.0 109.394 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' SER . . . . . 0.514 ' N ' HG11 ' A' ' 269' ' ' VAL . 7.1 t -115.69 138.29 51.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 272' ' ' SER . . . 123.74 -15.63 7.94 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 271' ' ' GLY . 0.2 OUTLIER 167.73 165.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -1.197 . . . . 0.0 109.432 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 84.0 p -104.46 -24.46 13.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 109.519 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.75 77.43 6.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 108.744 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.574 ' CZ3' HG22 ' A' ' 277' ' ' VAL . 9.8 p-90 -130.33 158.26 40.3 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.362 -0.836 . . . . 0.0 109.786 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.3 m -111.1 95.66 5.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.095 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.574 HG22 ' CZ3' ' A' ' 275' ' ' TRP . 42.4 t -80.08 128.99 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.915 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 30.0 m-20 -107.55 130.74 54.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.856 . . . . 0.0 108.886 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.426 HD13 HG23 ' A' ' 304' ' ' VAL . 60.8 mt -118.94 126.45 51.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 0.0 109.578 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -110.47 82.56 1.61 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.298 -0.876 . . . . 0.0 109.497 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.519 HD13 ' CG1' ' A' ' 317' ' ' VAL . 4.3 mm? -59.75 145.23 45.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.984 . . . . 0.0 109.414 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.454 ' O ' ' HG3' ' A' ' 285' ' ' GLN . 2.3 m-80 -96.04 170.39 9.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.215 -0.928 . . . . 0.0 109.525 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 282' ' ' ASN . . . 45.34 -151.41 0.96 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 2.8 p -101.61 48.32 0.89 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -1.189 . . . . 0.0 109.466 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.46 ' OE1' HD11 ' A' ' 281' ' ' LEU . 64.8 mt-30 -68.81 164.06 22.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.455 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.412 HG21 ' O ' ' A' ' 285' ' ' GLN . 21.0 p -150.35 145.33 26.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 109.461 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.516 ' CD1' HG21 ' A' ' 317' ' ' VAL . 33.2 mm -88.69 135.64 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 109.423 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . 0.497 ' OE1' ' CG ' ' A' ' 318' ' ' MET . 0.6 OUTLIER -112.14 -18.45 12.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -143.15 157.24 44.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 109.477 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 314' ' ' GLY . 1.7 p -168.6 134.81 1.84 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.473 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.525 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 34.8 p90 -144.2 155.01 43.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.521 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.47 ' CB ' ' HA ' ' A' ' 313' ' ' PHE . 0.4 OUTLIER 72.66 6.5 5.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.589 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.517 ' HB2' ' CB ' ' A' ' 313' ' ' PHE . . . 177.69 170.19 0.65 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.518 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.455 ' O ' HG11 ' A' ' 304' ' ' VAL . 38.7 m-80 -117.87 166.25 12.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.898 . . . . 0.0 109.505 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 86.1 t -138.93 116.51 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.459 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' THR . . . . . 0.466 ' O ' ' HG2' ' A' ' 302' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.27 0.557 . . . . 0.0 109.526 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 301' ' ' THR . 0.1 OUTLIER -155.7 84.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.358 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.1 m -63.18 169.28 3.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.357 -0.84 . . . . 0.0 109.809 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.455 HG11 ' O ' ' A' ' 294' ' ' ASN . 54.9 t -155.62 130.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 109.368 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 10.1 p -132.0 150.41 76.03 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.166 -0.959 . . . . 0.0 109.499 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.92 -174.03 2.06 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.584 2.19 . . . . 0.0 110.41 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -149.45 18.73 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 79.24 51.05 5.48 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.4 t -135.02 -85.2 0.4 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -1.129 . . . . 0.0 109.427 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -126.78 175.34 17.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . 0.481 ' N ' ' ND2' ' A' ' 311' ' ' ASN . 0.8 OUTLIER -108.18 -1.2 20.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -1.134 . . . . 0.0 109.612 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.469 ' O ' ' CB ' ' A' ' 292' ' ' ASN . 30.2 m -116.9 107.29 14.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.17 -0.957 . . . . 0.0 109.428 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.517 ' CB ' ' HB2' ' A' ' 293' ' ' ALA . 39.0 p90 -117.47 149.08 41.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.525 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -112.96 160.15 13.28 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.441 ' O ' HG21 ' A' ' 315' ' ' VAL . 11.2 m -143.19 146.28 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -1.152 . . . . 0.0 109.453 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 54.5 m -103.8 102.59 12.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.527 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.576 ' HB ' ' CZ ' ' A' ' 263' ' ' PHE . 60.6 t -90.4 132.72 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.482 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' MET . . . . . 0.497 ' CG ' ' OE1' ' A' ' 288' ' ' GLN . 28.1 mmm -87.45 143.75 27.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.577 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -57.11 -76.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.497 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 54.15 23.88 4.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.25 -0.906 . . . . 0.0 109.446 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 101.83 32.61 4.99 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 13.2 t -158.02 117.45 3.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -1.116 . . . . 0.0 109.432 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.13 3.39 17.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.579 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' THR . . . . . . . . . . . . . 1.2 m -98.53 128.08 44.72 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.137 -0.977 . . . . 0.0 108.927 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.576 HG21 ' CE1' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -59.45 165.66 3.82 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.89 . . . . 0.0 109.528 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 325' ' ' THR . 34.1 Cg_endo -77.43 171.56 17.42 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.643 2.228 . . . . 0.0 110.675 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -103.82 132.56 49.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -0.898 . . . . 0.0 109.289 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.54 ' HB3' ' CD1' ' A' ' 267' ' ' TYR . . . -107.12 148.72 28.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.655 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 278' ' ' ASN . 52.7 p -149.18 125.86 11.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.35 -0.843 . . . . 0.0 109.465 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 40.6 t -88.12 130.32 35.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -0.927 . . . . 0.0 109.492 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.522 179.964 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 30.1 p . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.69 175.67 9.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.591 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 268' ' ' SER . 0.8 OUTLIER -130.47 107.66 14.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.401 -0.812 . . . . 0.0 109.588 -179.177 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 34.2 p -96.86 112.37 24.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.378 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.575 ' HB3' ' CE2' ' A' ' 267' ' ' TYR . . . -95.6 140.43 30.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.601 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 23.5 m -130.32 149.67 51.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 109.377 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.05 122.89 29.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.927 . . . . 0.0 109.491 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -103.42 -148.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.7 132.43 14.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 109.412 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -107.94 157.15 18.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.607 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' TRP . . . . . 0.456 ' HB2' ' O ' ' A' ' 262' ' ' ARG . 5.1 m-90 -136.25 -170.13 2.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 54.3 m -103.1 -9.54 19.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 109.484 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 262' ' ' ARG . 13.1 p-10 -133.75 17.25 3.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.435 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' ARG . . . . . 0.524 ' N ' ' HG2' ' A' ' 319' ' ' LYS . 0.4 OUTLIER 175.95 166.44 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -0.952 . . . . 0.0 109.492 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' PHE . . . . . 0.633 ' CZ ' ' CG1' ' A' ' 317' ' ' VAL . 55.0 p90 -148.66 136.2 20.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -87.24 155.06 20.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.495 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 1.8 t -137.8 137.51 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 19.8 m -105.91 91.69 3.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.457 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' TYR . . . . . 0.575 ' CE2' ' HB3' ' A' ' 253' ' ' ALA . 27.2 m-85 -80.58 136.05 36.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.463 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 251' ' ' VAL . 2.7 t -131.59 159.49 38.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.908 . . . . 0.0 109.541 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' VAL . . . . . 0.434 HG21 ' C ' ' A' ' 268' ' ' SER . 96.0 t -152.44 97.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 0.0 109.495 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.61 -168.29 2.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.342 -0.849 . . . . 0.0 109.533 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 88.09 -41.71 3.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 57.5 p -173.11 170.54 4.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.277 -1.131 . . . . 0.0 109.359 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.17 -34.0 7.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.396 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.76 77.45 6.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.954 . . . . 0.0 108.638 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.576 ' CE3' HG22 ' A' ' 277' ' ' VAL . 17.2 p-90 -127.46 153.53 46.18 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.326 -0.859 . . . . 0.0 109.797 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 87.2 m -113.96 95.19 5.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.116 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' VAL . . . . . 0.576 HG22 ' CE3' ' A' ' 275' ' ' TRP . 48.4 t -107.56 149.53 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.621 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ASN . . . . . 0.515 ' N ' HG11 ' A' ' 277' ' ' VAL . 3.7 m-20 -127.46 132.87 49.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -0.878 . . . . 0.0 109.404 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.575 HD22 ' CE2' ' A' ' 267' ' ' TYR . 7.1 mt -85.05 155.95 21.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.479 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 327' ' ' ALA . . . -137.07 84.43 2.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.618 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.463 HD11 ' O ' ' A' ' 285' ' ' GLN . 19.0 mt -59.99 172.41 0.78 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.456 ' O ' ' C ' ' A' ' 283' ' ' GLY . 12.1 m-80 -86.84 59.45 5.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 109.772 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 282' ' ' ASN . . . 37.7 43.0 1.12 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 285' ' ' GLN . 73.7 m -158.94 -87.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.1 -1.235 . . . . 0.0 109.63 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' GLN . . . . . 0.518 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . 0.0 OUTLIER -43.13 140.81 1.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.2 p -115.97 179.7 3.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 109.513 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ILE . . . . . 0.452 HD13 ' HB ' ' A' ' 315' ' ' VAL . 18.1 mm -102.3 149.36 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.23 -33.86 3.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.188 -0.945 . . . . 0.0 109.469 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -151.48 169.21 22.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.488 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -160.16 140.56 11.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.394 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' TRP . . . . . 0.565 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 31.2 p90 -136.58 148.57 47.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.943 . . . . 0.0 109.507 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 291' ' ' TRP . 0.7 OUTLIER 73.77 7.71 4.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.494 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ALA . . . . . 0.507 ' HB1' ' CB ' ' A' ' 313' ' ' PHE . . . 176.96 149.85 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.456 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -106.77 136.38 46.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.453 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 303' ' ' THR . 17.5 t -115.15 136.43 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.458 -179.995 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' ARG . . . . . 0.418 ' HB3' ' CG1' ' A' ' 295' ' ' VAL . 0.0 OUTLIER -146.67 141.3 26.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.449 ' O ' HG21 ' A' ' 304' ' ' VAL . 1.7 m -92.61 169.13 10.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 277' ' ' VAL . 61.9 t -155.95 122.24 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.49 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 52.9 p -130.66 155.39 81.32 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.99 146.13 22.81 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.67 2.247 . . . . 0.0 110.437 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -112.7 -10.25 13.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 119.29 29.6 1.73 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.8 -30.35 6.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -1.146 . . . . 0.0 109.414 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 151.79 -156.55 26.75 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 311' ' ' ASN . 0.8 OUTLIER -117.17 8.27 13.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.225 -1.162 . . . . 0.0 109.573 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 11.1 m -109.61 96.57 6.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.408 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.507 ' CB ' ' HB1' ' A' ' 293' ' ' ALA . 47.3 p90 -117.66 144.33 45.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' GLY . . . . . 0.565 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -109.77 168.35 13.15 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.452 ' HB ' HD13 ' A' ' 287' ' ' ILE . 5.5 m -141.96 144.01 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -1.114 . . . . 0.0 109.452 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 7.5 m -94.06 92.54 7.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 109.494 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' VAL . . . . . 0.633 ' CG1' ' CZ ' ' A' ' 263' ' ' PHE . 16.4 t -83.63 153.43 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.456 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' MET . . . . . 0.425 ' O ' ' CG ' ' A' ' 285' ' ' GLN . 29.6 mtp -113.43 144.42 42.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.541 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' LYS . . . . . 0.524 ' HG2' ' N ' ' A' ' 262' ' ' ARG . 21.9 mmtp -65.95 -73.68 0.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 0.0 109.473 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 319' ' ' LYS . 4.3 m-20 63.16 24.02 14.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.332 -0.855 . . . . 0.0 109.408 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 99.56 37.95 3.84 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' SER . . . . . 0.458 ' O ' ' HD2' ' A' ' 319' ' ' LYS . 0.3 OUTLIER -159.76 -157.42 0.57 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -1.188 . . . . 0.0 109.467 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 324' ' ' THR . 0.0 OUTLIER 179.89 -47.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 109.438 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -40.16 125.08 1.97 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.599 -0.688 . . . . 0.0 110.102 -179.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.493 HG21 ' CE2' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -64.46 167.0 9.51 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.381 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 325' ' ' THR . 33.2 Cg_endo -76.26 163.37 32.66 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.522 2.148 . . . . 0.0 110.614 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' ALA . . . . . 0.458 ' O ' ' HB1' ' A' ' 280' ' ' ALA . . . -110.98 115.15 29.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 0.0 109.376 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' ALA . . . . . 0.454 ' HB1' ' CE2' ' A' ' 267' ' ' TYR . . . -103.61 163.56 12.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.494 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' THR . . . . . 0.418 ' C ' HG12 ' A' ' 277' ' ' VAL . 35.8 p -149.49 127.17 11.68 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.303 -0.873 . . . . 0.0 109.367 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' CYS . . . . . 0.485 ' HA ' ' CG2' ' A' ' 277' ' ' VAL . 42.8 t -86.43 125.4 33.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.356 -0.84 . . . . 0.0 109.505 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.41 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 83.48 148.12 8.01 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.418 ' C ' ' SG ' ' A' ' 330' ' ' CYS . 3.5 p -117.66 171.35 8.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -1.128 . . . . 0.0 109.359 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.53 173.73 11.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.658 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 268' ' ' SER . 0.9 OUTLIER -136.55 134.36 49.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.444 -179.16 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.1 OUTLIER -116.59 134.51 54.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 109.505 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.497 ' HB1' ' CE2' ' A' ' 267' ' ' TYR . . . -124.89 106.89 10.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.526 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.5 m -103.59 135.33 45.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.462 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -69.8 111.51 5.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.87 . . . . 0.0 109.469 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -82.75 -74.43 0.35 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.451 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . 0.479 ' HB3' ' CH2' ' A' ' 259' ' ' TRP . 3.1 mm-40 -106.62 138.06 43.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.436 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -125.16 128.73 48.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 109.502 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . 0.479 ' CH2' ' HB3' ' A' ' 257' ' ' GLU . 8.9 m-90 -120.01 -178.69 3.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.216 -0.928 . . . . 0.0 109.463 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 m -91.96 9.74 31.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.453 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.22 -39.26 0.93 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.431 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.92 154.8 43.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.47 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 263' ' ' PHE . 40.4 p90 -130.25 133.69 46.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.93 . . . . 0.0 109.457 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -89.11 160.81 16.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.485 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 1.6 t -136.88 159.23 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 109.422 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 253' ' ' ALA . 3.2 m -123.66 92.54 3.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.547 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' TYR . . . . . 0.578 ' CD2' ' HB3' ' A' ' 328' ' ' ALA . 45.2 m-85 -87.65 150.74 23.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.3 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 251' ' ' VAL . 11.2 p -160.13 148.67 17.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 109.678 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.502 HG11 ' N ' ' A' ' 270' ' ' SER . 89.1 t -129.54 143.03 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -0.879 . . . . 0.0 109.41 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.502 ' N ' HG11 ' A' ' 269' ' ' VAL . 0.8 OUTLIER -115.57 156.79 25.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.207 -0.933 . . . . 0.0 109.531 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 110.9 -62.85 0.28 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.25 171.38 14.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -1.12 . . . . 0.0 109.427 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 31.3 t -106.13 -26.91 11.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.501 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.64 78.0 6.22 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.578 ' CE3' HG21 ' A' ' 277' ' ' VAL . 6.4 p-90 -128.36 163.23 25.29 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.367 -0.833 . . . . 0.0 109.988 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 34.9 m -113.37 99.76 8.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.578 HG21 ' CE3' ' A' ' 275' ' ' TRP . 41.9 t -79.8 99.09 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.166 -0.959 . . . . 0.0 109.99 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 0.4 OUTLIER -87.14 133.17 33.66 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 302' ' ' ARG . 82.6 mt -116.98 132.61 56.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -0.978 . . . . 0.0 109.698 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -104.67 77.28 1.35 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.254 -0.904 . . . . 0.0 109.109 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.495 ' N ' HD21 ' A' ' 281' ' ' LEU . 4.1 mm? -59.41 131.96 52.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.425 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -86.75 147.38 25.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.28 -0.887 . . . . 0.0 109.514 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 66.08 -148.39 50.87 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 69.4 m -103.7 48.99 0.83 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -1.15 . . . . 0.0 109.461 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.459 ' OE1' HD11 ' A' ' 281' ' ' LEU . 64.4 mt-30 -69.56 150.51 47.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.863 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.431 ' O ' ' HG2' ' A' ' 318' ' ' MET . 23.0 p -139.04 146.96 41.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.459 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.444 ' CD1' HG21 ' A' ' 317' ' ' VAL . 32.0 mm -94.36 136.17 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.277 -0.889 . . . . 0.0 109.469 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.24 11.86 12.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.537 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.445 ' HB1' ' OG1' ' A' ' 316' ' ' THR . . . -168.18 153.51 6.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.94 . . . . 0.0 109.465 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.6 p -165.41 127.97 2.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.48 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.574 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 19.1 p90 -127.61 142.48 51.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.497 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.497 ' HB3' ' CB ' ' A' ' 313' ' ' PHE . 15.8 t-20 69.78 17.68 7.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.407 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.505 ' HB1' ' CB ' ' A' ' 313' ' ' PHE . . . 174.27 151.52 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -110.15 143.65 39.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.425 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 20.9 t -118.72 123.94 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.9 -170.15 3.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 110.63 137.44 7.51 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.17 166.14 10.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -1.123 . . . . 0.0 109.505 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 106.4 -166.07 13.73 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 1.6 m -88.15 -16.31 33.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.202 -1.175 . . . . 0.0 109.489 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.43 171.99 8.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.928 . . . . 0.0 109.521 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 279' ' ' LEU . 7.6 mmt-85 -138.45 160.76 38.71 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.323 -0.861 . . . . 0.0 109.207 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.511 HG23 ' N ' ' A' ' 304' ' ' VAL . 21.1 m -142.85 161.16 38.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.956 . . . . 0.0 109.71 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.511 ' N ' HG23 ' A' ' 303' ' ' THR . 56.1 t -142.0 144.94 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.358 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 21.6 p -137.42 147.77 59.14 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.403 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.71 152.33 29.08 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.547 2.165 . . . . 0.0 110.446 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -113.77 -10.48 13.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.499 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 116.54 57.2 0.32 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 58.5 m -135.16 -59.9 0.77 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -1.174 . . . . 0.0 109.429 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -169.36 -146.04 4.88 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -129.31 13.97 6.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -1.145 . . . . 0.0 109.456 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 2.2 m -122.19 111.99 17.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 313' ' ' PHE . 4.6 p90 -135.37 165.81 24.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.412 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.574 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -128.43 161.25 22.19 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 32.5 m -134.38 158.17 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -1.154 . . . . 0.0 109.49 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' THR . . . . . 0.445 ' OG1' ' HB1' ' A' ' 289' ' ' ALA . 19.0 m -113.23 95.22 5.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.504 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.499 ' CG1' ' CZ ' ' A' ' 263' ' ' PHE . 53.7 t -85.75 147.9 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 286' ' ' THR . 67.0 mmm -106.09 128.13 53.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.507 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' A' ' 322' ' ' SER . 18.0 mmtp -45.22 -68.18 0.22 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 53.13 37.7 25.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 87.28 25.49 33.49 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' SER . . . . . 0.466 ' O ' ' HD2' ' A' ' 319' ' ' LYS . 0.2 OUTLIER -150.73 -178.64 6.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -1.167 . . . . 0.0 109.462 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 324' ' ' THR . 0.0 OUTLIER -164.2 -46.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.415 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' THR . . . . . 0.435 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -41.45 120.91 1.54 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.418 -0.801 . . . . 0.0 109.873 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.535 HG21 ' CE1' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -61.06 165.45 6.24 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.923 . . . . 0.0 109.463 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 325' ' ' THR . 33.6 Cg_endo -77.66 170.94 18.3 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.676 2.251 . . . . 0.0 110.775 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -106.32 119.48 39.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 109.089 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.578 ' HB3' ' CD2' ' A' ' 267' ' ' TYR . . . -93.89 147.99 22.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.204 -0.935 . . . . 0.0 109.946 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 41.1 p -142.11 126.71 17.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.478 -0.764 . . . . 0.0 109.23 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 330' ' ' CYS . 15.6 p -85.38 128.72 34.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.199 -0.938 . . . . 0.0 109.57 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -143.66 132.03 22.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 109.515 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 119.54 39.89 0.64 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 81.1 p . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.28 -1.13 . . . . 0.0 109.479 179.995 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -108.89 -109.45 3.29 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.51 ' N ' ' SG ' ' A' ' 330' ' ' CYS . 11.7 p -173.18 178.63 2.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -1.123 . . . . 0.0 109.514 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.57 174.74 5.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.432 -0.793 . . . . 0.0 109.88 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.422 ' HA ' HG23 ' A' ' 269' ' ' VAL . 0.8 OUTLIER -129.5 169.57 20.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.359 -179.196 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.0 115.17 5.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.227 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.522 ' HB3' ' CE2' ' A' ' 267' ' ' TYR . . . -126.95 150.88 49.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 109.505 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.95 160.74 16.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.423 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.433 ' HG2' HG22 ' A' ' 325' ' ' THR . 2.6 mtm180 -95.85 136.58 36.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -117.8 -66.57 1.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.497 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -107.77 117.61 34.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.491 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -107.2 136.34 47.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 0.0 109.45 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 2.6 m-90 -120.74 -173.83 2.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.928 . . . . 0.0 109.449 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.8 m -92.66 17.65 9.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.918 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.9 -43.57 0.3 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.436 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.25 158.03 43.35 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.186 -0.946 . . . . 0.0 109.438 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.573 ' CE1' HG21 ' A' ' 325' ' ' THR . 27.9 p90 -123.7 160.62 26.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.432 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -98.25 151.86 20.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -0.873 . . . . 0.0 109.388 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.487 ' CG1' ' CE1' ' A' ' 267' ' ' TYR . 1.7 t -133.99 139.2 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.458 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.99 96.39 6.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.222 -0.924 . . . . 0.0 109.471 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 253' ' ' ALA . 38.4 m-85 -95.74 100.74 12.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.46 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.26 152.34 34.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.662 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.51 HG11 ' N ' ' A' ' 270' ' ' SER . 59.9 t -140.64 142.86 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.352 -0.843 . . . . 0.0 109.495 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.51 ' N ' HG11 ' A' ' 269' ' ' VAL . 1.8 m -134.84 163.73 29.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 109.526 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' A' ' 272' ' ' SER . . . 104.64 -10.41 49.33 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 271' ' ' GLY . 0.5 OUTLIER 169.37 159.7 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -1.109 . . . . 0.0 109.321 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 48.5 t -105.34 -29.5 10.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.6 77.96 6.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 108.661 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.574 ' CZ3' HG22 ' A' ' 277' ' ' VAL . 10.7 p-90 -128.69 157.1 42.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.41 -0.806 . . . . 0.0 109.934 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 16.0 m -110.61 96.48 6.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.406 -0.809 . . . . 0.0 108.863 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.574 HG22 ' CZ3' ' A' ' 275' ' ' TRP . 40.2 t -79.76 104.15 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.919 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . 0.472 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 5.7 t-20 -93.47 138.96 31.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.369 -0.832 . . . . 0.0 108.783 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 327' ' ' ALA . 34.1 mt -122.61 132.3 54.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.174 -0.954 . . . . 0.0 109.568 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -110.1 83.2 1.72 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 109.271 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.531 ' N ' HD21 ' A' ' 281' ' ' LEU . 4.2 mm? -59.26 139.26 57.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.466 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -83.86 122.71 29.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.405 -0.809 . . . . 0.0 109.422 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 82.91 -149.21 26.49 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 58.8 m -100.47 34.11 2.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -1.104 . . . . 0.0 109.538 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.46 ' O ' HG21 ' A' ' 286' ' ' THR . 85.3 mt-30 -57.13 169.57 0.55 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.932 . . . . 0.0 109.522 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.46 HG21 ' O ' ' A' ' 285' ' ' GLN . 15.8 p -155.81 148.25 23.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.491 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.515 ' CD1' HG23 ' A' ' 317' ' ' VAL . 38.2 mm -83.25 153.46 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 109.398 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.423 ' NE2' ' HE2' ' A' ' 318' ' ' MET . 3.6 tp-100 -118.52 -28.38 5.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.461 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.408 ' C ' ' OG ' ' A' ' 290' ' ' SER . . . -145.46 166.99 24.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.953 . . . . 0.0 109.459 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' SER . . . . . 0.408 ' OG ' ' C ' ' A' ' 289' ' ' ALA . 0.8 OUTLIER -169.99 137.26 1.58 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.567 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 28.0 p90 -136.4 150.62 48.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.476 ' HB3' ' CB ' ' A' ' 313' ' ' PHE . 0.6 OUTLIER 70.48 15.82 7.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 109.451 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.464 ' HB1' ' CB ' ' A' ' 313' ' ' PHE . . . 172.41 157.8 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.47 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -108.27 134.05 51.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.9 . . . . 0.0 109.501 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.427 ' O ' HG21 ' A' ' 296' ' ' THR . 59.9 t -112.75 118.92 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.427 HG21 ' O ' ' A' ' 295' ' ' VAL . 71.2 p -150.76 173.86 13.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.447 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 151.47 -132.05 3.69 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 301' ' ' THR . 32.7 p -148.97 -173.22 4.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -1.183 . . . . 0.0 109.497 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 300' ' ' SER . . . -74.55 162.66 54.14 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 299' ' ' GLY . 4.2 t 83.13 -44.15 0.11 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.65 -0.912 . . . . 0.0 109.764 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.425 ' O ' ' O ' ' A' ' 298' ' ' SER . 0.8 OUTLIER -139.8 172.2 13.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.184 -0.948 . . . . 0.0 109.385 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 279' ' ' LEU . 18.4 mmt-85 -145.26 162.47 37.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.244 -0.91 . . . . 0.0 109.253 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 7.6 m -140.28 167.63 21.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.711 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.557 HG12 ' CE2' ' A' ' 313' ' ' PHE . 38.6 t -154.23 142.33 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.366 -0.834 . . . . 0.0 109.314 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 62.3 p -145.66 150.36 43.21 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 109.473 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.83 164.44 27.73 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.678 2.252 . . . . 0.0 110.39 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -119.29 -12.16 9.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.868 . . . . 0.0 109.443 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 114.49 42.89 0.79 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.51 -59.24 1.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -1.159 . . . . 0.0 109.467 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -156.8 162.82 31.89 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -90.18 -7.45 53.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -1.138 . . . . 0.0 109.505 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.423 ' O ' ' CG ' ' A' ' 292' ' ' ASN . 32.1 m -100.59 117.4 34.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.463 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.557 ' CE2' HG12 ' A' ' 304' ' ' VAL . 12.5 p90 -135.81 153.31 51.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 0.0 109.518 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.567 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -117.1 152.33 17.85 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.92 148.16 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -1.166 . . . . 0.0 109.503 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' THR . . . . . 0.447 ' O ' HG21 ' A' ' 287' ' ' ILE . 23.9 m -107.43 129.82 54.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.552 ' HB ' ' CZ ' ' A' ' 263' ' ' PHE . 40.3 t -114.88 149.51 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.939 . . . . 0.0 109.481 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' MET . . . . . 0.426 ' O ' ' C ' ' A' ' 319' ' ' LYS . 0.8 OUTLIER -103.68 128.39 51.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 109.399 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 322' ' ' SER . 10.1 mptt -43.79 -66.13 0.42 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.893 . . . . 0.0 109.538 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 319' ' ' LYS . 19.3 m-20 59.42 31.27 20.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.915 . . . . 0.0 109.436 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 111.36 -47.81 1.0 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 319' ' ' LYS . 0.0 OUTLIER -103.71 158.4 16.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.224 -1.163 . . . . 0.0 109.471 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 324' ' ' THR . 65.1 m -122.34 -32.46 3.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.429 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -41.51 119.82 1.32 Allowed 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.355 -0.841 . . . . 0.0 109.967 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.573 HG21 ' CE1' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -56.42 166.22 1.3 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.335 179.587 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . 0.492 ' HB3' ' CD2' ' A' ' 281' ' ' LEU . 32.9 Cg_endo -77.55 157.2 32.36 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.552 2.168 . . . . 0.0 110.721 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 279' ' ' LEU . . . -88.65 165.16 14.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.105 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 278' ' ' ASN . . . -138.18 152.36 48.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.045 -1.034 . . . . 0.0 109.763 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 278' ' ' ASN . 80.4 p -146.4 127.72 14.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.647 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 249' ' ' CYS . 1.6 t -91.1 138.29 31.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.421 -0.799 . . . . 0.0 108.969 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -133.99 152.18 51.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.903 . . . . 0.0 109.504 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -147.07 -175.23 19.8 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.289 -1.124 . . . . 0.0 109.465 -179.928 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -142.65 126.04 2.78 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.418 ' C ' ' SG ' ' A' ' 330' ' ' CYS . 6.0 p -124.43 169.95 11.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.237 -1.155 . . . . 0.0 109.321 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.471 ' O ' HG21 ' A' ' 269' ' ' VAL . 52.6 p -149.06 173.23 13.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.96 . . . . 0.0 109.538 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 268' ' ' SER . 0.9 OUTLIER -135.87 120.19 25.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.528 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.55 118.62 37.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.888 . . . . 0.0 109.453 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.493 ' HB1' ' CE2' ' A' ' 267' ' ' TYR . . . -109.19 101.57 10.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 109.458 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.97 169.04 10.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.868 . . . . 0.0 109.415 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.481 ' NH1' ' CD2' ' A' ' 263' ' ' PHE . 0.0 OUTLIER -98.3 142.67 29.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 109.493 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -110.42 -55.21 2.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 109.413 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . 0.517 ' HB3' ' CZ2' ' A' ' 259' ' ' TRP . 52.1 mm-40 -144.04 144.42 31.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -122.63 122.58 39.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.45 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . 0.517 ' CZ2' ' HB3' ' A' ' 257' ' ' GLU . 6.1 m-90 -124.82 -176.64 3.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 73.2 m -93.37 2.11 56.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.914 . . . . 0.0 109.67 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.42 -24.62 7.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.426 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . 0.459 ' HB2' ' O ' ' A' ' 317' ' ' VAL . 10.1 ptt180 -178.51 166.31 1.79 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.912 . . . . 0.0 109.451 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.576 ' CE2' HG21 ' A' ' 325' ' ' THR . 47.3 p90 -133.37 151.27 51.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.408 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -97.82 150.75 20.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.333 -0.854 . . . . 0.0 109.469 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.88 164.67 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.468 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 253' ' ' ALA . 0.9 OUTLIER -133.52 95.22 3.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' TYR . . . . . 0.565 ' HB2' ' CZ ' ' A' ' 313' ' ' PHE . 44.3 m-85 -91.13 140.85 29.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -0.854 . . . . 0.0 109.317 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' A' ' 251' ' ' VAL . 0.8 OUTLIER -149.88 157.58 43.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.925 . . . . 0.0 109.602 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 250' ' ' SER . 98.5 t -144.3 145.85 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.202 -0.936 . . . . 0.0 109.46 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.465 ' N ' HG11 ' A' ' 269' ' ' VAL . 7.6 p -127.76 173.09 10.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.337 -0.852 . . . . 0.0 109.534 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 106.24 -55.11 0.55 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 274' ' ' ALA . 0.3 OUTLIER -154.53 104.79 2.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -1.145 . . . . 0.0 109.367 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 272' ' ' SER . 2.4 t -42.06 -26.74 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 0.0 109.87 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 272' ' ' SER . . . -79.37 78.3 5.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.068 -1.02 . . . . 0.0 108.665 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.572 ' CE3' HG21 ' A' ' 277' ' ' VAL . 7.8 p-90 -128.95 172.78 11.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.286 -0.884 . . . . 0.0 109.855 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.7 m -132.15 102.25 5.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.488 -0.757 . . . . 0.0 108.983 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.572 HG21 ' CE3' ' A' ' 275' ' ' TRP . 12.3 t -79.96 127.45 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.253 -0.905 . . . . 0.0 109.961 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 1.5 t30 -112.46 109.65 19.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.35 -0.844 . . . . 0.0 108.976 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 327' ' ' ALA . 22.2 mt -90.29 140.93 29.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 109.682 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -138.38 93.06 2.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.325 -0.86 . . . . 0.0 109.3 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.45 HD12 ' HB3' ' A' ' 285' ' ' GLN . 24.1 mt -59.83 170.2 1.22 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.94 . . . . 0.0 109.68 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -116.62 85.08 2.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.926 . . . . 0.0 109.439 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 129.52 -145.43 16.4 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.6 4.96 52.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -1.16 . . . . 0.0 109.588 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.45 ' HB3' HD12 ' A' ' 281' ' ' LEU . 57.6 mt-30 -47.06 154.5 0.35 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.458 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 30.8 p -145.61 174.67 10.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 109.532 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 29.2 mt -124.17 152.36 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 109.408 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -141.55 11.96 2.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.181 -0.949 . . . . 0.0 109.699 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -154.3 153.99 32.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.069 -1.019 . . . . 0.0 109.603 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 24.0 p -165.37 126.02 1.9 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.39 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.578 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 22.4 p90 -124.98 138.85 54.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.659 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.518 ' HB3' ' CB ' ' A' ' 313' ' ' PHE . 1.4 t-20 71.98 33.96 1.56 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.885 . . . . 0.0 109.508 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . . . . . . . . . . . 172.3 157.76 0.1 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.484 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -104.86 99.08 8.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.487 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 48.0 t -95.48 112.44 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.919 . . . . 0.0 109.469 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 1.4 p -142.45 176.18 9.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.966 . . . . 0.0 109.591 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 116.09 -154.7 16.71 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' SER . . . . . 0.414 ' O ' ' HD2' ' A' ' 302' ' ' ARG . 2.5 m -94.93 179.08 5.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -1.115 . . . . 0.0 109.43 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -77.11 -41.76 21.23 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.79 -32.21 13.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -1.143 . . . . 0.0 109.452 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.0 p -147.12 138.67 24.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.199 -0.938 . . . . 0.0 109.481 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 298' ' ' SER . 18.3 mmm180 -119.35 102.09 8.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.2 -0.938 . . . . 0.0 109.394 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 40.0 m -69.21 149.72 48.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.469 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.452 ' HB ' ' HB ' ' A' ' 277' ' ' VAL . 58.5 t -140.27 139.76 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.447 HG21 ' O ' ' A' ' 304' ' ' VAL . 30.0 p -145.17 155.83 54.56 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.47 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.08 140.63 18.03 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.626 2.217 . . . . 0.0 110.479 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -120.44 26.08 9.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 74.43 55.43 5.58 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.14 -60.4 0.77 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -1.133 . . . . 0.0 109.467 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -162.24 -179.77 37.07 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -103.15 -2.68 26.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -1.107 . . . . 0.0 109.571 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.45 ' O ' ' ND2' ' A' ' 292' ' ' ASN . 40.9 m -113.77 162.06 16.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 109.539 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.565 ' CZ ' ' HB2' ' A' ' 267' ' ' TYR . 3.0 p90 -176.99 155.65 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.381 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.578 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -125.54 166.84 18.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 16.9 m -136.89 167.45 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -1.155 . . . . 0.0 109.515 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 89.1 m -117.52 108.55 15.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.883 . . . . 0.0 109.483 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.57 ' HB ' ' CZ ' ' A' ' 263' ' ' PHE . 40.4 t -100.91 149.95 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.879 . . . . 0.0 109.347 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 7.2 mtp -99.84 135.19 41.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.92 . . . . 0.0 109.501 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 320' ' ' ASN . 17.9 mmtp -46.92 -69.4 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.533 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 319' ' ' LYS . 24.9 m-20 61.27 24.64 14.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.467 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 97.13 -28.27 14.7 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.79 148.57 25.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -1.121 . . . . 0.0 109.495 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 324' ' ' THR . 23.3 t -123.27 -37.19 2.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 109.456 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -41.89 117.51 0.96 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.472 -0.768 . . . . 0.0 109.826 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.576 HG21 ' CE2' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -52.86 164.35 0.7 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.92 . . . . 0.0 109.416 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . 0.466 ' HG2' ' OH ' ' A' ' 267' ' ' TYR . 33.3 Cg_endo -77.78 166.39 25.41 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.673 2.249 . . . . 0.0 110.69 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 279' ' ' LEU . . . -92.72 170.52 9.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.839 . . . . 0.0 109.135 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 278' ' ' ASN . . . -147.78 149.0 31.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.136 -0.978 . . . . 0.0 110.011 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' THR . . . . . 0.462 ' OG1' ' HB3' ' A' ' 278' ' ' ASN . 40.2 p -140.17 128.0 21.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 109.352 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . 0.418 ' SG ' ' C ' ' A' ' 249' ' ' CYS . 16.6 p -82.43 171.63 13.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 109.517 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -127.54 133.64 49.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.455 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -126.92 9.87 7.09 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 56.3 p . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.262 -1.14 . . . . 0.0 109.457 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 40.2 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.326 0.584 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 91.29 -83.16 1.26 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 22.5 p -136.3 169.18 18.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.133 -1.216 . . . . 0.0 109.444 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.461 ' O ' HG21 ' A' ' 269' ' ' VAL . 60.5 p -151.06 174.59 13.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.933 . . . . 0.0 109.6 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.457 HG12 HG23 ' A' ' 277' ' ' VAL . 0.8 OUTLIER -132.17 171.49 17.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.462 -0.774 . . . . 0.0 109.608 -179.168 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.98 119.24 3.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.349 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.568 ' HB3' ' CE1' ' A' ' 267' ' ' TYR . . . -111.56 149.16 31.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 109.491 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 23.8 m -151.07 130.37 12.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.481 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.414 ' HG2' HG22 ' A' ' 325' ' ' THR . 2.7 mtm-85 -77.88 137.95 38.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.446 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -107.49 -69.14 0.86 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.449 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -107.71 136.09 48.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.504 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -111.2 129.25 56.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.411 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -124.7 172.31 9.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 109.453 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 57.2 m -88.99 4.34 48.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.895 . . . . 0.0 109.63 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -119.09 -26.5 5.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.169 -0.957 . . . . 0.0 109.48 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 317' ' ' VAL . 16.0 ptt180 -173.41 162.42 4.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.45 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.576 ' CE1' HG21 ' A' ' 325' ' ' THR . 34.0 p90 -124.75 144.75 50.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.886 . . . . 0.0 109.508 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -85.47 157.93 20.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.44 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.525 ' CG1' ' CE2' ' A' ' 267' ' ' TYR . 1.9 t -136.12 152.23 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 0.0 109.505 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 253' ' ' ALA . 10.1 m -126.78 91.26 3.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.428 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' TYR . . . . . 0.568 ' CE1' ' HB3' ' A' ' 253' ' ' ALA . 58.8 m-85 -91.34 144.29 25.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.404 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.447 ' O ' HG11 ' A' ' 251' ' ' VAL . 24.9 p -159.93 158.26 30.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.211 -0.93 . . . . 0.0 109.585 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.514 HG11 ' N ' ' A' ' 270' ' ' SER . 74.2 t -134.87 141.47 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.302 -0.873 . . . . 0.0 109.394 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.514 ' N ' HG11 ' A' ' 269' ' ' VAL . 7.1 t -115.69 138.29 51.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 272' ' ' SER . . . 123.74 -15.63 7.94 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 271' ' ' GLY . 0.2 OUTLIER 167.73 165.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -1.197 . . . . 0.0 109.432 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 84.0 p -104.46 -24.46 13.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 109.519 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.75 77.43 6.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 108.744 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.574 ' CZ3' HG22 ' A' ' 277' ' ' VAL . 9.8 p-90 -130.33 158.26 40.3 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.362 -0.836 . . . . 0.0 109.786 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.3 m -111.1 95.66 5.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.095 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.574 HG22 ' CZ3' ' A' ' 275' ' ' TRP . 42.4 t -80.08 128.99 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.915 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 30.0 m-20 -107.55 130.74 54.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.856 . . . . 0.0 108.886 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.426 HD13 HG23 ' A' ' 304' ' ' VAL . 60.8 mt -118.94 126.45 51.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 0.0 109.578 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -110.47 82.56 1.61 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.298 -0.876 . . . . 0.0 109.497 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.519 HD13 ' CG1' ' A' ' 317' ' ' VAL . 4.3 mm? -59.75 145.23 45.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.984 . . . . 0.0 109.414 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.454 ' O ' ' HG3' ' A' ' 285' ' ' GLN . 2.3 m-80 -96.04 170.39 9.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.215 -0.928 . . . . 0.0 109.525 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 282' ' ' ASN . . . 45.34 -151.41 0.96 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 2.8 p -101.61 48.32 0.89 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -1.189 . . . . 0.0 109.466 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.46 ' OE1' HD11 ' A' ' 281' ' ' LEU . 64.8 mt-30 -68.81 164.06 22.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.455 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.412 HG21 ' O ' ' A' ' 285' ' ' GLN . 21.0 p -150.35 145.33 26.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 109.461 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.516 ' CD1' HG21 ' A' ' 317' ' ' VAL . 33.2 mm -88.69 135.64 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 109.423 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.497 ' OE1' ' CG ' ' A' ' 318' ' ' MET . 0.6 OUTLIER -112.14 -18.45 12.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -143.15 157.24 44.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 109.477 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 314' ' ' GLY . 1.7 p -168.6 134.81 1.84 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.473 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.525 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 34.8 p90 -144.2 155.01 43.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.521 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.47 ' CB ' ' HA ' ' A' ' 313' ' ' PHE . 0.4 OUTLIER 72.66 6.5 5.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.589 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.517 ' HB2' ' CB ' ' A' ' 313' ' ' PHE . . . 177.69 170.19 0.65 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.518 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.455 ' O ' HG11 ' A' ' 304' ' ' VAL . 38.7 m-80 -117.87 166.25 12.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.898 . . . . 0.0 109.505 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 86.1 t -138.93 116.51 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 13.6 p -135.62 -170.05 2.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.459 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.6 171.1 34.5 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.5 -176.16 3.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -1.144 . . . . 0.0 109.455 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 83.22 62.0 1.85 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 55.72 30.58 15.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -1.179 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.466 ' O ' ' HG2' ' A' ' 302' ' ' ARG . 0.8 OUTLIER -148.31 171.18 16.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.89 . . . . 0.0 109.526 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 301' ' ' THR . 0.1 OUTLIER -155.7 84.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.358 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.1 m -63.18 169.28 3.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.357 -0.84 . . . . 0.0 109.809 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.455 HG11 ' O ' ' A' ' 294' ' ' ASN . 54.9 t -155.62 130.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 109.368 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 10.1 p -132.0 150.41 76.03 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.166 -0.959 . . . . 0.0 109.499 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.92 -174.03 2.06 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.584 2.19 . . . . 0.0 110.41 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -149.45 18.73 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 79.24 51.05 5.48 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.4 t -135.02 -85.2 0.4 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -1.129 . . . . 0.0 109.427 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -126.78 175.34 17.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . 0.481 ' N ' ' ND2' ' A' ' 311' ' ' ASN . 0.8 OUTLIER -108.18 -1.2 20.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -1.134 . . . . 0.0 109.612 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.469 ' O ' ' CB ' ' A' ' 292' ' ' ASN . 30.2 m -116.9 107.29 14.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.17 -0.957 . . . . 0.0 109.428 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.517 ' CB ' ' HB2' ' A' ' 293' ' ' ALA . 39.0 p90 -117.47 149.08 41.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.525 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -112.96 160.15 13.28 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.441 ' O ' HG21 ' A' ' 315' ' ' VAL . 11.2 m -143.19 146.28 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -1.152 . . . . 0.0 109.453 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 54.5 m -103.8 102.59 12.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.527 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.576 ' HB ' ' CZ ' ' A' ' 263' ' ' PHE . 60.6 t -90.4 132.72 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.482 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' MET . . . . . 0.497 ' CG ' ' OE1' ' A' ' 288' ' ' GLN . 28.1 mmm -87.45 143.75 27.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.577 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -57.11 -76.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.497 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 54.15 23.88 4.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.25 -0.906 . . . . 0.0 109.446 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 101.83 32.61 4.99 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 13.2 t -158.02 117.45 3.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -1.116 . . . . 0.0 109.432 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.13 3.39 17.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.579 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' THR . . . . . . . . . . . . . 1.2 m -98.53 128.08 44.72 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.137 -0.977 . . . . 0.0 108.927 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.576 HG21 ' CE1' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -59.45 165.66 3.82 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.89 . . . . 0.0 109.528 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 325' ' ' THR . 34.1 Cg_endo -77.43 171.56 17.42 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.643 2.228 . . . . 0.0 110.675 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -103.82 132.56 49.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -0.898 . . . . 0.0 109.289 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.54 ' HB3' ' CD1' ' A' ' 267' ' ' TYR . . . -107.12 148.72 28.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.655 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 278' ' ' ASN . 52.7 p -149.18 125.86 11.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.35 -0.843 . . . . 0.0 109.465 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 40.6 t -88.12 130.32 35.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -0.927 . . . . 0.0 109.492 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -126.09 119.04 26.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.522 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -86.95 121.47 5.81 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.215 -1.168 . . . . 0.0 109.444 -179.917 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.99 165.31 12.04 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 30.1 p -162.15 153.39 18.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -1.119 . . . . 0.0 109.491 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.69 175.67 9.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.591 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 268' ' ' SER . 0.8 OUTLIER -130.47 107.66 14.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.401 -0.812 . . . . 0.0 109.588 -179.177 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 34.2 p -96.86 112.37 24.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.378 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.575 ' HB3' ' CE2' ' A' ' 267' ' ' TYR . . . -95.6 140.43 30.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.601 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 23.5 m -130.32 149.67 51.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 109.377 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.05 122.89 29.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.927 . . . . 0.0 109.491 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -103.42 -148.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -47.7 132.43 14.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 109.412 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -107.94 157.15 18.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.607 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . 0.456 ' HB2' ' O ' ' A' ' 262' ' ' ARG . 5.1 m-90 -136.25 -170.13 2.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 54.3 m -103.1 -9.54 19.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 109.484 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 262' ' ' ARG . 13.1 p-10 -133.75 17.25 3.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.435 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' ARG . . . . . 0.524 ' N ' ' HG2' ' A' ' 319' ' ' LYS . 0.4 OUTLIER 175.95 166.44 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -0.952 . . . . 0.0 109.492 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.633 ' CZ ' ' CG1' ' A' ' 317' ' ' VAL . 55.0 p90 -148.66 136.2 20.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -87.24 155.06 20.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.495 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 1.8 t -137.8 137.51 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 19.8 m -105.91 91.69 3.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.457 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' TYR . . . . . 0.575 ' CE2' ' HB3' ' A' ' 253' ' ' ALA . 27.2 m-85 -80.58 136.05 36.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.463 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 251' ' ' VAL . 2.7 t -131.59 159.49 38.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.908 . . . . 0.0 109.541 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.434 HG21 ' C ' ' A' ' 268' ' ' SER . 96.0 t -152.44 97.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 0.0 109.495 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.61 -168.29 2.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.342 -0.849 . . . . 0.0 109.533 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 88.09 -41.71 3.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 57.5 p -173.11 170.54 4.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.277 -1.131 . . . . 0.0 109.359 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.17 -34.0 7.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.396 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.76 77.45 6.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.954 . . . . 0.0 108.638 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.576 ' CE3' HG22 ' A' ' 277' ' ' VAL . 17.2 p-90 -127.46 153.53 46.18 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.326 -0.859 . . . . 0.0 109.797 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 87.2 m -113.96 95.19 5.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.116 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.576 HG22 ' CE3' ' A' ' 275' ' ' TRP . 48.4 t -107.56 149.53 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.621 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . 0.515 ' N ' HG11 ' A' ' 277' ' ' VAL . 3.7 m-20 -127.46 132.87 49.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -0.878 . . . . 0.0 109.404 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.575 HD22 ' CE2' ' A' ' 267' ' ' TYR . 7.1 mt -85.05 155.95 21.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.479 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 327' ' ' ALA . . . -137.07 84.43 2.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.618 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.463 HD11 ' O ' ' A' ' 285' ' ' GLN . 19.0 mt -59.99 172.41 0.78 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.456 ' O ' ' C ' ' A' ' 283' ' ' GLY . 12.1 m-80 -86.84 59.45 5.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 109.772 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 282' ' ' ASN . . . 37.7 43.0 1.12 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 285' ' ' GLN . 73.7 m -158.94 -87.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.1 -1.235 . . . . 0.0 109.63 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.518 ' HB3' ' CG1' ' A' ' 317' ' ' VAL . 0.0 OUTLIER -43.13 140.81 1.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.2 p -115.97 179.7 3.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 109.513 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.452 HD13 ' HB ' ' A' ' 315' ' ' VAL . 18.1 mm -102.3 149.36 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.23 -33.86 3.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.188 -0.945 . . . . 0.0 109.469 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -151.48 169.21 22.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.488 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -160.16 140.56 11.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.394 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.565 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 31.2 p90 -136.58 148.57 47.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.943 . . . . 0.0 109.507 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 291' ' ' TRP . 0.7 OUTLIER 73.77 7.71 4.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.494 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.507 ' HB1' ' CB ' ' A' ' 313' ' ' PHE . . . 176.96 149.85 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.456 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -106.77 136.38 46.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.453 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 303' ' ' THR . 17.5 t -115.15 136.43 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 44.2 p -108.73 161.23 15.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -91.19 144.99 17.53 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 19.5 m -150.75 -172.22 4.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -1.177 . . . . 0.0 109.458 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 300' ' ' SER . . . -68.15 106.76 1.82 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 299' ' ' GLY . 0.4 OUTLIER 44.16 28.37 0.27 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -1.145 . . . . 0.0 109.473 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.4 p -152.57 168.88 24.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.214 -0.929 . . . . 0.0 109.398 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . 0.418 ' HB3' ' CG1' ' A' ' 295' ' ' VAL . 0.0 OUTLIER -146.67 141.3 26.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.449 ' O ' HG21 ' A' ' 304' ' ' VAL . 1.7 m -92.61 169.13 10.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 277' ' ' VAL . 61.9 t -155.95 122.24 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.49 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 52.9 p -130.66 155.39 81.32 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.99 146.13 22.81 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.67 2.247 . . . . 0.0 110.437 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -112.7 -10.25 13.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 119.29 29.6 1.73 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.8 -30.35 6.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -1.146 . . . . 0.0 109.414 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 151.79 -156.55 26.75 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 311' ' ' ASN . 0.8 OUTLIER -117.17 8.27 13.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.225 -1.162 . . . . 0.0 109.573 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 11.1 m -109.61 96.57 6.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.408 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.507 ' CB ' ' HB1' ' A' ' 293' ' ' ALA . 47.3 p90 -117.66 144.33 45.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.565 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -109.77 168.35 13.15 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.452 ' HB ' HD13 ' A' ' 287' ' ' ILE . 5.5 m -141.96 144.01 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -1.114 . . . . 0.0 109.452 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 7.5 m -94.06 92.54 7.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 109.494 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.633 ' CG1' ' CZ ' ' A' ' 263' ' ' PHE . 16.4 t -83.63 153.43 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.456 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' MET . . . . . 0.425 ' O ' ' CG ' ' A' ' 285' ' ' GLN . 29.6 mtp -113.43 144.42 42.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.541 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' LYS . . . . . 0.524 ' HG2' ' N ' ' A' ' 262' ' ' ARG . 21.9 mmtp -65.95 -73.68 0.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 0.0 109.473 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 319' ' ' LYS . 4.3 m-20 63.16 24.02 14.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.332 -0.855 . . . . 0.0 109.408 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 99.56 37.95 3.84 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' SER . . . . . 0.458 ' O ' ' HD2' ' A' ' 319' ' ' LYS . 0.3 OUTLIER -159.76 -157.42 0.57 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -1.188 . . . . 0.0 109.467 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 324' ' ' THR . 0.0 OUTLIER 179.89 -47.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 109.438 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -40.16 125.08 1.97 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.599 -0.688 . . . . 0.0 110.102 -179.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.493 HG21 ' CE2' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -64.46 167.0 9.51 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.381 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 325' ' ' THR . 33.2 Cg_endo -76.26 163.37 32.66 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.522 2.148 . . . . 0.0 110.614 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . 0.458 ' O ' ' HB1' ' A' ' 280' ' ' ALA . . . -110.98 115.15 29.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 0.0 109.376 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.454 ' HB1' ' CE2' ' A' ' 267' ' ' TYR . . . -103.61 163.56 12.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.494 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' THR . . . . . 0.418 ' C ' HG12 ' A' ' 277' ' ' VAL . 35.8 p -149.49 127.17 11.68 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.303 -0.873 . . . . 0.0 109.367 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . 0.485 ' HA ' ' CG2' ' A' ' 277' ' ' VAL . 42.8 t -86.43 125.4 33.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.356 -0.84 . . . . 0.0 109.505 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -139.13 170.27 16.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.41 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 144.27 141.04 3.7 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.192 -1.181 . . . . 0.0 109.44 -179.992 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 249' ' ' CYS . . . . . 0.418 ' C ' ' SG ' ' A' ' 330' ' ' CYS . 3.5 p . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.53 173.73 11.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.658 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.657 HG13 ' CG2' ' A' ' 269' ' ' VAL . 0.9 OUTLIER -136.55 134.36 49.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.444 -179.16 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 252' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.1 OUTLIER -116.59 134.51 54.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 109.505 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.776 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -124.89 106.89 10.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.526 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.5 m -103.59 135.33 45.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.462 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -69.8 111.51 5.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.87 . . . . 0.0 109.469 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -82.75 -74.43 0.35 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.451 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.5 ' HB3' ' CH2' ' A' ' 259' ' ' TRP . 3.1 mm-40 -106.62 138.06 43.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.436 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -125.16 128.73 48.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 109.502 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' TRP . . . . . 0.5 ' CH2' ' HB3' ' A' ' 257' ' ' GLU . 8.9 m-90 -120.01 -178.69 3.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.216 -0.928 . . . . 0.0 109.463 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 m -91.96 9.74 31.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.453 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.22 -39.26 0.93 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.431 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.92 154.8 43.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.47 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.556 ' CZ ' HG11 ' A' ' 317' ' ' VAL . 40.4 p90 -130.25 133.69 46.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.93 . . . . 0.0 109.457 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -89.11 160.81 16.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.485 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 1.6 t -136.88 159.23 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 109.422 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 253' ' ' ALA . 3.2 m -123.66 92.54 3.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.547 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' TYR . . . . . 0.838 ' CE2' ' HB2' ' A' ' 328' ' ' ALA . 45.2 m-85 -87.65 150.74 23.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.3 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 251' ' ' VAL . 11.2 p -160.13 148.67 17.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 109.678 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' VAL . . . . . 0.657 ' CG2' HG13 ' A' ' 251' ' ' VAL . 89.1 t -129.54 143.03 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -0.879 . . . . 0.0 109.41 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.57 156.79 25.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.207 -0.933 . . . . 0.0 109.531 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 110.9 -62.85 0.28 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.25 171.38 14.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -1.12 . . . . 0.0 109.427 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 31.3 t -106.13 -26.91 11.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.501 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.64 78.0 6.22 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.943 ' CE3' HG23 ' A' ' 277' ' ' VAL . 6.4 p-90 -128.36 163.23 25.29 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.367 -0.833 . . . . 0.0 109.988 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 34.9 m -113.37 99.76 8.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.943 HG23 ' CE3' ' A' ' 275' ' ' TRP . 41.9 t -79.8 99.09 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.166 -0.959 . . . . 0.0 109.99 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 0.4 OUTLIER -87.14 133.17 33.66 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' A' ' 328' ' ' ALA . 82.6 mt -116.98 132.61 56.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -0.978 . . . . 0.0 109.698 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -104.67 77.28 1.35 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.254 -0.904 . . . . 0.0 109.109 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.668 HD22 ' HB3' ' A' ' 326' ' ' PRO . 4.1 mm? -59.41 131.96 52.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.425 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -86.75 147.38 25.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.28 -0.887 . . . . 0.0 109.514 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 66.08 -148.39 50.87 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 69.4 m -103.7 48.99 0.83 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -1.15 . . . . 0.0 109.461 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.514 ' CB ' HD12 ' A' ' 281' ' ' LEU . 64.4 mt-30 -69.56 150.51 47.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.863 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.443 ' O ' ' HG2' ' A' ' 318' ' ' MET . 23.0 p -139.04 146.96 41.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.459 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.48 HG22 ' H ' ' A' ' 289' ' ' ALA . 32.0 mm -94.36 136.17 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.277 -0.889 . . . . 0.0 109.469 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.24 11.86 12.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.537 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.619 ' HB3' ' OG1' ' A' ' 316' ' ' THR . . . -168.18 153.51 6.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.94 . . . . 0.0 109.465 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.6 p -165.41 127.97 2.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.48 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.569 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 19.1 p90 -127.61 142.48 51.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.497 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.531 ' O ' ' HB2' ' A' ' 293' ' ' ALA . 15.8 t-20 69.78 17.68 7.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.407 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 292' ' ' ASN . . . 174.27 151.52 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -110.15 143.65 39.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.425 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.855 HG22 HG22 ' A' ' 304' ' ' VAL . 20.9 t -118.72 123.94 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.269 0.556 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 279' ' ' LEU . 7.6 mmt-85 -138.45 160.76 38.71 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.323 -0.861 . . . . 0.0 109.207 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.521 HG22 ' N ' ' A' ' 304' ' ' VAL . 21.1 m -142.85 161.16 38.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.956 . . . . 0.0 109.71 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.855 HG22 HG22 ' A' ' 295' ' ' VAL . 56.1 t -142.0 144.94 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.358 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 21.6 p -137.42 147.77 59.14 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.403 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.71 152.33 29.08 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.547 2.165 . . . . 0.0 110.446 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -113.77 -10.48 13.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.499 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 116.54 57.2 0.32 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 58.5 m -135.16 -59.9 0.77 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -1.174 . . . . 0.0 109.429 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -169.36 -146.04 4.88 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -129.31 13.97 6.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -1.145 . . . . 0.0 109.456 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 2.2 m -122.19 111.99 17.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.688 ' HZ ' HG11 ' A' ' 277' ' ' VAL . 4.6 p90 -135.37 165.81 24.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.412 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.569 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -128.43 161.25 22.19 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 32.5 m -134.38 158.17 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -1.154 . . . . 0.0 109.49 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' THR . . . . . 0.619 ' OG1' ' HB3' ' A' ' 289' ' ' ALA . 19.0 m -113.23 95.22 5.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.504 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.556 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 53.7 t -85.75 147.9 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 286' ' ' THR . 67.0 mmm -106.09 128.13 53.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.507 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' LYS . . . . . 0.49 ' HD2' ' O ' ' A' ' 322' ' ' SER . 18.0 mmtp -45.22 -68.18 0.22 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 53.13 37.7 25.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 87.28 25.49 33.49 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 322' ' ' SER . . . . . 0.49 ' O ' ' HD2' ' A' ' 319' ' ' LYS . 0.2 OUTLIER -150.73 -178.64 6.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -1.167 . . . . 0.0 109.462 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 323' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 324' ' ' THR . 0.0 OUTLIER -164.2 -46.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.415 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 324' ' ' THR . . . . . 0.435 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -41.45 120.91 1.54 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.418 -0.801 . . . . 0.0 109.873 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.524 HG22 ' HE1' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -61.06 165.45 6.24 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.923 . . . . 0.0 109.463 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 326' ' ' PRO . . . . . 0.668 ' HB3' HD22 ' A' ' 281' ' ' LEU . 33.6 Cg_endo -77.66 170.94 18.3 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.676 2.251 . . . . 0.0 110.775 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -106.32 119.48 39.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 109.089 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.838 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -93.89 147.99 22.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.204 -0.935 . . . . 0.0 109.946 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 41.1 p -142.11 126.71 17.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.478 -0.764 . . . . 0.0 109.23 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 330' ' ' CYS . 15.6 p -85.38 128.72 34.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.199 -0.938 . . . . 0.0 109.57 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 109.515 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 249' ' ' CYS . . . . . 0.51 ' N ' ' SG ' ' A' ' 330' ' ' CYS . 11.7 p . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.567 ' O ' HG13 ' A' ' 269' ' ' VAL . 1.0 OUTLIER -111.57 174.74 5.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.432 -0.793 . . . . 0.0 109.88 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.703 HG13 ' CG2' ' A' ' 269' ' ' VAL . 0.8 OUTLIER -129.5 169.57 20.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.359 -179.196 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.0 115.17 5.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.227 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.441 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -126.95 150.88 49.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 109.505 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.95 160.74 16.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.423 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -95.85 136.58 36.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.468 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -117.8 -66.57 1.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.497 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -107.77 117.61 34.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.491 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -107.2 136.34 47.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 0.0 109.45 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 2.6 m-90 -120.74 -173.83 2.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.928 . . . . 0.0 109.449 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.8 m -92.66 17.65 9.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.918 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.9 -43.57 0.3 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.436 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.423 ' HB3' ' HA ' ' A' ' 318' ' ' MET . 0.0 OUTLIER -151.25 158.03 43.35 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.186 -0.946 . . . . 0.0 109.438 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.679 ' CE1' HG22 ' A' ' 325' ' ' THR . 27.9 p90 -123.7 160.62 26.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.432 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -98.25 151.86 20.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -0.873 . . . . 0.0 109.388 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.538 HG11 ' CE1' ' A' ' 267' ' ' TYR . 1.7 t -133.99 139.2 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.458 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.99 96.39 6.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.222 -0.924 . . . . 0.0 109.471 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' TYR . . . . . 0.635 ' HE2' ' HB2' ' A' ' 328' ' ' ALA . 38.4 m-85 -95.74 100.74 12.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.46 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.26 152.34 34.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.662 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' VAL . . . . . 0.703 ' CG2' HG13 ' A' ' 251' ' ' VAL . 59.9 t -140.64 142.86 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.352 -0.843 . . . . 0.0 109.495 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.8 m -134.84 163.73 29.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 109.526 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' A' ' 272' ' ' SER . . . 104.64 -10.41 49.33 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 271' ' ' GLY . 0.5 OUTLIER 169.37 159.7 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -1.109 . . . . 0.0 109.321 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 48.5 t -105.34 -29.5 10.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.6 77.96 6.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 108.661 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.994 ' CE3' HG23 ' A' ' 277' ' ' VAL . 10.7 p-90 -128.69 157.1 42.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.41 -0.806 . . . . 0.0 109.934 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 16.0 m -110.61 96.48 6.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.406 -0.809 . . . . 0.0 108.863 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.994 HG23 ' CE3' ' A' ' 275' ' ' TRP . 40.2 t -79.76 104.15 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.919 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ASN . . . . . 0.481 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 5.7 t-20 -93.47 138.96 31.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.369 -0.832 . . . . 0.0 108.783 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 327' ' ' ALA . 34.1 mt -122.61 132.3 54.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.174 -0.954 . . . . 0.0 109.568 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -110.1 83.2 1.72 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 109.271 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.785 HD22 ' HB3' ' A' ' 326' ' ' PRO . 4.2 mm? -59.26 139.26 57.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.466 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -83.86 122.71 29.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.405 -0.809 . . . . 0.0 109.422 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 82.91 -149.21 26.49 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 58.8 m -100.47 34.11 2.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -1.104 . . . . 0.0 109.538 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.514 ' CB ' HD12 ' A' ' 281' ' ' LEU . 85.3 mt-30 -57.13 169.57 0.55 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.932 . . . . 0.0 109.522 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.449 ' CG2' ' C ' ' A' ' 285' ' ' GLN . 15.8 p -155.81 148.25 23.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.491 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.623 HG13 HG11 ' A' ' 295' ' ' VAL . 38.2 mm -83.25 153.46 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 109.398 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' GLN . . . . . 0.442 ' HB2' ' HE3' ' A' ' 318' ' ' MET . 3.6 tp-100 -118.52 -28.38 5.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.461 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.408 ' C ' ' OG ' ' A' ' 290' ' ' SER . . . -145.46 166.99 24.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.953 . . . . 0.0 109.459 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' SER . . . . . 0.408 ' OG ' ' C ' ' A' ' 289' ' ' ALA . 0.8 OUTLIER -169.99 137.26 1.58 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.565 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 28.0 p90 -136.4 150.62 48.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 293' ' ' ALA . 0.6 OUTLIER 70.48 15.82 7.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 109.451 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 292' ' ' ASN . . . 172.41 157.8 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.47 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -108.27 134.05 51.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.9 . . . . 0.0 109.501 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.861 HG22 HG22 ' A' ' 304' ' ' VAL . 59.9 t -112.75 118.92 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 71.2 p . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.447 -179.963 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.358 0.599 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 279' ' ' LEU . 18.4 mmt-85 -145.26 162.47 37.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.244 -0.91 . . . . 0.0 109.253 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 304' ' ' VAL . 7.6 m -140.28 167.63 21.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.711 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.861 HG22 HG22 ' A' ' 295' ' ' VAL . 38.6 t -154.23 142.33 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.366 -0.834 . . . . 0.0 109.314 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 62.3 p -145.66 150.36 43.21 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 109.473 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.83 164.44 27.73 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.678 2.252 . . . . 0.0 110.39 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -119.29 -12.16 9.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.868 . . . . 0.0 109.443 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 114.49 42.89 0.79 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.51 -59.24 1.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -1.159 . . . . 0.0 109.467 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -156.8 162.82 31.89 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -90.18 -7.45 53.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -1.138 . . . . 0.0 109.505 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.423 ' O ' ' CG ' ' A' ' 292' ' ' ASN . 32.1 m -100.59 117.4 34.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.463 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.698 ' HZ ' HG11 ' A' ' 277' ' ' VAL . 12.5 p90 -135.81 153.31 51.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 0.0 109.518 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.565 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -117.1 152.33 17.85 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.92 148.16 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -1.166 . . . . 0.0 109.503 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 287' ' ' ILE . 23.9 m -107.43 129.82 54.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.607 HG22 ' CD1' ' A' ' 287' ' ' ILE . 40.3 t -114.88 149.51 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.939 . . . . 0.0 109.481 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' MET . . . . . 0.442 ' HE3' ' HB2' ' A' ' 288' ' ' GLN . 0.8 OUTLIER -103.68 128.39 51.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 109.399 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 319' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 322' ' ' SER . 10.1 mptt -43.79 -66.13 0.42 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.893 . . . . 0.0 109.538 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 319' ' ' LYS . 19.3 m-20 59.42 31.27 20.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.915 . . . . 0.0 109.436 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 111.36 -47.81 1.0 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 319' ' ' LYS . 0.0 OUTLIER -103.71 158.4 16.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.224 -1.163 . . . . 0.0 109.471 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 323' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 324' ' ' THR . 65.1 m -122.34 -32.46 3.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.429 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -41.51 119.82 1.32 Allowed 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.355 -0.841 . . . . 0.0 109.967 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.679 HG22 ' CE1' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -56.42 166.22 1.3 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.335 179.587 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 326' ' ' PRO . . . . . 0.785 ' HB3' HD22 ' A' ' 281' ' ' LEU . 32.9 Cg_endo -77.55 157.2 32.36 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.552 2.168 . . . . 0.0 110.721 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 279' ' ' LEU . . . -88.65 165.16 14.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.105 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.635 ' HB2' ' HE2' ' A' ' 267' ' ' TYR . . . -138.18 152.36 48.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.045 -1.034 . . . . 0.0 109.763 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' THR . . . . . 0.439 ' OG1' ' HB3' ' A' ' 278' ' ' ASN . 80.4 p -146.4 127.72 14.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.647 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 249' ' ' CYS . 1.6 t -91.1 138.29 31.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.421 -0.799 . . . . 0.0 108.969 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.903 . . . . 0.0 109.504 179.975 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 249' ' ' CYS . . . . . 0.418 ' C ' ' SG ' ' A' ' 330' ' ' CYS . 6.0 p . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.545 ' O ' HG22 ' A' ' 269' ' ' VAL . 52.6 p -149.06 173.23 13.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.96 . . . . 0.0 109.538 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.651 HG13 ' CG2' ' A' ' 269' ' ' VAL . 0.9 OUTLIER -135.87 120.19 25.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.528 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.55 118.62 37.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.888 . . . . 0.0 109.453 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.564 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -109.19 101.57 10.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 109.458 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.97 169.04 10.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.868 . . . . 0.0 109.415 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.481 ' NH1' ' CD2' ' A' ' 263' ' ' PHE . 0.0 OUTLIER -98.3 142.67 29.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 109.493 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -110.42 -55.21 2.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 109.413 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.536 ' HB3' ' CZ2' ' A' ' 259' ' ' TRP . 52.1 mm-40 -144.04 144.42 31.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -122.63 122.58 39.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.45 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' TRP . . . . . 0.536 ' CZ2' ' HB3' ' A' ' 257' ' ' GLU . 6.1 m-90 -124.82 -176.64 3.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 73.2 m -93.37 2.11 56.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.914 . . . . 0.0 109.67 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.42 -24.62 7.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.426 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 317' ' ' VAL . 10.1 ptt180 -178.51 166.31 1.79 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.912 . . . . 0.0 109.451 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.576 ' CZ ' ' HB ' ' A' ' 317' ' ' VAL . 47.3 p90 -133.37 151.27 51.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.408 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -97.82 150.75 20.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.333 -0.854 . . . . 0.0 109.469 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.464 HG11 ' CE1' ' A' ' 267' ' ' TYR . 2.1 t -130.88 164.67 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.468 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 253' ' ' ALA . 0.9 OUTLIER -133.52 95.22 3.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 267' ' ' TYR . . . . . 0.762 ' CE2' ' HB2' ' A' ' 328' ' ' ALA . 44.3 m-85 -91.13 140.85 29.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -0.854 . . . . 0.0 109.317 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 251' ' ' VAL . 0.8 OUTLIER -149.88 157.58 43.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.925 . . . . 0.0 109.602 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 269' ' ' VAL . . . . . 0.651 ' CG2' HG13 ' A' ' 251' ' ' VAL . 98.5 t -144.3 145.85 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.202 -0.936 . . . . 0.0 109.46 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 7.6 p -127.76 173.09 10.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.337 -0.852 . . . . 0.0 109.534 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 106.24 -55.11 0.55 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 274' ' ' ALA . 0.3 OUTLIER -154.53 104.79 2.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -1.145 . . . . 0.0 109.367 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 273' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 272' ' ' SER . 2.4 t -42.06 -26.74 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 0.0 109.87 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 272' ' ' SER . . . -79.37 78.3 5.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.068 -1.02 . . . . 0.0 108.665 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.925 ' CZ3' HG23 ' A' ' 277' ' ' VAL . 7.8 p-90 -128.95 172.78 11.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.286 -0.884 . . . . 0.0 109.855 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 331' ' ' ALA . 1.7 m -132.15 102.25 5.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.488 -0.757 . . . . 0.0 108.983 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.925 HG23 ' CZ3' ' A' ' 275' ' ' TRP . 12.3 t -79.96 127.45 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.253 -0.905 . . . . 0.0 109.961 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ASN . . . . . 0.488 ' HB3' ' OG1' ' A' ' 329' ' ' THR . 1.5 t30 -112.46 109.65 19.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.35 -0.844 . . . . 0.0 108.976 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 327' ' ' ALA . 22.2 mt -90.29 140.93 29.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 109.682 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -138.38 93.06 2.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.325 -0.86 . . . . 0.0 109.3 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.715 HD13 ' HB3' ' A' ' 285' ' ' GLN . 24.1 mt -59.83 170.2 1.22 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.94 . . . . 0.0 109.68 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -116.62 85.08 2.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.926 . . . . 0.0 109.439 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 129.52 -145.43 16.4 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 286' ' ' THR . 0.7 OUTLIER -92.6 4.96 52.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -1.16 . . . . 0.0 109.588 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.715 ' HB3' HD13 ' A' ' 281' ' ' LEU . 57.6 mt-30 -47.06 154.5 0.35 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.458 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 284' ' ' SER . 30.8 p -145.61 174.67 10.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 109.532 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 29.2 mt -124.17 152.36 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 109.408 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -141.55 11.96 2.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.181 -0.949 . . . . 0.0 109.699 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.733 ' HB3' ' OG1' ' A' ' 316' ' ' THR . . . -154.3 153.99 32.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.069 -1.019 . . . . 0.0 109.603 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 24.0 p -165.37 126.02 1.9 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.39 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.567 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 22.4 p90 -124.98 138.85 54.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.659 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.545 ' O ' ' HB2' ' A' ' 293' ' ' ALA . 1.4 t-20 71.98 33.96 1.56 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.885 . . . . 0.0 109.508 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 292' ' ' ASN . . . 172.3 157.76 0.1 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.484 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -104.86 99.08 8.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.487 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.648 HG22 HG22 ' A' ' 304' ' ' VAL . 48.0 t -95.48 112.44 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.919 . . . . 0.0 109.469 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.966 . . . . 0.0 109.591 179.945 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 302' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' A' ' 279' ' ' LEU . 18.3 mmm180 -119.35 102.09 8.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.2 -0.938 . . . . 0.0 109.394 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 40.0 m -69.21 149.72 48.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.469 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.648 HG22 HG22 ' A' ' 295' ' ' VAL . 58.5 t -140.27 139.76 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 30.0 p -145.17 155.83 54.56 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.47 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.08 140.63 18.03 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.626 2.217 . . . . 0.0 110.479 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -120.44 26.08 9.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 74.43 55.43 5.58 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.14 -60.4 0.77 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -1.133 . . . . 0.0 109.467 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -162.24 -179.77 37.07 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -103.15 -2.68 26.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -1.107 . . . . 0.0 109.571 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 313' ' ' PHE . 40.9 m -113.77 162.06 16.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 109.539 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 267' ' ' TYR . 3.0 p90 -176.99 155.65 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.381 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.567 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -125.54 166.84 18.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 16.9 m -136.89 167.45 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -1.155 . . . . 0.0 109.515 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' THR . . . . . 0.733 ' OG1' ' HB3' ' A' ' 289' ' ' ALA . 89.1 m -117.52 108.55 15.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.883 . . . . 0.0 109.483 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.576 ' HB ' ' CZ ' ' A' ' 263' ' ' PHE . 40.4 t -100.91 149.95 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.879 . . . . 0.0 109.347 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 7.2 mtp -99.84 135.19 41.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.92 . . . . 0.0 109.501 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 320' ' ' ASN . 17.9 mmtp -46.92 -69.4 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.533 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 319' ' ' LYS . 24.9 m-20 61.27 24.64 14.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.467 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 97.13 -28.27 14.7 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.79 148.57 25.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -1.121 . . . . 0.0 109.495 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 324' ' ' THR . 23.3 t -123.27 -37.19 2.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 109.456 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -41.89 117.51 0.96 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.472 -0.768 . . . . 0.0 109.826 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.53 HG22 ' HE2' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -52.86 164.35 0.7 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.92 . . . . 0.0 109.416 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 326' ' ' PRO . . . . . 0.503 ' HB3' HD23 ' A' ' 281' ' ' LEU . 33.3 Cg_endo -77.78 166.39 25.41 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.673 2.249 . . . . 0.0 110.69 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 279' ' ' LEU . . . -92.72 170.52 9.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.839 . . . . 0.0 109.135 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.762 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -147.78 149.0 31.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.136 -0.978 . . . . 0.0 110.011 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' THR . . . . . 0.488 ' OG1' ' HB3' ' A' ' 278' ' ' ASN . 40.2 p -140.17 128.0 21.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 109.352 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' CYS . . . . . 0.418 ' HB3' HG22 ' A' ' 251' ' ' VAL . 16.6 p -82.43 171.63 13.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 109.517 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' ALA . . . . . 0.455 ' HB2' ' HB ' ' A' ' 276' ' ' THR . . . . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.455 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 22.5 p . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.841 ' O ' HG13 ' A' ' 269' ' ' VAL . 60.5 p -151.06 174.59 13.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.933 . . . . 0.0 109.6 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.574 HG13 ' CG2' ' A' ' 269' ' ' VAL . 0.8 OUTLIER -132.17 171.49 17.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.462 -0.774 . . . . 0.0 109.608 -179.168 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.98 119.24 3.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.349 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.767 ' HB2' ' CE1' ' A' ' 267' ' ' TYR . . . -111.56 149.16 31.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 109.491 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 23.8 m -151.07 130.37 12.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.481 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.524 ' HD3' HG23 ' A' ' 325' ' ' THR . 2.7 mtm-85 -77.88 137.95 38.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.446 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -107.49 -69.14 0.86 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.449 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -107.71 136.09 48.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.504 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -111.2 129.25 56.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.411 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -124.7 172.31 9.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 109.453 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 57.2 m -88.99 4.34 48.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.895 . . . . 0.0 109.63 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -119.09 -26.5 5.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.169 -0.957 . . . . 0.0 109.48 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 317' ' ' VAL . 16.0 ptt180 -173.41 162.42 4.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.45 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.585 ' CZ ' ' HB ' ' A' ' 317' ' ' VAL . 34.0 p90 -124.75 144.75 50.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.886 . . . . 0.0 109.508 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -85.47 157.93 20.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.44 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' VAL . . . . . 0.688 HG11 ' CE2' ' A' ' 267' ' ' TYR . 1.9 t -136.12 152.23 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 0.0 109.505 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 253' ' ' ALA . 10.1 m -126.78 91.26 3.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.428 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' TYR . . . . . 0.827 ' CE1' ' HB2' ' A' ' 328' ' ' ALA . 58.8 m-85 -91.34 144.29 25.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.404 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.607 ' HB3' HG23 ' A' ' 312' ' ' THR . 24.9 p -159.93 158.26 30.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.211 -0.93 . . . . 0.0 109.585 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 250' ' ' SER . 74.2 t -134.87 141.47 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.302 -0.873 . . . . 0.0 109.394 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 7.1 t -115.69 138.29 51.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.526 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 272' ' ' SER . . . 123.74 -15.63 7.94 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 271' ' ' GLY . 0.2 OUTLIER 167.73 165.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -1.197 . . . . 0.0 109.432 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 84.0 p -104.46 -24.46 13.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 109.519 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.75 77.43 6.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 108.744 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.983 ' CE3' HG23 ' A' ' 277' ' ' VAL . 9.8 p-90 -130.33 158.26 40.3 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.362 -0.836 . . . . 0.0 109.786 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.3 m -111.1 95.66 5.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.095 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.983 HG23 ' CE3' ' A' ' 275' ' ' TRP . 42.4 t -80.08 128.99 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.915 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 30.0 m-20 -107.55 130.74 54.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.856 . . . . 0.0 108.886 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.498 HD12 HG21 ' A' ' 304' ' ' VAL . 60.8 mt -118.94 126.45 51.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 0.0 109.578 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -110.47 82.56 1.61 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.298 -0.876 . . . . 0.0 109.497 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.624 HD22 ' HB3' ' A' ' 326' ' ' PRO . 4.3 mm? -59.75 145.23 45.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.984 . . . . 0.0 109.414 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.453 ' O ' ' HG3' ' A' ' 285' ' ' GLN . 2.3 m-80 -96.04 170.39 9.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.215 -0.928 . . . . 0.0 109.525 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 282' ' ' ASN . . . 45.34 -151.41 0.96 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 2.8 p -101.61 48.32 0.89 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -1.189 . . . . 0.0 109.466 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 282' ' ' ASN . 64.8 mt-30 -68.81 164.06 22.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.455 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 21.0 p -150.35 145.33 26.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 109.461 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.412 ' CD1' HG22 ' A' ' 317' ' ' VAL . 33.2 mm -88.69 135.64 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 109.423 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' GLN . . . . . 0.497 ' OE1' ' CG ' ' A' ' 318' ' ' MET . 0.6 OUTLIER -112.14 -18.45 12.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -143.15 157.24 44.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 109.477 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 314' ' ' GLY . 1.7 p -168.6 134.81 1.84 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.473 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.524 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 34.8 p90 -144.2 155.01 43.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.521 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.476 ' CB ' ' HA ' ' A' ' 313' ' ' PHE . 0.4 OUTLIER 72.66 6.5 5.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.589 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.544 ' HB3' ' CB ' ' A' ' 313' ' ' PHE . . . 177.69 170.19 0.65 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.518 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.653 ' O ' HG13 ' A' ' 304' ' ' VAL . 38.7 m-80 -117.87 166.25 12.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.898 . . . . 0.0 109.505 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 304' ' ' VAL . 86.1 t -138.93 116.51 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.459 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 301' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 302' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.27 0.557 . . . . 0.0 109.526 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 301' ' ' THR . 0.1 OUTLIER -155.7 84.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.358 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 304' ' ' VAL . 5.1 m -63.18 169.28 3.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.357 -0.84 . . . . 0.0 109.809 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 295' ' ' VAL . 54.9 t -155.62 130.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 109.368 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 10.1 p -132.0 150.41 76.03 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.166 -0.959 . . . . 0.0 109.499 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.92 -174.03 2.06 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.584 2.19 . . . . 0.0 110.41 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -149.45 18.73 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 79.24 51.05 5.48 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.4 t -135.02 -85.2 0.4 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -1.129 . . . . 0.0 109.427 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -126.78 175.34 17.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -108.18 -1.2 20.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -1.134 . . . . 0.0 109.612 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.607 HG23 ' HB3' ' A' ' 268' ' ' SER . 30.2 m -116.9 107.29 14.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.17 -0.957 . . . . 0.0 109.428 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.65 ' HZ ' HG11 ' A' ' 277' ' ' VAL . 39.0 p90 -117.47 149.08 41.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.524 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -112.96 160.15 13.28 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 11.2 m -143.19 146.28 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -1.152 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 54.5 m -103.8 102.59 12.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.527 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.585 ' HB ' ' CZ ' ' A' ' 263' ' ' PHE . 60.6 t -90.4 132.72 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.482 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' MET . . . . . 0.497 ' CG ' ' OE1' ' A' ' 288' ' ' GLN . 28.1 mmm -87.45 143.75 27.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.577 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' LYS . . . . . 0.401 ' HE3' ' HB3' ' A' ' 323' ' ' SER . 37.5 mmtm -57.11 -76.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.497 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 54.15 23.88 4.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.25 -0.906 . . . . 0.0 109.446 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 101.83 32.61 4.99 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 13.2 t -158.02 117.45 3.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -1.116 . . . . 0.0 109.432 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' SER . . . . . 0.401 ' HB3' ' HE3' ' A' ' 319' ' ' LYS . 0.7 OUTLIER -112.13 3.39 17.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.579 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 324' ' ' THR . . . . . . . . . . . . . 1.2 m -98.53 128.08 44.72 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.137 -0.977 . . . . 0.0 108.927 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.569 HG22 ' CE1' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -59.45 165.66 3.82 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.89 . . . . 0.0 109.528 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 326' ' ' PRO . . . . . 0.624 ' HB3' HD22 ' A' ' 281' ' ' LEU . 34.1 Cg_endo -77.43 171.56 17.42 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.643 2.228 . . . . 0.0 110.675 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -103.82 132.56 49.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -0.898 . . . . 0.0 109.289 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.827 ' HB2' ' CE1' ' A' ' 267' ' ' TYR . . . -107.12 148.72 28.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.655 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 278' ' ' ASN . 52.7 p -149.18 125.86 11.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.35 -0.843 . . . . 0.0 109.465 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 40.6 t -88.12 130.32 35.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -0.927 . . . . 0.0 109.492 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.522 179.964 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 30.1 p . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.609 ' O ' HG13 ' A' ' 269' ' ' VAL . 0.0 OUTLIER -141.69 175.67 9.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.591 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.668 HG13 ' CG2' ' A' ' 269' ' ' VAL . 0.8 OUTLIER -130.47 107.66 14.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.401 -0.812 . . . . 0.0 109.588 -179.177 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 34.2 p -96.86 112.37 24.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.378 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.495 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -95.6 140.43 30.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.601 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 23.5 m -130.32 149.67 51.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 109.377 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.05 122.89 29.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.927 . . . . 0.0 109.491 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -103.42 -148.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLU . . . . . 0.426 ' HB3' ' CH2' ' A' ' 259' ' ' TRP . 0.5 OUTLIER -47.7 132.43 14.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 109.412 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -107.94 157.15 18.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.607 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' TRP . . . . . 0.467 ' HB2' ' O ' ' A' ' 262' ' ' ARG . 5.1 m-90 -136.25 -170.13 2.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 54.3 m -103.1 -9.54 19.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 109.484 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' ASP . . . . . 0.428 ' O ' ' HB3' ' A' ' 262' ' ' ARG . 13.1 p-10 -133.75 17.25 3.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.435 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' ARG . . . . . 0.546 ' N ' ' HG2' ' A' ' 319' ' ' LYS . 0.4 OUTLIER 175.95 166.44 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -0.952 . . . . 0.0 109.492 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 263' ' ' PHE . . . . . 0.714 ' CZ ' HG11 ' A' ' 317' ' ' VAL . 55.0 p90 -148.66 136.2 20.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -87.24 155.06 20.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.495 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 1.8 t -137.8 137.51 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 19.8 m -105.91 91.69 3.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.457 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' TYR . . . . . 0.793 ' CZ ' HD21 ' A' ' 279' ' ' LEU . 27.2 m-85 -80.58 136.05 36.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.463 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 251' ' ' VAL . 2.7 t -131.59 159.49 38.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.908 . . . . 0.0 109.541 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' VAL . . . . . 0.668 ' CG2' HG13 ' A' ' 251' ' ' VAL . 96.0 t -152.44 97.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 0.0 109.495 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.61 -168.29 2.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.342 -0.849 . . . . 0.0 109.533 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 88.09 -41.71 3.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 57.5 p -173.11 170.54 4.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.277 -1.131 . . . . 0.0 109.359 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.17 -34.0 7.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.396 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.76 77.45 6.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.954 . . . . 0.0 108.638 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.671 ' CE3' HG23 ' A' ' 277' ' ' VAL . 17.2 p-90 -127.46 153.53 46.18 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.326 -0.859 . . . . 0.0 109.797 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 87.2 m -113.96 95.19 5.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.116 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' VAL . . . . . 0.956 HG22 ' HA ' ' A' ' 330' ' ' CYS . 48.4 t -107.56 149.53 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.621 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 3.7 m-20 -127.46 132.87 49.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -0.878 . . . . 0.0 109.404 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.793 HD21 ' CZ ' ' A' ' 267' ' ' TYR . 7.1 mt -85.05 155.95 21.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.479 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -137.07 84.43 2.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.618 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 285' ' ' GLN . 19.0 mt -59.99 172.41 0.78 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.456 ' O ' ' C ' ' A' ' 283' ' ' GLY . 12.1 m-80 -86.84 59.45 5.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 109.772 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 282' ' ' ASN . . . 37.7 43.0 1.12 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 285' ' ' GLN . 73.7 m -158.94 -87.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.1 -1.235 . . . . 0.0 109.63 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' GLN . . . . . 0.801 ' O ' HD13 ' A' ' 281' ' ' LEU . 0.0 OUTLIER -43.13 140.81 1.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.2 p -115.97 179.7 3.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 109.513 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ILE . . . . . 0.493 HD12 ' HB ' ' A' ' 315' ' ' VAL . 18.1 mm -102.3 149.36 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.23 -33.86 3.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.188 -0.945 . . . . 0.0 109.469 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.401 ' HB3' ' OG1' ' A' ' 316' ' ' THR . . . -151.48 169.21 22.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.488 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -160.16 140.56 11.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.394 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' TRP . . . . . 0.56 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 31.2 p90 -136.58 148.57 47.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.943 . . . . 0.0 109.507 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 291' ' ' TRP . 0.7 OUTLIER 73.77 7.71 4.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.494 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ALA . . . . . 0.496 ' HB3' ' CB ' ' A' ' 313' ' ' PHE . . . 176.96 149.85 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.456 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -106.77 136.38 46.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.453 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' VAL . . . . . 0.651 HG22 HG22 ' A' ' 304' ' ' VAL . 17.5 t -115.15 136.43 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.458 -179.995 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 302' ' ' ARG . . . . . 0.425 ' HB3' ' CG1' ' A' ' 295' ' ' VAL . 0.0 OUTLIER -146.67 141.3 26.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 295' ' ' VAL . 1.7 m -92.61 169.13 10.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.651 HG22 HG22 ' A' ' 295' ' ' VAL . 61.9 t -155.95 122.24 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.49 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 52.9 p -130.66 155.39 81.32 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.99 146.13 22.81 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.67 2.247 . . . . 0.0 110.437 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -112.7 -10.25 13.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 119.29 29.6 1.73 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.8 -30.35 6.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -1.146 . . . . 0.0 109.414 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 151.79 -156.55 26.75 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 311' ' ' ASN . 0.8 OUTLIER -117.17 8.27 13.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.225 -1.162 . . . . 0.0 109.573 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 11.1 m -109.61 96.57 6.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.408 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.523 ' CZ ' HG11 ' A' ' 304' ' ' VAL . 47.3 p90 -117.66 144.33 45.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' GLY . . . . . 0.56 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -109.77 168.35 13.15 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' A' ' 287' ' ' ILE . 5.5 m -141.96 144.01 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -1.114 . . . . 0.0 109.452 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 289' ' ' ALA . 7.5 m -94.06 92.54 7.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 109.494 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' VAL . . . . . 0.714 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 16.4 t -83.63 153.43 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.456 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' MET . . . . . 0.425 ' O ' ' CG ' ' A' ' 285' ' ' GLN . 29.6 mtp -113.43 144.42 42.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.541 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' LYS . . . . . 0.546 ' HG2' ' N ' ' A' ' 262' ' ' ARG . 21.9 mmtp -65.95 -73.68 0.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 0.0 109.473 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 319' ' ' LYS . 4.3 m-20 63.16 24.02 14.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.332 -0.855 . . . . 0.0 109.408 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 99.56 37.95 3.84 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' SER . . . . . 0.472 ' O ' ' HD2' ' A' ' 319' ' ' LYS . 0.3 OUTLIER -159.76 -157.42 0.57 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -1.188 . . . . 0.0 109.467 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 323' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 324' ' ' THR . 0.0 OUTLIER 179.89 -47.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 109.438 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 324' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -40.16 125.08 1.97 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.599 -0.688 . . . . 0.0 110.102 -179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.582 HG22 ' HE2' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -64.46 167.0 9.51 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.381 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 326' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 325' ' ' THR . 33.2 Cg_endo -76.26 163.37 32.66 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.522 2.148 . . . . 0.0 110.614 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -110.98 115.15 29.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 0.0 109.376 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' ALA . . . . . 0.446 ' HB2' ' CD2' ' A' ' 279' ' ' LEU . . . -103.61 163.56 12.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.494 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' THR . . . . . 0.596 ' C ' HG13 ' A' ' 277' ' ' VAL . 35.8 p -149.49 127.17 11.68 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.303 -0.873 . . . . 0.0 109.367 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' CYS . . . . . 0.956 ' HA ' HG22 ' A' ' 277' ' ' VAL . 42.8 t -86.43 125.4 33.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.356 -0.84 . . . . 0.0 109.505 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.41 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 83.48 148.12 8.01 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.418 ' C ' ' SG ' ' A' ' 330' ' ' CYS . 3.5 p -117.66 171.35 8.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -1.128 . . . . 0.0 109.359 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.53 173.73 11.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.658 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.657 HG13 ' CG2' ' A' ' 269' ' ' VAL . 0.9 OUTLIER -136.55 134.36 49.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.444 -179.16 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.1 OUTLIER -116.59 134.51 54.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 109.505 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.776 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -124.89 106.89 10.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.526 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.5 m -103.59 135.33 45.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.462 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -69.8 111.51 5.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.87 . . . . 0.0 109.469 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -82.75 -74.43 0.35 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.451 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.5 ' HB3' ' CH2' ' A' ' 259' ' ' TRP . 3.1 mm-40 -106.62 138.06 43.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.436 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -125.16 128.73 48.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 109.502 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' TRP . . . . . 0.5 ' CH2' ' HB3' ' A' ' 257' ' ' GLU . 8.9 m-90 -120.01 -178.69 3.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.216 -0.928 . . . . 0.0 109.463 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 m -91.96 9.74 31.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.453 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.22 -39.26 0.93 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.431 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.92 154.8 43.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.47 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.556 ' CZ ' HG11 ' A' ' 317' ' ' VAL . 40.4 p90 -130.25 133.69 46.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.93 . . . . 0.0 109.457 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -89.11 160.81 16.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.485 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 1.6 t -136.88 159.23 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 109.422 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 253' ' ' ALA . 3.2 m -123.66 92.54 3.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.547 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' TYR . . . . . 0.838 ' CE2' ' HB2' ' A' ' 328' ' ' ALA . 45.2 m-85 -87.65 150.74 23.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.3 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 251' ' ' VAL . 11.2 p -160.13 148.67 17.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 109.678 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.657 ' CG2' HG13 ' A' ' 251' ' ' VAL . 89.1 t -129.54 143.03 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -0.879 . . . . 0.0 109.41 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.57 156.79 25.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.207 -0.933 . . . . 0.0 109.531 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 110.9 -62.85 0.28 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.25 171.38 14.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -1.12 . . . . 0.0 109.427 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 31.3 t -106.13 -26.91 11.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.501 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.64 78.0 6.22 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.943 ' CE3' HG23 ' A' ' 277' ' ' VAL . 6.4 p-90 -128.36 163.23 25.29 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.367 -0.833 . . . . 0.0 109.988 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 34.9 m -113.37 99.76 8.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.943 HG23 ' CE3' ' A' ' 275' ' ' TRP . 41.9 t -79.8 99.09 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.166 -0.959 . . . . 0.0 109.99 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 0.4 OUTLIER -87.14 133.17 33.66 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' A' ' 328' ' ' ALA . 82.6 mt -116.98 132.61 56.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -0.978 . . . . 0.0 109.698 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -104.67 77.28 1.35 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.254 -0.904 . . . . 0.0 109.109 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.668 HD22 ' HB3' ' A' ' 326' ' ' PRO . 4.1 mm? -59.41 131.96 52.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.425 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -86.75 147.38 25.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.28 -0.887 . . . . 0.0 109.514 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 66.08 -148.39 50.87 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 69.4 m -103.7 48.99 0.83 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -1.15 . . . . 0.0 109.461 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.514 ' CB ' HD12 ' A' ' 281' ' ' LEU . 64.4 mt-30 -69.56 150.51 47.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.863 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.443 ' O ' ' HG2' ' A' ' 318' ' ' MET . 23.0 p -139.04 146.96 41.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.459 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.48 HG22 ' H ' ' A' ' 289' ' ' ALA . 32.0 mm -94.36 136.17 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.277 -0.889 . . . . 0.0 109.469 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.24 11.86 12.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.537 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.619 ' HB3' ' OG1' ' A' ' 316' ' ' THR . . . -168.18 153.51 6.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.94 . . . . 0.0 109.465 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.6 p -165.41 127.97 2.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.48 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.569 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 19.1 p90 -127.61 142.48 51.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.497 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.531 ' O ' ' HB2' ' A' ' 293' ' ' ALA . 15.8 t-20 69.78 17.68 7.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.407 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 292' ' ' ASN . . . 174.27 151.52 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -110.15 143.65 39.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.425 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.855 HG22 HG22 ' A' ' 304' ' ' VAL . 20.9 t -118.72 123.94 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.9 -170.15 3.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 110.63 137.44 7.51 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.17 166.14 10.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -1.123 . . . . 0.0 109.505 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 106.4 -166.07 13.73 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 1.6 m -88.15 -16.31 33.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.202 -1.175 . . . . 0.0 109.489 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.43 171.99 8.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.928 . . . . 0.0 109.521 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 279' ' ' LEU . 7.6 mmt-85 -138.45 160.76 38.71 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.323 -0.861 . . . . 0.0 109.207 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.521 HG22 ' N ' ' A' ' 304' ' ' VAL . 21.1 m -142.85 161.16 38.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.956 . . . . 0.0 109.71 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.855 HG22 HG22 ' A' ' 295' ' ' VAL . 56.1 t -142.0 144.94 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.358 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 21.6 p -137.42 147.77 59.14 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.403 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.71 152.33 29.08 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.547 2.165 . . . . 0.0 110.446 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -113.77 -10.48 13.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.499 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 116.54 57.2 0.32 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 58.5 m -135.16 -59.9 0.77 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -1.174 . . . . 0.0 109.429 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -169.36 -146.04 4.88 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -129.31 13.97 6.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -1.145 . . . . 0.0 109.456 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 2.2 m -122.19 111.99 17.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.688 ' HZ ' HG11 ' A' ' 277' ' ' VAL . 4.6 p90 -135.37 165.81 24.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.412 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.569 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -128.43 161.25 22.19 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 32.5 m -134.38 158.17 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -1.154 . . . . 0.0 109.49 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' THR . . . . . 0.619 ' OG1' ' HB3' ' A' ' 289' ' ' ALA . 19.0 m -113.23 95.22 5.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.504 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.556 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 53.7 t -85.75 147.9 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 286' ' ' THR . 67.0 mmm -106.09 128.13 53.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.507 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' LYS . . . . . 0.49 ' HD2' ' O ' ' A' ' 322' ' ' SER . 18.0 mmtp -45.22 -68.18 0.22 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 53.13 37.7 25.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 87.28 25.49 33.49 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' SER . . . . . 0.49 ' O ' ' HD2' ' A' ' 319' ' ' LYS . 0.2 OUTLIER -150.73 -178.64 6.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -1.167 . . . . 0.0 109.462 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 323' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 324' ' ' THR . 0.0 OUTLIER -164.2 -46.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.415 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 324' ' ' THR . . . . . 0.435 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -41.45 120.91 1.54 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.418 -0.801 . . . . 0.0 109.873 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.524 HG22 ' HE1' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -61.06 165.45 6.24 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.923 . . . . 0.0 109.463 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.668 ' HB3' HD22 ' A' ' 281' ' ' LEU . 33.6 Cg_endo -77.66 170.94 18.3 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.676 2.251 . . . . 0.0 110.775 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -106.32 119.48 39.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 109.089 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.838 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -93.89 147.99 22.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.204 -0.935 . . . . 0.0 109.946 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 41.1 p -142.11 126.71 17.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.478 -0.764 . . . . 0.0 109.23 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 330' ' ' CYS . 15.6 p -85.38 128.72 34.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.199 -0.938 . . . . 0.0 109.57 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -143.66 132.03 22.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 109.515 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 119.54 39.89 0.64 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 81.1 p . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.28 -1.13 . . . . 0.0 109.479 179.995 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -108.89 -109.45 3.29 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.51 ' N ' ' SG ' ' A' ' 330' ' ' CYS . 11.7 p -173.18 178.63 2.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -1.123 . . . . 0.0 109.514 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.567 ' O ' HG13 ' A' ' 269' ' ' VAL . 1.0 OUTLIER -111.57 174.74 5.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.432 -0.793 . . . . 0.0 109.88 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.703 HG13 ' CG2' ' A' ' 269' ' ' VAL . 0.8 OUTLIER -129.5 169.57 20.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.359 -179.196 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.0 115.17 5.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.227 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.441 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -126.95 150.88 49.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 109.505 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.95 160.74 16.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.423 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -95.85 136.58 36.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.468 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -117.8 -66.57 1.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.497 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -107.77 117.61 34.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.491 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -107.2 136.34 47.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 0.0 109.45 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 2.6 m-90 -120.74 -173.83 2.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.928 . . . . 0.0 109.449 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.8 m -92.66 17.65 9.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.918 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.9 -43.57 0.3 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.436 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.423 ' HB3' ' HA ' ' A' ' 318' ' ' MET . 0.0 OUTLIER -151.25 158.03 43.35 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.186 -0.946 . . . . 0.0 109.438 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.679 ' CE1' HG22 ' A' ' 325' ' ' THR . 27.9 p90 -123.7 160.62 26.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.432 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -98.25 151.86 20.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -0.873 . . . . 0.0 109.388 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.538 HG11 ' CE1' ' A' ' 267' ' ' TYR . 1.7 t -133.99 139.2 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.458 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.99 96.39 6.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.222 -0.924 . . . . 0.0 109.471 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' TYR . . . . . 0.635 ' HE2' ' HB2' ' A' ' 328' ' ' ALA . 38.4 m-85 -95.74 100.74 12.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.46 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.26 152.34 34.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.662 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.703 ' CG2' HG13 ' A' ' 251' ' ' VAL . 59.9 t -140.64 142.86 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.352 -0.843 . . . . 0.0 109.495 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.8 m -134.84 163.73 29.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 109.526 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' A' ' 272' ' ' SER . . . 104.64 -10.41 49.33 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 271' ' ' GLY . 0.5 OUTLIER 169.37 159.7 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -1.109 . . . . 0.0 109.321 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 48.5 t -105.34 -29.5 10.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.6 77.96 6.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 108.661 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.994 ' CE3' HG23 ' A' ' 277' ' ' VAL . 10.7 p-90 -128.69 157.1 42.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.41 -0.806 . . . . 0.0 109.934 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 16.0 m -110.61 96.48 6.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.406 -0.809 . . . . 0.0 108.863 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.994 HG23 ' CE3' ' A' ' 275' ' ' TRP . 40.2 t -79.76 104.15 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.919 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ASN . . . . . 0.481 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 5.7 t-20 -93.47 138.96 31.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.369 -0.832 . . . . 0.0 108.783 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 327' ' ' ALA . 34.1 mt -122.61 132.3 54.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.174 -0.954 . . . . 0.0 109.568 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -110.1 83.2 1.72 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 109.271 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.785 HD22 ' HB3' ' A' ' 326' ' ' PRO . 4.2 mm? -59.26 139.26 57.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.466 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -83.86 122.71 29.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.405 -0.809 . . . . 0.0 109.422 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 82.91 -149.21 26.49 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 58.8 m -100.47 34.11 2.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -1.104 . . . . 0.0 109.538 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.514 ' CB ' HD12 ' A' ' 281' ' ' LEU . 85.3 mt-30 -57.13 169.57 0.55 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.932 . . . . 0.0 109.522 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.449 ' CG2' ' C ' ' A' ' 285' ' ' GLN . 15.8 p -155.81 148.25 23.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.491 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.623 HG13 HG11 ' A' ' 295' ' ' VAL . 38.2 mm -83.25 153.46 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 109.398 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.442 ' HB2' ' HE3' ' A' ' 318' ' ' MET . 3.6 tp-100 -118.52 -28.38 5.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.461 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.408 ' C ' ' OG ' ' A' ' 290' ' ' SER . . . -145.46 166.99 24.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.953 . . . . 0.0 109.459 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' SER . . . . . 0.408 ' OG ' ' C ' ' A' ' 289' ' ' ALA . 0.8 OUTLIER -169.99 137.26 1.58 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.565 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 28.0 p90 -136.4 150.62 48.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 293' ' ' ALA . 0.6 OUTLIER 70.48 15.82 7.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 109.451 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 292' ' ' ASN . . . 172.41 157.8 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.47 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -108.27 134.05 51.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.9 . . . . 0.0 109.501 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.861 HG22 HG22 ' A' ' 304' ' ' VAL . 59.9 t -112.75 118.92 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 71.2 p -150.76 173.86 13.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.447 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 151.47 -132.05 3.69 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 301' ' ' THR . 32.7 p -148.97 -173.22 4.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -1.183 . . . . 0.0 109.497 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 300' ' ' SER . . . -74.55 162.66 54.14 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 299' ' ' GLY . 4.2 t 83.13 -44.15 0.11 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.65 -0.912 . . . . 0.0 109.764 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.425 ' O ' ' O ' ' A' ' 298' ' ' SER . 0.8 OUTLIER -139.8 172.2 13.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.184 -0.948 . . . . 0.0 109.385 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 279' ' ' LEU . 18.4 mmt-85 -145.26 162.47 37.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.244 -0.91 . . . . 0.0 109.253 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 304' ' ' VAL . 7.6 m -140.28 167.63 21.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.711 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.861 HG22 HG22 ' A' ' 295' ' ' VAL . 38.6 t -154.23 142.33 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.366 -0.834 . . . . 0.0 109.314 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 62.3 p -145.66 150.36 43.21 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 109.473 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.83 164.44 27.73 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.678 2.252 . . . . 0.0 110.39 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -119.29 -12.16 9.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.868 . . . . 0.0 109.443 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 114.49 42.89 0.79 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.51 -59.24 1.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -1.159 . . . . 0.0 109.467 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -156.8 162.82 31.89 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -90.18 -7.45 53.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -1.138 . . . . 0.0 109.505 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.423 ' O ' ' CG ' ' A' ' 292' ' ' ASN . 32.1 m -100.59 117.4 34.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.463 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.698 ' HZ ' HG11 ' A' ' 277' ' ' VAL . 12.5 p90 -135.81 153.31 51.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 0.0 109.518 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.565 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -117.1 152.33 17.85 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.92 148.16 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -1.166 . . . . 0.0 109.503 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 287' ' ' ILE . 23.9 m -107.43 129.82 54.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.607 HG22 ' CD1' ' A' ' 287' ' ' ILE . 40.3 t -114.88 149.51 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.939 . . . . 0.0 109.481 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' MET . . . . . 0.442 ' HE3' ' HB2' ' A' ' 288' ' ' GLN . 0.8 OUTLIER -103.68 128.39 51.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 109.399 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 319' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 322' ' ' SER . 10.1 mptt -43.79 -66.13 0.42 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.893 . . . . 0.0 109.538 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 319' ' ' LYS . 19.3 m-20 59.42 31.27 20.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.915 . . . . 0.0 109.436 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 111.36 -47.81 1.0 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 319' ' ' LYS . 0.0 OUTLIER -103.71 158.4 16.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.224 -1.163 . . . . 0.0 109.471 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 323' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 324' ' ' THR . 65.1 m -122.34 -32.46 3.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.429 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -41.51 119.82 1.32 Allowed 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.355 -0.841 . . . . 0.0 109.967 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.679 HG22 ' CE1' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -56.42 166.22 1.3 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.335 179.587 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.785 ' HB3' HD22 ' A' ' 281' ' ' LEU . 32.9 Cg_endo -77.55 157.2 32.36 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.552 2.168 . . . . 0.0 110.721 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 279' ' ' LEU . . . -88.65 165.16 14.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.105 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.635 ' HB2' ' HE2' ' A' ' 267' ' ' TYR . . . -138.18 152.36 48.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.045 -1.034 . . . . 0.0 109.763 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' THR . . . . . 0.439 ' OG1' ' HB3' ' A' ' 278' ' ' ASN . 80.4 p -146.4 127.72 14.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.647 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 249' ' ' CYS . 1.6 t -91.1 138.29 31.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.421 -0.799 . . . . 0.0 108.969 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -133.99 152.18 51.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.903 . . . . 0.0 109.504 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -147.07 -175.23 19.8 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.289 -1.124 . . . . 0.0 109.465 -179.928 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -142.65 126.04 2.78 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.418 ' C ' ' SG ' ' A' ' 330' ' ' CYS . 6.0 p -124.43 169.95 11.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.237 -1.155 . . . . 0.0 109.321 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.545 ' O ' HG22 ' A' ' 269' ' ' VAL . 52.6 p -149.06 173.23 13.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.96 . . . . 0.0 109.538 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.651 HG13 ' CG2' ' A' ' 269' ' ' VAL . 0.9 OUTLIER -135.87 120.19 25.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.528 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.55 118.62 37.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.888 . . . . 0.0 109.453 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.564 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -109.19 101.57 10.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 109.458 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.97 169.04 10.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.868 . . . . 0.0 109.415 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.481 ' NH1' ' CD2' ' A' ' 263' ' ' PHE . 0.0 OUTLIER -98.3 142.67 29.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 109.493 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -110.42 -55.21 2.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 109.413 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.536 ' HB3' ' CZ2' ' A' ' 259' ' ' TRP . 52.1 mm-40 -144.04 144.42 31.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -122.63 122.58 39.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.45 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' TRP . . . . . 0.536 ' CZ2' ' HB3' ' A' ' 257' ' ' GLU . 6.1 m-90 -124.82 -176.64 3.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 73.2 m -93.37 2.11 56.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.914 . . . . 0.0 109.67 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.42 -24.62 7.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.426 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 317' ' ' VAL . 10.1 ptt180 -178.51 166.31 1.79 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.912 . . . . 0.0 109.451 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.576 ' CZ ' ' HB ' ' A' ' 317' ' ' VAL . 47.3 p90 -133.37 151.27 51.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.408 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -97.82 150.75 20.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.333 -0.854 . . . . 0.0 109.469 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.464 HG11 ' CE1' ' A' ' 267' ' ' TYR . 2.1 t -130.88 164.67 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.468 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 253' ' ' ALA . 0.9 OUTLIER -133.52 95.22 3.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 267' ' ' TYR . . . . . 0.762 ' CE2' ' HB2' ' A' ' 328' ' ' ALA . 44.3 m-85 -91.13 140.85 29.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -0.854 . . . . 0.0 109.317 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 251' ' ' VAL . 0.8 OUTLIER -149.88 157.58 43.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.925 . . . . 0.0 109.602 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.651 ' CG2' HG13 ' A' ' 251' ' ' VAL . 98.5 t -144.3 145.85 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.202 -0.936 . . . . 0.0 109.46 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 7.6 p -127.76 173.09 10.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.337 -0.852 . . . . 0.0 109.534 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 106.24 -55.11 0.55 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 274' ' ' ALA . 0.3 OUTLIER -154.53 104.79 2.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -1.145 . . . . 0.0 109.367 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 272' ' ' SER . 2.4 t -42.06 -26.74 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 0.0 109.87 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 272' ' ' SER . . . -79.37 78.3 5.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.068 -1.02 . . . . 0.0 108.665 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.925 ' CZ3' HG23 ' A' ' 277' ' ' VAL . 7.8 p-90 -128.95 172.78 11.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.286 -0.884 . . . . 0.0 109.855 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 331' ' ' ALA . 1.7 m -132.15 102.25 5.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.488 -0.757 . . . . 0.0 108.983 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.925 HG23 ' CZ3' ' A' ' 275' ' ' TRP . 12.3 t -79.96 127.45 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.253 -0.905 . . . . 0.0 109.961 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ASN . . . . . 0.488 ' HB3' ' OG1' ' A' ' 329' ' ' THR . 1.5 t30 -112.46 109.65 19.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.35 -0.844 . . . . 0.0 108.976 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 327' ' ' ALA . 22.2 mt -90.29 140.93 29.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 109.682 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -138.38 93.06 2.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.325 -0.86 . . . . 0.0 109.3 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.715 HD13 ' HB3' ' A' ' 285' ' ' GLN . 24.1 mt -59.83 170.2 1.22 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.94 . . . . 0.0 109.68 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -116.62 85.08 2.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.926 . . . . 0.0 109.439 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 129.52 -145.43 16.4 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 286' ' ' THR . 0.7 OUTLIER -92.6 4.96 52.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -1.16 . . . . 0.0 109.588 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.715 ' HB3' HD13 ' A' ' 281' ' ' LEU . 57.6 mt-30 -47.06 154.5 0.35 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.458 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 284' ' ' SER . 30.8 p -145.61 174.67 10.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 109.532 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 29.2 mt -124.17 152.36 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 109.408 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -141.55 11.96 2.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.181 -0.949 . . . . 0.0 109.699 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.733 ' HB3' ' OG1' ' A' ' 316' ' ' THR . . . -154.3 153.99 32.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.069 -1.019 . . . . 0.0 109.603 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 24.0 p -165.37 126.02 1.9 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.39 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.567 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 22.4 p90 -124.98 138.85 54.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.659 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.545 ' O ' ' HB2' ' A' ' 293' ' ' ALA . 1.4 t-20 71.98 33.96 1.56 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.885 . . . . 0.0 109.508 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 292' ' ' ASN . . . 172.3 157.76 0.1 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.484 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -104.86 99.08 8.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.487 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.648 HG22 HG22 ' A' ' 304' ' ' VAL . 48.0 t -95.48 112.44 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.919 . . . . 0.0 109.469 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 1.4 p -142.45 176.18 9.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.966 . . . . 0.0 109.591 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 116.09 -154.7 16.71 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' SER . . . . . 0.438 ' O ' ' HD2' ' A' ' 302' ' ' ARG . 2.5 m -94.93 179.08 5.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -1.115 . . . . 0.0 109.43 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -77.11 -41.76 21.23 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.79 -32.21 13.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -1.143 . . . . 0.0 109.452 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.0 p -147.12 138.67 24.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.199 -0.938 . . . . 0.0 109.481 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 298' ' ' SER . 18.3 mmm180 -119.35 102.09 8.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.2 -0.938 . . . . 0.0 109.394 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 40.0 m -69.21 149.72 48.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.469 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.648 HG22 HG22 ' A' ' 295' ' ' VAL . 58.5 t -140.27 139.76 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 30.0 p -145.17 155.83 54.56 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.47 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.08 140.63 18.03 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.626 2.217 . . . . 0.0 110.479 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -120.44 26.08 9.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 74.43 55.43 5.58 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.14 -60.4 0.77 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -1.133 . . . . 0.0 109.467 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -162.24 -179.77 37.07 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -103.15 -2.68 26.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -1.107 . . . . 0.0 109.571 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 313' ' ' PHE . 40.9 m -113.77 162.06 16.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 109.539 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 267' ' ' TYR . 3.0 p90 -176.99 155.65 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.381 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.567 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -125.54 166.84 18.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 16.9 m -136.89 167.45 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -1.155 . . . . 0.0 109.515 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' THR . . . . . 0.733 ' OG1' ' HB3' ' A' ' 289' ' ' ALA . 89.1 m -117.52 108.55 15.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.883 . . . . 0.0 109.483 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.576 ' HB ' ' CZ ' ' A' ' 263' ' ' PHE . 40.4 t -100.91 149.95 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.879 . . . . 0.0 109.347 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 7.2 mtp -99.84 135.19 41.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.92 . . . . 0.0 109.501 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 320' ' ' ASN . 17.9 mmtp -46.92 -69.4 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.533 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 319' ' ' LYS . 24.9 m-20 61.27 24.64 14.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.467 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 97.13 -28.27 14.7 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.79 148.57 25.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -1.121 . . . . 0.0 109.495 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 324' ' ' THR . 23.3 t -123.27 -37.19 2.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 109.456 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -41.89 117.51 0.96 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.472 -0.768 . . . . 0.0 109.826 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.53 HG22 ' HE2' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -52.86 164.35 0.7 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.92 . . . . 0.0 109.416 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.503 ' HB3' HD23 ' A' ' 281' ' ' LEU . 33.3 Cg_endo -77.78 166.39 25.41 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.673 2.249 . . . . 0.0 110.69 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 279' ' ' LEU . . . -92.72 170.52 9.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.839 . . . . 0.0 109.135 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.762 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -147.78 149.0 31.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.136 -0.978 . . . . 0.0 110.011 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' THR . . . . . 0.488 ' OG1' ' HB3' ' A' ' 278' ' ' ASN . 40.2 p -140.17 128.0 21.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 109.352 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' CYS . . . . . 0.418 ' HB3' HG22 ' A' ' 251' ' ' VAL . 16.6 p -82.43 171.63 13.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 109.517 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' ALA . . . . . 0.455 ' HB2' ' HB ' ' A' ' 276' ' ' THR . . . -127.54 133.64 49.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.455 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -126.92 9.87 7.09 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 56.3 p . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.262 -1.14 . . . . 0.0 109.457 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 40.2 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.326 0.584 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 91.29 -83.16 1.26 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 22.5 p -136.3 169.18 18.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.133 -1.216 . . . . 0.0 109.444 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.841 ' O ' HG13 ' A' ' 269' ' ' VAL . 60.5 p -151.06 174.59 13.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.933 . . . . 0.0 109.6 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.574 HG13 ' CG2' ' A' ' 269' ' ' VAL . 0.8 OUTLIER -132.17 171.49 17.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.462 -0.774 . . . . 0.0 109.608 -179.168 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.98 119.24 3.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.349 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.767 ' HB2' ' CE1' ' A' ' 267' ' ' TYR . . . -111.56 149.16 31.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 109.491 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 23.8 m -151.07 130.37 12.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.481 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.524 ' HD3' HG23 ' A' ' 325' ' ' THR . 2.7 mtm-85 -77.88 137.95 38.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.446 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -107.49 -69.14 0.86 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.449 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -107.71 136.09 48.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.504 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -111.2 129.25 56.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.411 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -124.7 172.31 9.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 109.453 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 57.2 m -88.99 4.34 48.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.895 . . . . 0.0 109.63 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -119.09 -26.5 5.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.169 -0.957 . . . . 0.0 109.48 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 317' ' ' VAL . 16.0 ptt180 -173.41 162.42 4.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.45 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.585 ' CZ ' ' HB ' ' A' ' 317' ' ' VAL . 34.0 p90 -124.75 144.75 50.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.886 . . . . 0.0 109.508 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -85.47 157.93 20.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.44 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.688 HG11 ' CE2' ' A' ' 267' ' ' TYR . 1.9 t -136.12 152.23 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 0.0 109.505 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 253' ' ' ALA . 10.1 m -126.78 91.26 3.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.428 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' TYR . . . . . 0.827 ' CE1' ' HB2' ' A' ' 328' ' ' ALA . 58.8 m-85 -91.34 144.29 25.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.404 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.607 ' HB3' HG23 ' A' ' 312' ' ' THR . 24.9 p -159.93 158.26 30.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.211 -0.93 . . . . 0.0 109.585 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 250' ' ' SER . 74.2 t -134.87 141.47 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.302 -0.873 . . . . 0.0 109.394 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 7.1 t -115.69 138.29 51.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.526 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 272' ' ' SER . . . 123.74 -15.63 7.94 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 271' ' ' GLY . 0.2 OUTLIER 167.73 165.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -1.197 . . . . 0.0 109.432 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 84.0 p -104.46 -24.46 13.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 109.519 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.75 77.43 6.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 108.744 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.983 ' CE3' HG23 ' A' ' 277' ' ' VAL . 9.8 p-90 -130.33 158.26 40.3 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.362 -0.836 . . . . 0.0 109.786 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.3 m -111.1 95.66 5.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.095 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.983 HG23 ' CE3' ' A' ' 275' ' ' TRP . 42.4 t -80.08 128.99 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.915 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 30.0 m-20 -107.55 130.74 54.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.856 . . . . 0.0 108.886 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.498 HD12 HG21 ' A' ' 304' ' ' VAL . 60.8 mt -118.94 126.45 51.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 0.0 109.578 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -110.47 82.56 1.61 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.298 -0.876 . . . . 0.0 109.497 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.624 HD22 ' HB3' ' A' ' 326' ' ' PRO . 4.3 mm? -59.75 145.23 45.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.984 . . . . 0.0 109.414 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.453 ' O ' ' HG3' ' A' ' 285' ' ' GLN . 2.3 m-80 -96.04 170.39 9.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.215 -0.928 . . . . 0.0 109.525 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 282' ' ' ASN . . . 45.34 -151.41 0.96 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 2.8 p -101.61 48.32 0.89 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -1.189 . . . . 0.0 109.466 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 282' ' ' ASN . 64.8 mt-30 -68.81 164.06 22.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.455 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 21.0 p -150.35 145.33 26.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 109.461 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.412 ' CD1' HG22 ' A' ' 317' ' ' VAL . 33.2 mm -88.69 135.64 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 109.423 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.497 ' OE1' ' CG ' ' A' ' 318' ' ' MET . 0.6 OUTLIER -112.14 -18.45 12.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -143.15 157.24 44.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 109.477 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 314' ' ' GLY . 1.7 p -168.6 134.81 1.84 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.473 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.524 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 34.8 p90 -144.2 155.01 43.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.521 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.476 ' CB ' ' HA ' ' A' ' 313' ' ' PHE . 0.4 OUTLIER 72.66 6.5 5.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.589 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.544 ' HB3' ' CB ' ' A' ' 313' ' ' PHE . . . 177.69 170.19 0.65 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.518 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.653 ' O ' HG13 ' A' ' 304' ' ' VAL . 38.7 m-80 -117.87 166.25 12.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.898 . . . . 0.0 109.505 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 304' ' ' VAL . 86.1 t -138.93 116.51 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 13.6 p -135.62 -170.05 2.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.459 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.6 171.1 34.5 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.5 -176.16 3.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -1.144 . . . . 0.0 109.455 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 83.22 62.0 1.85 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 55.72 30.58 15.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -1.179 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 302' ' ' ARG . 0.8 OUTLIER -148.31 171.18 16.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.89 . . . . 0.0 109.526 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 301' ' ' THR . 0.1 OUTLIER -155.7 84.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.358 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 304' ' ' VAL . 5.1 m -63.18 169.28 3.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.357 -0.84 . . . . 0.0 109.809 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 295' ' ' VAL . 54.9 t -155.62 130.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 109.368 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 10.1 p -132.0 150.41 76.03 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.166 -0.959 . . . . 0.0 109.499 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.92 -174.03 2.06 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.584 2.19 . . . . 0.0 110.41 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -149.45 18.73 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 79.24 51.05 5.48 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.4 t -135.02 -85.2 0.4 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -1.129 . . . . 0.0 109.427 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -126.78 175.34 17.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -108.18 -1.2 20.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -1.134 . . . . 0.0 109.612 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.607 HG23 ' HB3' ' A' ' 268' ' ' SER . 30.2 m -116.9 107.29 14.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.17 -0.957 . . . . 0.0 109.428 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.65 ' HZ ' HG11 ' A' ' 277' ' ' VAL . 39.0 p90 -117.47 149.08 41.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.524 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -112.96 160.15 13.28 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 11.2 m -143.19 146.28 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -1.152 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 54.5 m -103.8 102.59 12.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.527 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.585 ' HB ' ' CZ ' ' A' ' 263' ' ' PHE . 60.6 t -90.4 132.72 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.482 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' MET . . . . . 0.497 ' CG ' ' OE1' ' A' ' 288' ' ' GLN . 28.1 mmm -87.45 143.75 27.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.577 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' LYS . . . . . 0.401 ' HE3' ' HB3' ' A' ' 323' ' ' SER . 37.5 mmtm -57.11 -76.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.497 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 54.15 23.88 4.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.25 -0.906 . . . . 0.0 109.446 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 101.83 32.61 4.99 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 13.2 t -158.02 117.45 3.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -1.116 . . . . 0.0 109.432 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' SER . . . . . 0.401 ' HB3' ' HE3' ' A' ' 319' ' ' LYS . 0.7 OUTLIER -112.13 3.39 17.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.579 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 324' ' ' THR . . . . . . . . . . . . . 1.2 m -98.53 128.08 44.72 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.137 -0.977 . . . . 0.0 108.927 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.569 HG22 ' CE1' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -59.45 165.66 3.82 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.89 . . . . 0.0 109.528 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.624 ' HB3' HD22 ' A' ' 281' ' ' LEU . 34.1 Cg_endo -77.43 171.56 17.42 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.643 2.228 . . . . 0.0 110.675 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -103.82 132.56 49.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -0.898 . . . . 0.0 109.289 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.827 ' HB2' ' CE1' ' A' ' 267' ' ' TYR . . . -107.12 148.72 28.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.655 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 278' ' ' ASN . 52.7 p -149.18 125.86 11.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.35 -0.843 . . . . 0.0 109.465 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 40.6 t -88.12 130.32 35.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -0.927 . . . . 0.0 109.492 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -126.09 119.04 26.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.522 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -86.95 121.47 5.81 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.215 -1.168 . . . . 0.0 109.444 -179.917 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.99 165.31 12.04 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 30.1 p -162.15 153.39 18.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -1.119 . . . . 0.0 109.491 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.609 ' O ' HG13 ' A' ' 269' ' ' VAL . 0.0 OUTLIER -141.69 175.67 9.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.591 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.668 HG13 ' CG2' ' A' ' 269' ' ' VAL . 0.8 OUTLIER -130.47 107.66 14.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.401 -0.812 . . . . 0.0 109.588 -179.177 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 34.2 p -96.86 112.37 24.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.378 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.495 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -95.6 140.43 30.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.601 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 23.5 m -130.32 149.67 51.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 109.377 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.05 122.89 29.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.927 . . . . 0.0 109.491 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -103.42 -148.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLU . . . . . 0.426 ' HB3' ' CH2' ' A' ' 259' ' ' TRP . 0.5 OUTLIER -47.7 132.43 14.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 109.412 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -107.94 157.15 18.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.607 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' TRP . . . . . 0.467 ' HB2' ' O ' ' A' ' 262' ' ' ARG . 5.1 m-90 -136.25 -170.13 2.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 54.3 m -103.1 -9.54 19.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 109.484 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' ASP . . . . . 0.428 ' O ' ' HB3' ' A' ' 262' ' ' ARG . 13.1 p-10 -133.75 17.25 3.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.435 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' ARG . . . . . 0.546 ' N ' ' HG2' ' A' ' 319' ' ' LYS . 0.4 OUTLIER 175.95 166.44 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -0.952 . . . . 0.0 109.492 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.714 ' CZ ' HG11 ' A' ' 317' ' ' VAL . 55.0 p90 -148.66 136.2 20.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -87.24 155.06 20.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.495 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 1.8 t -137.8 137.51 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 19.8 m -105.91 91.69 3.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.457 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' TYR . . . . . 0.793 ' CZ ' HD21 ' A' ' 279' ' ' LEU . 27.2 m-85 -80.58 136.05 36.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.463 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 251' ' ' VAL . 2.7 t -131.59 159.49 38.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.908 . . . . 0.0 109.541 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.668 ' CG2' HG13 ' A' ' 251' ' ' VAL . 96.0 t -152.44 97.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 0.0 109.495 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.61 -168.29 2.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.342 -0.849 . . . . 0.0 109.533 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 88.09 -41.71 3.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 57.5 p -173.11 170.54 4.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.277 -1.131 . . . . 0.0 109.359 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.17 -34.0 7.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.396 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.76 77.45 6.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.954 . . . . 0.0 108.638 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.671 ' CE3' HG23 ' A' ' 277' ' ' VAL . 17.2 p-90 -127.46 153.53 46.18 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.326 -0.859 . . . . 0.0 109.797 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 87.2 m -113.96 95.19 5.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.116 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.956 HG22 ' HA ' ' A' ' 330' ' ' CYS . 48.4 t -107.56 149.53 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.621 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 3.7 m-20 -127.46 132.87 49.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -0.878 . . . . 0.0 109.404 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.793 HD21 ' CZ ' ' A' ' 267' ' ' TYR . 7.1 mt -85.05 155.95 21.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.479 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -137.07 84.43 2.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.618 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 285' ' ' GLN . 19.0 mt -59.99 172.41 0.78 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.456 ' O ' ' C ' ' A' ' 283' ' ' GLY . 12.1 m-80 -86.84 59.45 5.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 109.772 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 282' ' ' ASN . . . 37.7 43.0 1.12 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 285' ' ' GLN . 73.7 m -158.94 -87.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.1 -1.235 . . . . 0.0 109.63 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.801 ' O ' HD13 ' A' ' 281' ' ' LEU . 0.0 OUTLIER -43.13 140.81 1.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.2 p -115.97 179.7 3.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 109.513 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.493 HD12 ' HB ' ' A' ' 315' ' ' VAL . 18.1 mm -102.3 149.36 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.23 -33.86 3.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.188 -0.945 . . . . 0.0 109.469 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.401 ' HB3' ' OG1' ' A' ' 316' ' ' THR . . . -151.48 169.21 22.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.488 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -160.16 140.56 11.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.394 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.56 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 31.2 p90 -136.58 148.57 47.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.943 . . . . 0.0 109.507 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 291' ' ' TRP . 0.7 OUTLIER 73.77 7.71 4.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.494 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.496 ' HB3' ' CB ' ' A' ' 313' ' ' PHE . . . 176.96 149.85 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.456 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -106.77 136.38 46.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.453 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 0.651 HG22 HG22 ' A' ' 304' ' ' VAL . 17.5 t -115.15 136.43 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 44.2 p -108.73 161.23 15.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -91.19 144.99 17.53 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 19.5 m -150.75 -172.22 4.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -1.177 . . . . 0.0 109.458 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 300' ' ' SER . . . -68.15 106.76 1.82 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 299' ' ' GLY . 0.4 OUTLIER 44.16 28.37 0.27 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -1.145 . . . . 0.0 109.473 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.4 p -152.57 168.88 24.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.214 -0.929 . . . . 0.0 109.398 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ARG . . . . . 0.425 ' HB3' ' CG1' ' A' ' 295' ' ' VAL . 0.0 OUTLIER -146.67 141.3 26.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 295' ' ' VAL . 1.7 m -92.61 169.13 10.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.651 HG22 HG22 ' A' ' 295' ' ' VAL . 61.9 t -155.95 122.24 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.49 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 52.9 p -130.66 155.39 81.32 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.99 146.13 22.81 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.67 2.247 . . . . 0.0 110.437 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -112.7 -10.25 13.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 119.29 29.6 1.73 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.8 -30.35 6.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -1.146 . . . . 0.0 109.414 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 151.79 -156.55 26.75 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 311' ' ' ASN . 0.8 OUTLIER -117.17 8.27 13.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.225 -1.162 . . . . 0.0 109.573 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 11.1 m -109.61 96.57 6.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.408 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.523 ' CZ ' HG11 ' A' ' 304' ' ' VAL . 47.3 p90 -117.66 144.33 45.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.56 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -109.77 168.35 13.15 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' A' ' 287' ' ' ILE . 5.5 m -141.96 144.01 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -1.114 . . . . 0.0 109.452 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 289' ' ' ALA . 7.5 m -94.06 92.54 7.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 109.494 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.714 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 16.4 t -83.63 153.43 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.456 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' MET . . . . . 0.425 ' O ' ' CG ' ' A' ' 285' ' ' GLN . 29.6 mtp -113.43 144.42 42.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.541 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' LYS . . . . . 0.546 ' HG2' ' N ' ' A' ' 262' ' ' ARG . 21.9 mmtp -65.95 -73.68 0.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 0.0 109.473 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 319' ' ' LYS . 4.3 m-20 63.16 24.02 14.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.332 -0.855 . . . . 0.0 109.408 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 99.56 37.95 3.84 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' SER . . . . . 0.472 ' O ' ' HD2' ' A' ' 319' ' ' LYS . 0.3 OUTLIER -159.76 -157.42 0.57 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -1.188 . . . . 0.0 109.467 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 323' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 324' ' ' THR . 0.0 OUTLIER 179.89 -47.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 109.438 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 324' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -40.16 125.08 1.97 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.599 -0.688 . . . . 0.0 110.102 -179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.582 HG22 ' HE2' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -64.46 167.0 9.51 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.381 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 325' ' ' THR . 33.2 Cg_endo -76.26 163.37 32.66 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.522 2.148 . . . . 0.0 110.614 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -110.98 115.15 29.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 0.0 109.376 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.446 ' HB2' ' CD2' ' A' ' 279' ' ' LEU . . . -103.61 163.56 12.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.494 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' THR . . . . . 0.596 ' C ' HG13 ' A' ' 277' ' ' VAL . 35.8 p -149.49 127.17 11.68 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.303 -0.873 . . . . 0.0 109.367 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' CYS . . . . . 0.956 ' HA ' HG22 ' A' ' 277' ' ' VAL . 42.8 t -86.43 125.4 33.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.356 -0.84 . . . . 0.0 109.505 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -139.13 170.27 16.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.41 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 144.27 141.04 3.7 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.192 -1.181 . . . . 0.0 109.44 -179.992 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . 0.418 ' C ' ' SG ' ' A' ' 330' ' ' CYS . 3.5 p . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.53 173.73 11.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.658 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.657 HG13 ' CG2' ' A' ' 269' ' ' VAL . 0.9 OUTLIER -136.55 134.36 49.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.444 -179.16 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.1 OUTLIER -116.59 134.51 54.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 109.505 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.776 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -124.89 106.89 10.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.526 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.5 m -103.59 135.33 45.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.462 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -69.8 111.51 5.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.87 . . . . 0.0 109.469 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -82.75 -74.43 0.35 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.451 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.5 ' HB3' ' CH2' ' A' ' 259' ' ' TRP . 3.1 mm-40 -106.62 138.06 43.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.436 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -125.16 128.73 48.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 109.502 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' TRP . . . . . 0.5 ' CH2' ' HB3' ' A' ' 257' ' ' GLU . 8.9 m-90 -120.01 -178.69 3.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.216 -0.928 . . . . 0.0 109.463 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 m -91.96 9.74 31.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.453 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.22 -39.26 0.93 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.431 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.92 154.8 43.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.47 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.556 ' CZ ' HG11 ' A' ' 317' ' ' VAL . 40.4 p90 -130.25 133.69 46.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.93 . . . . 0.0 109.457 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -89.11 160.81 16.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.485 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 1.6 t -136.88 159.23 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 109.422 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 253' ' ' ALA . 3.2 m -123.66 92.54 3.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.547 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' TYR . . . . . 0.838 ' CE2' ' HB2' ' A' ' 328' ' ' ALA . 45.2 m-85 -87.65 150.74 23.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.3 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 251' ' ' VAL . 11.2 p -160.13 148.67 17.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 109.678 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . 0.657 ' CG2' HG13 ' A' ' 251' ' ' VAL . 89.1 t -129.54 143.03 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -0.879 . . . . 0.0 109.41 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.57 156.79 25.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.207 -0.933 . . . . 0.0 109.531 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 110.9 -62.85 0.28 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.25 171.38 14.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -1.12 . . . . 0.0 109.427 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 31.3 t -106.13 -26.91 11.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.501 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.64 78.0 6.22 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.943 ' CE3' HG23 ' A' ' 277' ' ' VAL . 6.4 p-90 -128.36 163.23 25.29 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.367 -0.833 . . . . 0.0 109.988 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 34.9 m -113.37 99.76 8.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.943 HG23 ' CE3' ' A' ' 275' ' ' TRP . 41.9 t -79.8 99.09 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.166 -0.959 . . . . 0.0 109.99 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 0.4 OUTLIER -87.14 133.17 33.66 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' A' ' 328' ' ' ALA . 82.6 mt -116.98 132.61 56.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -0.978 . . . . 0.0 109.698 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -104.67 77.28 1.35 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.254 -0.904 . . . . 0.0 109.109 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.668 HD22 ' HB3' ' A' ' 326' ' ' PRO . 4.1 mm? -59.41 131.96 52.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.425 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -86.75 147.38 25.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.28 -0.887 . . . . 0.0 109.514 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 66.08 -148.39 50.87 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 69.4 m -103.7 48.99 0.83 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -1.15 . . . . 0.0 109.461 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.514 ' CB ' HD12 ' A' ' 281' ' ' LEU . 64.4 mt-30 -69.56 150.51 47.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.863 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.443 ' O ' ' HG2' ' A' ' 318' ' ' MET . 23.0 p -139.04 146.96 41.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.459 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.48 HG22 ' H ' ' A' ' 289' ' ' ALA . 32.0 mm -94.36 136.17 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.277 -0.889 . . . . 0.0 109.469 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.24 11.86 12.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.537 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.619 ' HB3' ' OG1' ' A' ' 316' ' ' THR . . . -168.18 153.51 6.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.94 . . . . 0.0 109.465 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.6 p -165.41 127.97 2.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.48 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.569 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 19.1 p90 -127.61 142.48 51.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.497 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.531 ' O ' ' HB2' ' A' ' 293' ' ' ALA . 15.8 t-20 69.78 17.68 7.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.407 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 292' ' ' ASN . . . 174.27 151.52 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -110.15 143.65 39.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.425 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.855 HG22 HG22 ' A' ' 304' ' ' VAL . 20.9 t -118.72 123.94 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.269 0.556 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 279' ' ' LEU . 7.6 mmt-85 -138.45 160.76 38.71 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.323 -0.861 . . . . 0.0 109.207 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.521 HG22 ' N ' ' A' ' 304' ' ' VAL . 21.1 m -142.85 161.16 38.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.956 . . . . 0.0 109.71 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.855 HG22 HG22 ' A' ' 295' ' ' VAL . 56.1 t -142.0 144.94 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.358 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 21.6 p -137.42 147.77 59.14 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.403 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.71 152.33 29.08 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.547 2.165 . . . . 0.0 110.446 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -113.77 -10.48 13.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.499 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 116.54 57.2 0.32 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 58.5 m -135.16 -59.9 0.77 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -1.174 . . . . 0.0 109.429 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -169.36 -146.04 4.88 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -129.31 13.97 6.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -1.145 . . . . 0.0 109.456 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 2.2 m -122.19 111.99 17.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.688 ' HZ ' HG11 ' A' ' 277' ' ' VAL . 4.6 p90 -135.37 165.81 24.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.412 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.569 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -128.43 161.25 22.19 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 32.5 m -134.38 158.17 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -1.154 . . . . 0.0 109.49 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . 0.619 ' OG1' ' HB3' ' A' ' 289' ' ' ALA . 19.0 m -113.23 95.22 5.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.504 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.556 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 53.7 t -85.75 147.9 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 286' ' ' THR . 67.0 mmm -106.09 128.13 53.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.507 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' LYS . . . . . 0.49 ' HD2' ' O ' ' A' ' 322' ' ' SER . 18.0 mmtp -45.22 -68.18 0.22 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 53.13 37.7 25.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 87.28 25.49 33.49 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . 0.49 ' O ' ' HD2' ' A' ' 319' ' ' LYS . 0.2 OUTLIER -150.73 -178.64 6.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -1.167 . . . . 0.0 109.462 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 324' ' ' THR . 0.0 OUTLIER -164.2 -46.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.415 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' THR . . . . . 0.435 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -41.45 120.91 1.54 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.418 -0.801 . . . . 0.0 109.873 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.524 HG22 ' HE1' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -61.06 165.45 6.24 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.923 . . . . 0.0 109.463 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . 0.668 ' HB3' HD22 ' A' ' 281' ' ' LEU . 33.6 Cg_endo -77.66 170.94 18.3 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.676 2.251 . . . . 0.0 110.775 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -106.32 119.48 39.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 109.089 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.838 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -93.89 147.99 22.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.204 -0.935 . . . . 0.0 109.946 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 41.1 p -142.11 126.71 17.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.478 -0.764 . . . . 0.0 109.23 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 330' ' ' CYS . 15.6 p -85.38 128.72 34.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.199 -0.938 . . . . 0.0 109.57 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 109.515 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . 0.51 ' N ' ' SG ' ' A' ' 330' ' ' CYS . 11.7 p . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.567 ' O ' HG13 ' A' ' 269' ' ' VAL . 1.0 OUTLIER -111.57 174.74 5.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.432 -0.793 . . . . 0.0 109.88 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.703 HG13 ' CG2' ' A' ' 269' ' ' VAL . 0.8 OUTLIER -129.5 169.57 20.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.359 -179.196 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.0 115.17 5.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.227 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.441 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -126.95 150.88 49.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 109.505 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.95 160.74 16.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.423 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -95.85 136.58 36.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.468 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -117.8 -66.57 1.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.497 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -107.77 117.61 34.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.491 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -107.2 136.34 47.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 0.0 109.45 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 2.6 m-90 -120.74 -173.83 2.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.928 . . . . 0.0 109.449 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.8 m -92.66 17.65 9.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.918 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.9 -43.57 0.3 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.436 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.423 ' HB3' ' HA ' ' A' ' 318' ' ' MET . 0.0 OUTLIER -151.25 158.03 43.35 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.186 -0.946 . . . . 0.0 109.438 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.679 ' CE1' HG22 ' A' ' 325' ' ' THR . 27.9 p90 -123.7 160.62 26.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.432 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -98.25 151.86 20.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -0.873 . . . . 0.0 109.388 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.538 HG11 ' CE1' ' A' ' 267' ' ' TYR . 1.7 t -133.99 139.2 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.458 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.99 96.39 6.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.222 -0.924 . . . . 0.0 109.471 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' TYR . . . . . 0.635 ' HE2' ' HB2' ' A' ' 328' ' ' ALA . 38.4 m-85 -95.74 100.74 12.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.46 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.26 152.34 34.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.662 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . 0.703 ' CG2' HG13 ' A' ' 251' ' ' VAL . 59.9 t -140.64 142.86 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.352 -0.843 . . . . 0.0 109.495 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.8 m -134.84 163.73 29.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 109.526 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' A' ' 272' ' ' SER . . . 104.64 -10.41 49.33 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 271' ' ' GLY . 0.5 OUTLIER 169.37 159.7 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -1.109 . . . . 0.0 109.321 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 48.5 t -105.34 -29.5 10.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.6 77.96 6.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 108.661 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.994 ' CE3' HG23 ' A' ' 277' ' ' VAL . 10.7 p-90 -128.69 157.1 42.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.41 -0.806 . . . . 0.0 109.934 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 16.0 m -110.61 96.48 6.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.406 -0.809 . . . . 0.0 108.863 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.994 HG23 ' CE3' ' A' ' 275' ' ' TRP . 40.2 t -79.76 104.15 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.919 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . 0.481 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 5.7 t-20 -93.47 138.96 31.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.369 -0.832 . . . . 0.0 108.783 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 327' ' ' ALA . 34.1 mt -122.61 132.3 54.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.174 -0.954 . . . . 0.0 109.568 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -110.1 83.2 1.72 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 109.271 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.785 HD22 ' HB3' ' A' ' 326' ' ' PRO . 4.2 mm? -59.26 139.26 57.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.466 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -83.86 122.71 29.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.405 -0.809 . . . . 0.0 109.422 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 82.91 -149.21 26.49 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 58.8 m -100.47 34.11 2.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -1.104 . . . . 0.0 109.538 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.514 ' CB ' HD12 ' A' ' 281' ' ' LEU . 85.3 mt-30 -57.13 169.57 0.55 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.932 . . . . 0.0 109.522 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.449 ' CG2' ' C ' ' A' ' 285' ' ' GLN . 15.8 p -155.81 148.25 23.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.491 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.623 HG13 HG11 ' A' ' 295' ' ' VAL . 38.2 mm -83.25 153.46 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 109.398 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . 0.442 ' HB2' ' HE3' ' A' ' 318' ' ' MET . 3.6 tp-100 -118.52 -28.38 5.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.461 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.408 ' C ' ' OG ' ' A' ' 290' ' ' SER . . . -145.46 166.99 24.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.953 . . . . 0.0 109.459 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . 0.408 ' OG ' ' C ' ' A' ' 289' ' ' ALA . 0.8 OUTLIER -169.99 137.26 1.58 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.565 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 28.0 p90 -136.4 150.62 48.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 293' ' ' ALA . 0.6 OUTLIER 70.48 15.82 7.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 109.451 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 292' ' ' ASN . . . 172.41 157.8 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.47 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -108.27 134.05 51.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.9 . . . . 0.0 109.501 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.861 HG22 HG22 ' A' ' 304' ' ' VAL . 59.9 t -112.75 118.92 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 71.2 p . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.447 -179.963 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.358 0.599 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 279' ' ' LEU . 18.4 mmt-85 -145.26 162.47 37.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.244 -0.91 . . . . 0.0 109.253 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 304' ' ' VAL . 7.6 m -140.28 167.63 21.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.711 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.861 HG22 HG22 ' A' ' 295' ' ' VAL . 38.6 t -154.23 142.33 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.366 -0.834 . . . . 0.0 109.314 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 62.3 p -145.66 150.36 43.21 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 109.473 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.83 164.44 27.73 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.678 2.252 . . . . 0.0 110.39 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -119.29 -12.16 9.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.868 . . . . 0.0 109.443 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 114.49 42.89 0.79 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.51 -59.24 1.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -1.159 . . . . 0.0 109.467 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -156.8 162.82 31.89 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -90.18 -7.45 53.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -1.138 . . . . 0.0 109.505 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.423 ' O ' ' CG ' ' A' ' 292' ' ' ASN . 32.1 m -100.59 117.4 34.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.463 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.698 ' HZ ' HG11 ' A' ' 277' ' ' VAL . 12.5 p90 -135.81 153.31 51.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 0.0 109.518 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.565 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -117.1 152.33 17.85 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.92 148.16 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -1.166 . . . . 0.0 109.503 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 287' ' ' ILE . 23.9 m -107.43 129.82 54.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.607 HG22 ' CD1' ' A' ' 287' ' ' ILE . 40.3 t -114.88 149.51 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.939 . . . . 0.0 109.481 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . 0.442 ' HE3' ' HB2' ' A' ' 288' ' ' GLN . 0.8 OUTLIER -103.68 128.39 51.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 109.399 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 322' ' ' SER . 10.1 mptt -43.79 -66.13 0.42 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.893 . . . . 0.0 109.538 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 319' ' ' LYS . 19.3 m-20 59.42 31.27 20.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.915 . . . . 0.0 109.436 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 111.36 -47.81 1.0 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 319' ' ' LYS . 0.0 OUTLIER -103.71 158.4 16.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.224 -1.163 . . . . 0.0 109.471 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 324' ' ' THR . 65.1 m -122.34 -32.46 3.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.429 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -41.51 119.82 1.32 Allowed 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.355 -0.841 . . . . 0.0 109.967 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.679 HG22 ' CE1' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -56.42 166.22 1.3 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.335 179.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . 0.785 ' HB3' HD22 ' A' ' 281' ' ' LEU . 32.9 Cg_endo -77.55 157.2 32.36 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.552 2.168 . . . . 0.0 110.721 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 279' ' ' LEU . . . -88.65 165.16 14.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.105 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.635 ' HB2' ' HE2' ' A' ' 267' ' ' TYR . . . -138.18 152.36 48.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.045 -1.034 . . . . 0.0 109.763 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . 0.439 ' OG1' ' HB3' ' A' ' 278' ' ' ASN . 80.4 p -146.4 127.72 14.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.647 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 249' ' ' CYS . 1.6 t -91.1 138.29 31.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.421 -0.799 . . . . 0.0 108.969 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.903 . . . . 0.0 109.504 179.975 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . 0.418 ' C ' ' SG ' ' A' ' 330' ' ' CYS . 6.0 p . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.545 ' O ' HG22 ' A' ' 269' ' ' VAL . 52.6 p -149.06 173.23 13.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.96 . . . . 0.0 109.538 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.651 HG13 ' CG2' ' A' ' 269' ' ' VAL . 0.9 OUTLIER -135.87 120.19 25.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.528 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.55 118.62 37.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.888 . . . . 0.0 109.453 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.564 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -109.19 101.57 10.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 109.458 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.97 169.04 10.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.868 . . . . 0.0 109.415 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.481 ' NH1' ' CD2' ' A' ' 263' ' ' PHE . 0.0 OUTLIER -98.3 142.67 29.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 109.493 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -110.42 -55.21 2.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 109.413 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.536 ' HB3' ' CZ2' ' A' ' 259' ' ' TRP . 52.1 mm-40 -144.04 144.42 31.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -122.63 122.58 39.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.45 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' TRP . . . . . 0.536 ' CZ2' ' HB3' ' A' ' 257' ' ' GLU . 6.1 m-90 -124.82 -176.64 3.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 73.2 m -93.37 2.11 56.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.914 . . . . 0.0 109.67 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.42 -24.62 7.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.426 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 317' ' ' VAL . 10.1 ptt180 -178.51 166.31 1.79 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.912 . . . . 0.0 109.451 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.576 ' CZ ' ' HB ' ' A' ' 317' ' ' VAL . 47.3 p90 -133.37 151.27 51.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.408 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -97.82 150.75 20.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.333 -0.854 . . . . 0.0 109.469 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.464 HG11 ' CE1' ' A' ' 267' ' ' TYR . 2.1 t -130.88 164.67 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.468 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 253' ' ' ALA . 0.9 OUTLIER -133.52 95.22 3.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' TYR . . . . . 0.762 ' CE2' ' HB2' ' A' ' 328' ' ' ALA . 44.3 m-85 -91.13 140.85 29.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -0.854 . . . . 0.0 109.317 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 251' ' ' VAL . 0.8 OUTLIER -149.88 157.58 43.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.925 . . . . 0.0 109.602 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . 0.651 ' CG2' HG13 ' A' ' 251' ' ' VAL . 98.5 t -144.3 145.85 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.202 -0.936 . . . . 0.0 109.46 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 7.6 p -127.76 173.09 10.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.337 -0.852 . . . . 0.0 109.534 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 106.24 -55.11 0.55 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 274' ' ' ALA . 0.3 OUTLIER -154.53 104.79 2.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -1.145 . . . . 0.0 109.367 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 272' ' ' SER . 2.4 t -42.06 -26.74 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 0.0 109.87 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 272' ' ' SER . . . -79.37 78.3 5.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.068 -1.02 . . . . 0.0 108.665 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.925 ' CZ3' HG23 ' A' ' 277' ' ' VAL . 7.8 p-90 -128.95 172.78 11.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.286 -0.884 . . . . 0.0 109.855 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 331' ' ' ALA . 1.7 m -132.15 102.25 5.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.488 -0.757 . . . . 0.0 108.983 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.925 HG23 ' CZ3' ' A' ' 275' ' ' TRP . 12.3 t -79.96 127.45 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.253 -0.905 . . . . 0.0 109.961 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . 0.488 ' HB3' ' OG1' ' A' ' 329' ' ' THR . 1.5 t30 -112.46 109.65 19.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.35 -0.844 . . . . 0.0 108.976 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 327' ' ' ALA . 22.2 mt -90.29 140.93 29.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 109.682 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -138.38 93.06 2.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.325 -0.86 . . . . 0.0 109.3 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.715 HD13 ' HB3' ' A' ' 285' ' ' GLN . 24.1 mt -59.83 170.2 1.22 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.94 . . . . 0.0 109.68 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -116.62 85.08 2.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.926 . . . . 0.0 109.439 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 129.52 -145.43 16.4 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 286' ' ' THR . 0.7 OUTLIER -92.6 4.96 52.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -1.16 . . . . 0.0 109.588 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.715 ' HB3' HD13 ' A' ' 281' ' ' LEU . 57.6 mt-30 -47.06 154.5 0.35 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.458 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 284' ' ' SER . 30.8 p -145.61 174.67 10.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 109.532 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 29.2 mt -124.17 152.36 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 109.408 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -141.55 11.96 2.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.181 -0.949 . . . . 0.0 109.699 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.733 ' HB3' ' OG1' ' A' ' 316' ' ' THR . . . -154.3 153.99 32.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.069 -1.019 . . . . 0.0 109.603 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 24.0 p -165.37 126.02 1.9 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.39 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.567 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 22.4 p90 -124.98 138.85 54.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.659 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.545 ' O ' ' HB2' ' A' ' 293' ' ' ALA . 1.4 t-20 71.98 33.96 1.56 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.885 . . . . 0.0 109.508 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 292' ' ' ASN . . . 172.3 157.76 0.1 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.484 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -104.86 99.08 8.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.487 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.648 HG22 HG22 ' A' ' 304' ' ' VAL . 48.0 t -95.48 112.44 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.919 . . . . 0.0 109.469 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.966 . . . . 0.0 109.591 179.945 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' A' ' 279' ' ' LEU . 18.3 mmm180 -119.35 102.09 8.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.2 -0.938 . . . . 0.0 109.394 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 40.0 m -69.21 149.72 48.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.469 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.648 HG22 HG22 ' A' ' 295' ' ' VAL . 58.5 t -140.27 139.76 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 30.0 p -145.17 155.83 54.56 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.47 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.08 140.63 18.03 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.626 2.217 . . . . 0.0 110.479 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -120.44 26.08 9.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 74.43 55.43 5.58 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.14 -60.4 0.77 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -1.133 . . . . 0.0 109.467 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -162.24 -179.77 37.07 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -103.15 -2.68 26.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -1.107 . . . . 0.0 109.571 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 313' ' ' PHE . 40.9 m -113.77 162.06 16.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 109.539 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 267' ' ' TYR . 3.0 p90 -176.99 155.65 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.381 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.567 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -125.54 166.84 18.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 16.9 m -136.89 167.45 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -1.155 . . . . 0.0 109.515 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . 0.733 ' OG1' ' HB3' ' A' ' 289' ' ' ALA . 89.1 m -117.52 108.55 15.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.883 . . . . 0.0 109.483 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.576 ' HB ' ' CZ ' ' A' ' 263' ' ' PHE . 40.4 t -100.91 149.95 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.879 . . . . 0.0 109.347 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 7.2 mtp -99.84 135.19 41.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.92 . . . . 0.0 109.501 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 320' ' ' ASN . 17.9 mmtp -46.92 -69.4 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.533 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 319' ' ' LYS . 24.9 m-20 61.27 24.64 14.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.467 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 97.13 -28.27 14.7 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.79 148.57 25.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -1.121 . . . . 0.0 109.495 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 324' ' ' THR . 23.3 t -123.27 -37.19 2.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 109.456 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -41.89 117.51 0.96 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.472 -0.768 . . . . 0.0 109.826 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.53 HG22 ' HE2' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -52.86 164.35 0.7 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.92 . . . . 0.0 109.416 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . 0.503 ' HB3' HD23 ' A' ' 281' ' ' LEU . 33.3 Cg_endo -77.78 166.39 25.41 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.673 2.249 . . . . 0.0 110.69 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 279' ' ' LEU . . . -92.72 170.52 9.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.839 . . . . 0.0 109.135 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.762 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -147.78 149.0 31.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.136 -0.978 . . . . 0.0 110.011 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . 0.488 ' OG1' ' HB3' ' A' ' 278' ' ' ASN . 40.2 p -140.17 128.0 21.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 109.352 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . 0.418 ' HB3' HG22 ' A' ' 251' ' ' VAL . 16.6 p -82.43 171.63 13.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 109.517 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . 0.455 ' HB2' ' HB ' ' A' ' 276' ' ' THR . . . . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.455 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 22.5 p . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.841 ' O ' HG13 ' A' ' 269' ' ' VAL . 60.5 p -151.06 174.59 13.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.933 . . . . 0.0 109.6 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.574 HG13 ' CG2' ' A' ' 269' ' ' VAL . 0.8 OUTLIER -132.17 171.49 17.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.462 -0.774 . . . . 0.0 109.608 -179.168 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.98 119.24 3.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.349 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.767 ' HB2' ' CE1' ' A' ' 267' ' ' TYR . . . -111.56 149.16 31.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 109.491 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 23.8 m -151.07 130.37 12.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.481 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.524 ' HD3' HG23 ' A' ' 325' ' ' THR . 2.7 mtm-85 -77.88 137.95 38.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.446 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -107.49 -69.14 0.86 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.449 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -107.71 136.09 48.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.504 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -111.2 129.25 56.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.411 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -124.7 172.31 9.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 109.453 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 57.2 m -88.99 4.34 48.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.895 . . . . 0.0 109.63 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -119.09 -26.5 5.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.169 -0.957 . . . . 0.0 109.48 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 317' ' ' VAL . 16.0 ptt180 -173.41 162.42 4.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.45 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.585 ' CZ ' ' HB ' ' A' ' 317' ' ' VAL . 34.0 p90 -124.75 144.75 50.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.886 . . . . 0.0 109.508 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -85.47 157.93 20.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.44 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . 0.688 HG11 ' CE2' ' A' ' 267' ' ' TYR . 1.9 t -136.12 152.23 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 0.0 109.505 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 253' ' ' ALA . 10.1 m -126.78 91.26 3.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.428 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' TYR . . . . . 0.827 ' CE1' ' HB2' ' A' ' 328' ' ' ALA . 58.8 m-85 -91.34 144.29 25.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.404 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.607 ' HB3' HG23 ' A' ' 312' ' ' THR . 24.9 p -159.93 158.26 30.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.211 -0.93 . . . . 0.0 109.585 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 250' ' ' SER . 74.2 t -134.87 141.47 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.302 -0.873 . . . . 0.0 109.394 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 7.1 t -115.69 138.29 51.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.526 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 272' ' ' SER . . . 123.74 -15.63 7.94 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 271' ' ' GLY . 0.2 OUTLIER 167.73 165.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -1.197 . . . . 0.0 109.432 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 84.0 p -104.46 -24.46 13.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 109.519 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.75 77.43 6.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 108.744 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.983 ' CE3' HG23 ' A' ' 277' ' ' VAL . 9.8 p-90 -130.33 158.26 40.3 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.362 -0.836 . . . . 0.0 109.786 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.3 m -111.1 95.66 5.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.095 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.983 HG23 ' CE3' ' A' ' 275' ' ' TRP . 42.4 t -80.08 128.99 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.915 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 30.0 m-20 -107.55 130.74 54.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.856 . . . . 0.0 108.886 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.498 HD12 HG21 ' A' ' 304' ' ' VAL . 60.8 mt -118.94 126.45 51.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 0.0 109.578 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -110.47 82.56 1.61 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.298 -0.876 . . . . 0.0 109.497 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.624 HD22 ' HB3' ' A' ' 326' ' ' PRO . 4.3 mm? -59.75 145.23 45.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.984 . . . . 0.0 109.414 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.453 ' O ' ' HG3' ' A' ' 285' ' ' GLN . 2.3 m-80 -96.04 170.39 9.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.215 -0.928 . . . . 0.0 109.525 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 282' ' ' ASN . . . 45.34 -151.41 0.96 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 2.8 p -101.61 48.32 0.89 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -1.189 . . . . 0.0 109.466 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 282' ' ' ASN . 64.8 mt-30 -68.81 164.06 22.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.455 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 21.0 p -150.35 145.33 26.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 109.461 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.412 ' CD1' HG22 ' A' ' 317' ' ' VAL . 33.2 mm -88.69 135.64 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 109.423 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . 0.497 ' OE1' ' CG ' ' A' ' 318' ' ' MET . 0.6 OUTLIER -112.14 -18.45 12.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -143.15 157.24 44.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 109.477 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 314' ' ' GLY . 1.7 p -168.6 134.81 1.84 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.473 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.524 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 34.8 p90 -144.2 155.01 43.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.521 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.476 ' CB ' ' HA ' ' A' ' 313' ' ' PHE . 0.4 OUTLIER 72.66 6.5 5.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.589 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.544 ' HB3' ' CB ' ' A' ' 313' ' ' PHE . . . 177.69 170.19 0.65 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.518 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.653 ' O ' HG13 ' A' ' 304' ' ' VAL . 38.7 m-80 -117.87 166.25 12.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.898 . . . . 0.0 109.505 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 304' ' ' VAL . 86.1 t -138.93 116.51 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.459 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 302' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.27 0.557 . . . . 0.0 109.526 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 301' ' ' THR . 0.1 OUTLIER -155.7 84.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.358 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 304' ' ' VAL . 5.1 m -63.18 169.28 3.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.357 -0.84 . . . . 0.0 109.809 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 295' ' ' VAL . 54.9 t -155.62 130.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 109.368 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 10.1 p -132.0 150.41 76.03 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.166 -0.959 . . . . 0.0 109.499 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.92 -174.03 2.06 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.584 2.19 . . . . 0.0 110.41 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -149.45 18.73 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 79.24 51.05 5.48 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.4 t -135.02 -85.2 0.4 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -1.129 . . . . 0.0 109.427 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -126.78 175.34 17.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . 0.481 ' N ' ' ND2' ' A' ' 311' ' ' ASN . 0.8 OUTLIER -108.18 -1.2 20.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -1.134 . . . . 0.0 109.612 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.607 HG23 ' HB3' ' A' ' 268' ' ' SER . 30.2 m -116.9 107.29 14.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.17 -0.957 . . . . 0.0 109.428 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.65 ' HZ ' HG11 ' A' ' 277' ' ' VAL . 39.0 p90 -117.47 149.08 41.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.524 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -112.96 160.15 13.28 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 11.2 m -143.19 146.28 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -1.152 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 54.5 m -103.8 102.59 12.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.527 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.585 ' HB ' ' CZ ' ' A' ' 263' ' ' PHE . 60.6 t -90.4 132.72 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.482 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . 0.497 ' CG ' ' OE1' ' A' ' 288' ' ' GLN . 28.1 mmm -87.45 143.75 27.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.577 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' LYS . . . . . 0.401 ' HE3' ' HB3' ' A' ' 323' ' ' SER . 37.5 mmtm -57.11 -76.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.497 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 54.15 23.88 4.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.25 -0.906 . . . . 0.0 109.446 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 101.83 32.61 4.99 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 13.2 t -158.02 117.45 3.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -1.116 . . . . 0.0 109.432 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' SER . . . . . 0.401 ' HB3' ' HE3' ' A' ' 319' ' ' LYS . 0.7 OUTLIER -112.13 3.39 17.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.579 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' THR . . . . . . . . . . . . . 1.2 m -98.53 128.08 44.72 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.137 -0.977 . . . . 0.0 108.927 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.569 HG22 ' CE1' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -59.45 165.66 3.82 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.89 . . . . 0.0 109.528 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . 0.624 ' HB3' HD22 ' A' ' 281' ' ' LEU . 34.1 Cg_endo -77.43 171.56 17.42 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.643 2.228 . . . . 0.0 110.675 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -103.82 132.56 49.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -0.898 . . . . 0.0 109.289 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.827 ' HB2' ' CE1' ' A' ' 267' ' ' TYR . . . -107.12 148.72 28.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.655 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 278' ' ' ASN . 52.7 p -149.18 125.86 11.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.35 -0.843 . . . . 0.0 109.465 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 40.6 t -88.12 130.32 35.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -0.927 . . . . 0.0 109.492 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.522 179.964 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 30.1 p . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.609 ' O ' HG13 ' A' ' 269' ' ' VAL . 0.0 OUTLIER -141.69 175.67 9.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.591 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.668 HG13 ' CG2' ' A' ' 269' ' ' VAL . 0.8 OUTLIER -130.47 107.66 14.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.401 -0.812 . . . . 0.0 109.588 -179.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 34.2 p -96.86 112.37 24.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.378 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.495 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -95.6 140.43 30.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.601 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 23.5 m -130.32 149.67 51.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 109.377 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.05 122.89 29.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.927 . . . . 0.0 109.491 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -103.42 -148.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . 0.426 ' HB3' ' CH2' ' A' ' 259' ' ' TRP . 0.5 OUTLIER -47.7 132.43 14.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 109.412 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -107.94 157.15 18.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.607 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' TRP . . . . . 0.467 ' HB2' ' O ' ' A' ' 262' ' ' ARG . 5.1 m-90 -136.25 -170.13 2.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 54.3 m -103.1 -9.54 19.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 109.484 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' ASP . . . . . 0.428 ' O ' ' HB3' ' A' ' 262' ' ' ARG . 13.1 p-10 -133.75 17.25 3.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.435 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' ARG . . . . . 0.546 ' N ' ' HG2' ' A' ' 319' ' ' LYS . 0.4 OUTLIER 175.95 166.44 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -0.952 . . . . 0.0 109.492 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' PHE . . . . . 0.714 ' CZ ' HG11 ' A' ' 317' ' ' VAL . 55.0 p90 -148.66 136.2 20.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -87.24 155.06 20.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.495 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 1.8 t -137.8 137.51 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 19.8 m -105.91 91.69 3.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.457 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' TYR . . . . . 0.793 ' CZ ' HD21 ' A' ' 279' ' ' LEU . 27.2 m-85 -80.58 136.05 36.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.463 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 251' ' ' VAL . 2.7 t -131.59 159.49 38.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.908 . . . . 0.0 109.541 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' VAL . . . . . 0.668 ' CG2' HG13 ' A' ' 251' ' ' VAL . 96.0 t -152.44 97.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 0.0 109.495 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.61 -168.29 2.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.342 -0.849 . . . . 0.0 109.533 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 88.09 -41.71 3.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 57.5 p -173.11 170.54 4.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.277 -1.131 . . . . 0.0 109.359 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.17 -34.0 7.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.396 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.76 77.45 6.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.954 . . . . 0.0 108.638 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.671 ' CE3' HG23 ' A' ' 277' ' ' VAL . 17.2 p-90 -127.46 153.53 46.18 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.326 -0.859 . . . . 0.0 109.797 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 87.2 m -113.96 95.19 5.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.116 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' VAL . . . . . 0.956 HG22 ' HA ' ' A' ' 330' ' ' CYS . 48.4 t -107.56 149.53 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.621 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 3.7 m-20 -127.46 132.87 49.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -0.878 . . . . 0.0 109.404 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.793 HD21 ' CZ ' ' A' ' 267' ' ' TYR . 7.1 mt -85.05 155.95 21.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.479 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -137.07 84.43 2.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.618 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 285' ' ' GLN . 19.0 mt -59.99 172.41 0.78 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.456 ' O ' ' C ' ' A' ' 283' ' ' GLY . 12.1 m-80 -86.84 59.45 5.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 109.772 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 282' ' ' ASN . . . 37.7 43.0 1.12 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 285' ' ' GLN . 73.7 m -158.94 -87.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.1 -1.235 . . . . 0.0 109.63 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' GLN . . . . . 0.801 ' O ' HD13 ' A' ' 281' ' ' LEU . 0.0 OUTLIER -43.13 140.81 1.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.2 p -115.97 179.7 3.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 109.513 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ILE . . . . . 0.493 HD12 ' HB ' ' A' ' 315' ' ' VAL . 18.1 mm -102.3 149.36 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.23 -33.86 3.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.188 -0.945 . . . . 0.0 109.469 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.401 ' HB3' ' OG1' ' A' ' 316' ' ' THR . . . -151.48 169.21 22.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.488 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -160.16 140.56 11.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.394 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' TRP . . . . . 0.56 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 31.2 p90 -136.58 148.57 47.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.943 . . . . 0.0 109.507 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 291' ' ' TRP . 0.7 OUTLIER 73.77 7.71 4.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.494 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ALA . . . . . 0.496 ' HB3' ' CB ' ' A' ' 313' ' ' PHE . . . 176.96 149.85 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.456 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -106.77 136.38 46.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.453 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' VAL . . . . . 0.651 HG22 HG22 ' A' ' 304' ' ' VAL . 17.5 t -115.15 136.43 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 44.2 p . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.458 -179.995 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' ARG . . . . . 0.425 ' HB3' ' CG1' ' A' ' 295' ' ' VAL . 0.0 OUTLIER -146.67 141.3 26.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 295' ' ' VAL . 1.7 m -92.61 169.13 10.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.651 HG22 HG22 ' A' ' 295' ' ' VAL . 61.9 t -155.95 122.24 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.49 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 52.9 p -130.66 155.39 81.32 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.99 146.13 22.81 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.67 2.247 . . . . 0.0 110.437 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -112.7 -10.25 13.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 119.29 29.6 1.73 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.8 -30.35 6.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -1.146 . . . . 0.0 109.414 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 151.79 -156.55 26.75 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 311' ' ' ASN . 0.8 OUTLIER -117.17 8.27 13.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.225 -1.162 . . . . 0.0 109.573 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 11.1 m -109.61 96.57 6.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.408 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.523 ' CZ ' HG11 ' A' ' 304' ' ' VAL . 47.3 p90 -117.66 144.33 45.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' GLY . . . . . 0.56 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -109.77 168.35 13.15 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' A' ' 287' ' ' ILE . 5.5 m -141.96 144.01 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -1.114 . . . . 0.0 109.452 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 289' ' ' ALA . 7.5 m -94.06 92.54 7.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 109.494 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' VAL . . . . . 0.714 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 16.4 t -83.63 153.43 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.456 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' MET . . . . . 0.425 ' O ' ' CG ' ' A' ' 285' ' ' GLN . 29.6 mtp -113.43 144.42 42.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.541 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' LYS . . . . . 0.546 ' HG2' ' N ' ' A' ' 262' ' ' ARG . 21.9 mmtp -65.95 -73.68 0.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 0.0 109.473 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 319' ' ' LYS . 4.3 m-20 63.16 24.02 14.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.332 -0.855 . . . . 0.0 109.408 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 99.56 37.95 3.84 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' SER . . . . . 0.472 ' O ' ' HD2' ' A' ' 319' ' ' LYS . 0.3 OUTLIER -159.76 -157.42 0.57 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -1.188 . . . . 0.0 109.467 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 324' ' ' THR . 0.0 OUTLIER 179.89 -47.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 109.438 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -40.16 125.08 1.97 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.599 -0.688 . . . . 0.0 110.102 -179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.582 HG22 ' HE2' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -64.46 167.0 9.51 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.381 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 325' ' ' THR . 33.2 Cg_endo -76.26 163.37 32.66 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.522 2.148 . . . . 0.0 110.614 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -110.98 115.15 29.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 0.0 109.376 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' ALA . . . . . 0.446 ' HB2' ' CD2' ' A' ' 279' ' ' LEU . . . -103.61 163.56 12.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.494 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' THR . . . . . 0.596 ' C ' HG13 ' A' ' 277' ' ' VAL . 35.8 p -149.49 127.17 11.68 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.303 -0.873 . . . . 0.0 109.367 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' CYS . . . . . 0.956 ' HA ' HG22 ' A' ' 277' ' ' VAL . 42.8 t -86.43 125.4 33.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.356 -0.84 . . . . 0.0 109.505 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.41 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 83.48 148.12 8.01 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.418 ' C ' ' SG ' ' A' ' 330' ' ' CYS . 3.5 p -117.66 171.35 8.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -1.128 . . . . 0.0 109.359 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.53 173.73 11.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.658 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.657 HG13 ' CG2' ' A' ' 269' ' ' VAL . 0.9 OUTLIER -136.55 134.36 49.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.444 -179.16 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.1 OUTLIER -116.59 134.51 54.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.2 -0.938 . . . . 0.0 109.505 -179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.776 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -124.89 106.89 10.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.526 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.5 m -103.59 135.33 45.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.289 -0.882 . . . . 0.0 109.462 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -69.8 111.51 5.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.87 . . . . 0.0 109.469 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -82.75 -74.43 0.35 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.451 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.5 ' HB3' ' CH2' ' A' ' 259' ' ' TRP . 3.1 mm-40 -106.62 138.06 43.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.436 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -125.16 128.73 48.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.922 . . . . 0.0 109.502 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . 0.5 ' CH2' ' HB3' ' A' ' 257' ' ' GLU . 8.9 m-90 -120.01 -178.69 3.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.216 -0.928 . . . . 0.0 109.463 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.9 m -91.96 9.74 31.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.23 -0.919 . . . . 0.0 109.453 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.22 -39.26 0.93 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.431 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.92 154.8 43.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.47 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.556 ' CZ ' HG11 ' A' ' 317' ' ' VAL . 40.4 p90 -130.25 133.69 46.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.93 . . . . 0.0 109.457 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -89.11 160.81 16.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.485 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 1.6 t -136.88 159.23 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 109.422 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 253' ' ' ALA . 3.2 m -123.66 92.54 3.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.193 -0.942 . . . . 0.0 109.547 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' TYR . . . . . 0.838 ' CE2' ' HB2' ' A' ' 328' ' ' ALA . 45.2 m-85 -87.65 150.74 23.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.287 -0.883 . . . . 0.0 109.3 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 251' ' ' VAL . 11.2 p -160.13 148.67 17.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 109.678 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.657 ' CG2' HG13 ' A' ' 251' ' ' VAL . 89.1 t -129.54 143.03 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.293 -0.879 . . . . 0.0 109.41 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.57 156.79 25.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.207 -0.933 . . . . 0.0 109.531 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 110.9 -62.85 0.28 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.25 171.38 14.14 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -1.12 . . . . 0.0 109.427 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 31.3 t -106.13 -26.91 11.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.905 . . . . 0.0 109.501 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.64 78.0 6.22 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.943 ' CE3' HG23 ' A' ' 277' ' ' VAL . 6.4 p-90 -128.36 163.23 25.29 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.367 -0.833 . . . . 0.0 109.988 -179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 34.9 m -113.37 99.76 8.03 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.943 HG23 ' CE3' ' A' ' 275' ' ' TRP . 41.9 t -79.8 99.09 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.166 -0.959 . . . . 0.0 109.99 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 0.4 OUTLIER -87.14 133.17 33.66 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.566 HD23 ' HA ' ' A' ' 328' ' ' ALA . 82.6 mt -116.98 132.61 56.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.135 -0.978 . . . . 0.0 109.698 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -104.67 77.28 1.35 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.254 -0.904 . . . . 0.0 109.109 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.668 HD22 ' HB3' ' A' ' 326' ' ' PRO . 4.1 mm? -59.41 131.96 52.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.425 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -86.75 147.38 25.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.28 -0.887 . . . . 0.0 109.514 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 66.08 -148.39 50.87 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 69.4 m -103.7 48.99 0.83 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -1.15 . . . . 0.0 109.461 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.514 ' CB ' HD12 ' A' ' 281' ' ' LEU . 64.4 mt-30 -69.56 150.51 47.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.32 -0.863 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.443 ' O ' ' HG2' ' A' ' 318' ' ' MET . 23.0 p -139.04 146.96 41.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.459 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.48 HG22 ' H ' ' A' ' 289' ' ' ALA . 32.0 mm -94.36 136.17 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.277 -0.889 . . . . 0.0 109.469 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.24 11.86 12.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.537 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.619 ' HB3' ' OG1' ' A' ' 316' ' ' THR . . . -168.18 153.51 6.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.197 -0.94 . . . . 0.0 109.465 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 4.6 p -165.41 127.97 2.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 109.48 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.569 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 19.1 p90 -127.61 142.48 51.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.272 -0.892 . . . . 0.0 109.497 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.531 ' O ' ' HB2' ' A' ' 293' ' ' ALA . 15.8 t-20 69.78 17.68 7.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.407 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 292' ' ' ASN . . . 174.27 151.52 0.1 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -110.15 143.65 39.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.257 -0.902 . . . . 0.0 109.425 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.855 HG22 HG22 ' A' ' 304' ' ' VAL . 20.9 t -118.72 123.94 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -149.9 -170.15 3.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.479 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 110.63 137.44 7.51 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.17 166.14 10.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -1.123 . . . . 0.0 109.505 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 106.4 -166.07 13.73 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 1.6 m -88.15 -16.31 33.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.202 -1.175 . . . . 0.0 109.489 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.43 171.99 8.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.928 . . . . 0.0 109.521 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . 0.47 ' HB2' ' O ' ' A' ' 279' ' ' LEU . 7.6 mmt-85 -138.45 160.76 38.71 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.323 -0.861 . . . . 0.0 109.207 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.521 HG22 ' N ' ' A' ' 304' ' ' VAL . 21.1 m -142.85 161.16 38.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.956 . . . . 0.0 109.71 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.855 HG22 HG22 ' A' ' 295' ' ' VAL . 56.1 t -142.0 144.94 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.358 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 21.6 p -137.42 147.77 59.14 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.403 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.71 152.33 29.08 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.547 2.165 . . . . 0.0 110.446 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -113.77 -10.48 13.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.282 -0.886 . . . . 0.0 109.499 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 116.54 57.2 0.32 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 58.5 m -135.16 -59.9 0.77 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -1.174 . . . . 0.0 109.429 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -169.36 -146.04 4.88 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -129.31 13.97 6.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -1.145 . . . . 0.0 109.456 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 2.2 m -122.19 111.99 17.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.688 ' HZ ' HG11 ' A' ' 277' ' ' VAL . 4.6 p90 -135.37 165.81 24.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.412 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.569 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -128.43 161.25 22.19 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 32.5 m -134.38 158.17 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -1.154 . . . . 0.0 109.49 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . 0.619 ' OG1' ' HB3' ' A' ' 289' ' ' ALA . 19.0 m -113.23 95.22 5.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.504 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.556 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 53.7 t -85.75 147.9 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 286' ' ' THR . 67.0 mmm -106.09 128.13 53.66 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.507 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' LYS . . . . . 0.49 ' HD2' ' O ' ' A' ' 322' ' ' SER . 18.0 mmtp -45.22 -68.18 0.22 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 53.13 37.7 25.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.45 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 87.28 25.49 33.49 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . 0.49 ' O ' ' HD2' ' A' ' 319' ' ' LYS . 0.2 OUTLIER -150.73 -178.64 6.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -1.167 . . . . 0.0 109.462 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 324' ' ' THR . 0.0 OUTLIER -164.2 -46.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.415 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' THR . . . . . 0.435 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -41.45 120.91 1.54 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.418 -0.801 . . . . 0.0 109.873 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.524 HG22 ' HE1' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -61.06 165.45 6.24 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.923 . . . . 0.0 109.463 179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.668 ' HB3' HD22 ' A' ' 281' ' ' LEU . 33.6 Cg_endo -77.66 170.94 18.3 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.676 2.251 . . . . 0.0 110.775 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -106.32 119.48 39.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 109.089 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.838 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -93.89 147.99 22.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.204 -0.935 . . . . 0.0 109.946 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . . . . . . . . . 41.1 p -142.11 126.71 17.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.478 -0.764 . . . . 0.0 109.23 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . 0.438 ' O ' ' SG ' ' A' ' 330' ' ' CYS . 15.6 p -85.38 128.72 34.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.199 -0.938 . . . . 0.0 109.57 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -143.66 132.03 22.12 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.207 -0.933 . . . . 0.0 109.515 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 119.54 39.89 0.64 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 81.1 p . . . . . 0 N--CA 1.49 1.562 0 O-C-N 121.28 -1.13 . . . . 0.0 109.479 179.995 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 16.8 p . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -108.89 -109.45 3.29 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.51 ' N ' ' SG ' ' A' ' 330' ' ' CYS . 11.7 p -173.18 178.63 2.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -1.123 . . . . 0.0 109.514 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.567 ' O ' HG13 ' A' ' 269' ' ' VAL . 1.0 OUTLIER -111.57 174.74 5.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.432 -0.793 . . . . 0.0 109.88 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.703 HG13 ' CG2' ' A' ' 269' ' ' VAL . 0.8 OUTLIER -129.5 169.57 20.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.359 -179.196 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.0 115.17 5.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.227 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.441 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -126.95 150.88 49.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.941 . . . . 0.0 109.505 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.95 160.74 16.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.265 -0.897 . . . . 0.0 109.423 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 2.6 mtm180 -95.85 136.58 36.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.468 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -117.8 -66.57 1.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -0.865 . . . . 0.0 109.497 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -107.77 117.61 34.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.491 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -107.2 136.34 47.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.243 -0.911 . . . . 0.0 109.45 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 2.6 m-90 -120.74 -173.83 2.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.928 . . . . 0.0 109.449 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 1.8 m -92.66 17.65 9.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.232 -0.918 . . . . 0.0 109.487 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -142.9 -43.57 0.3 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 0.0 109.436 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.423 ' HB3' ' HA ' ' A' ' 318' ' ' MET . 0.0 OUTLIER -151.25 158.03 43.35 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.186 -0.946 . . . . 0.0 109.438 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.679 ' CE1' HG22 ' A' ' 325' ' ' THR . 27.9 p90 -123.7 160.62 26.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.432 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -98.25 151.86 20.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.303 -0.873 . . . . 0.0 109.388 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.538 HG11 ' CE1' ' A' ' 267' ' ' TYR . 1.7 t -133.99 139.2 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.458 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.99 96.39 6.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.222 -0.924 . . . . 0.0 109.471 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' TYR . . . . . 0.635 ' HE2' ' HB2' ' A' ' 328' ' ' ALA . 38.4 m-85 -95.74 100.74 12.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.46 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.26 152.34 34.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.662 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.703 ' CG2' HG13 ' A' ' 251' ' ' VAL . 59.9 t -140.64 142.86 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.352 -0.843 . . . . 0.0 109.495 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.8 m -134.84 163.73 29.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 109.526 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' A' ' 272' ' ' SER . . . 104.64 -10.41 49.33 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 271' ' ' GLY . 0.5 OUTLIER 169.37 159.7 0.05 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.314 -1.109 . . . . 0.0 109.321 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 48.5 t -105.34 -29.5 10.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.159 -0.963 . . . . 0.0 109.49 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.6 77.96 6.17 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 108.661 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.994 ' CE3' HG23 ' A' ' 277' ' ' VAL . 10.7 p-90 -128.69 157.1 42.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.41 -0.806 . . . . 0.0 109.934 -179.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 16.0 m -110.61 96.48 6.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.406 -0.809 . . . . 0.0 108.863 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.994 HG23 ' CE3' ' A' ' 275' ' ' TRP . 40.2 t -79.76 104.15 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.919 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . 0.481 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 5.7 t-20 -93.47 138.96 31.25 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.369 -0.832 . . . . 0.0 108.783 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.491 ' HA ' ' O ' ' A' ' 327' ' ' ALA . 34.1 mt -122.61 132.3 54.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.174 -0.954 . . . . 0.0 109.568 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -110.1 83.2 1.72 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.356 -0.84 . . . . 0.0 109.271 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.785 HD22 ' HB3' ' A' ' 326' ' ' PRO . 4.2 mm? -59.26 139.26 57.14 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.217 -0.927 . . . . 0.0 109.466 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -83.86 122.71 29.07 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.405 -0.809 . . . . 0.0 109.422 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 82.91 -149.21 26.49 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 58.8 m -100.47 34.11 2.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -1.104 . . . . 0.0 109.538 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.514 ' CB ' HD12 ' A' ' 281' ' ' LEU . 85.3 mt-30 -57.13 169.57 0.55 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.932 . . . . 0.0 109.522 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.449 ' CG2' ' C ' ' A' ' 285' ' ' GLN . 15.8 p -155.81 148.25 23.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.491 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.623 HG13 HG11 ' A' ' 295' ' ' VAL . 38.2 mm -83.25 153.46 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.334 -0.854 . . . . 0.0 109.398 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.442 ' HB2' ' HE3' ' A' ' 318' ' ' MET . 3.6 tp-100 -118.52 -28.38 5.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 0.0 109.461 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.408 ' C ' ' OG ' ' A' ' 290' ' ' SER . . . -145.46 166.99 24.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.953 . . . . 0.0 109.459 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . 0.408 ' OG ' ' C ' ' A' ' 289' ' ' ALA . 0.8 OUTLIER -169.99 137.26 1.58 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.565 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 28.0 p90 -136.4 150.62 48.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.567 ' O ' ' HB2' ' A' ' 293' ' ' ALA . 0.6 OUTLIER 70.48 15.82 7.15 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 109.451 179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 292' ' ' ASN . . . 172.41 157.8 0.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.47 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -108.27 134.05 51.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.9 . . . . 0.0 109.501 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.861 HG22 HG22 ' A' ' 304' ' ' VAL . 59.9 t -112.75 118.92 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.223 -0.923 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 71.2 p -150.76 173.86 13.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.447 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 151.47 -132.05 3.69 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 301' ' ' THR . 32.7 p -148.97 -173.22 4.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -1.183 . . . . 0.0 109.497 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 300' ' ' SER . . . -74.55 162.66 54.14 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 299' ' ' GLY . 4.2 t 83.13 -44.15 0.11 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.65 -0.912 . . . . 0.0 109.764 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.425 ' O ' ' O ' ' A' ' 298' ' ' SER . 0.8 OUTLIER -139.8 172.2 13.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.184 -0.948 . . . . 0.0 109.385 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 279' ' ' LEU . 18.4 mmt-85 -145.26 162.47 37.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.244 -0.91 . . . . 0.0 109.253 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 304' ' ' VAL . 7.6 m -140.28 167.63 21.7 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.711 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.861 HG22 HG22 ' A' ' 295' ' ' VAL . 38.6 t -154.23 142.33 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.366 -0.834 . . . . 0.0 109.314 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 62.3 p -145.66 150.36 43.21 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.312 -0.868 . . . . 0.0 109.473 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.83 164.44 27.73 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.678 2.252 . . . . 0.0 110.39 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -119.29 -12.16 9.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.31 -0.868 . . . . 0.0 109.443 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 114.49 42.89 0.79 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.51 -59.24 1.09 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -1.159 . . . . 0.0 109.467 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -156.8 162.82 31.89 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -90.18 -7.45 53.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -1.138 . . . . 0.0 109.505 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.423 ' O ' ' CG ' ' A' ' 292' ' ' ASN . 32.1 m -100.59 117.4 34.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.463 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.698 ' HZ ' HG11 ' A' ' 277' ' ' VAL . 12.5 p90 -135.81 153.31 51.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.324 -0.86 . . . . 0.0 109.518 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.565 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -117.1 152.33 17.85 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.92 148.16 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -1.166 . . . . 0.0 109.503 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 287' ' ' ILE . 23.9 m -107.43 129.82 54.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.396 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.607 HG22 ' CD1' ' A' ' 287' ' ' ILE . 40.3 t -114.88 149.51 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.197 -0.939 . . . . 0.0 109.481 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . 0.442 ' HE3' ' HB2' ' A' ' 288' ' ' GLN . 0.8 OUTLIER -103.68 128.39 51.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 109.399 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 322' ' ' SER . 10.1 mptt -43.79 -66.13 0.42 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.27 -0.893 . . . . 0.0 109.538 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 319' ' ' LYS . 19.3 m-20 59.42 31.27 20.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.915 . . . . 0.0 109.436 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 111.36 -47.81 1.0 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 319' ' ' LYS . 0.0 OUTLIER -103.71 158.4 16.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.224 -1.163 . . . . 0.0 109.471 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 324' ' ' THR . 65.1 m -122.34 -32.46 3.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.429 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -41.51 119.82 1.32 Allowed 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.355 -0.841 . . . . 0.0 109.967 -179.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.679 HG22 ' CE1' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -56.42 166.22 1.3 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.335 179.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.785 ' HB3' HD22 ' A' ' 281' ' ' LEU . 32.9 Cg_endo -77.55 157.2 32.36 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.552 2.168 . . . . 0.0 110.721 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 279' ' ' LEU . . . -88.65 165.16 14.97 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 0.0 109.105 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.635 ' HB2' ' HE2' ' A' ' 267' ' ' TYR . . . -138.18 152.36 48.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.045 -1.034 . . . . 0.0 109.763 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . 0.439 ' OG1' ' HB3' ' A' ' 278' ' ' ASN . 80.4 p -146.4 127.72 14.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.25 -0.906 . . . . 0.0 109.647 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . 0.51 ' SG ' ' N ' ' A' ' 249' ' ' CYS . 1.6 t -91.1 138.29 31.71 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.421 -0.799 . . . . 0.0 108.969 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -133.99 152.18 51.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.903 . . . . 0.0 109.504 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -147.07 -175.23 19.8 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.289 -1.124 . . . . 0.0 109.465 -179.928 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -142.65 126.04 2.78 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.418 ' C ' ' SG ' ' A' ' 330' ' ' CYS . 6.0 p -124.43 169.95 11.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.237 -1.155 . . . . 0.0 109.321 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.545 ' O ' HG22 ' A' ' 269' ' ' VAL . 52.6 p -149.06 173.23 13.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.96 . . . . 0.0 109.538 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.651 HG13 ' CG2' ' A' ' 269' ' ' VAL . 0.9 OUTLIER -135.87 120.19 25.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.528 -179.129 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.55 118.62 37.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.888 . . . . 0.0 109.453 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.564 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -109.19 101.57 10.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -0.868 . . . . 0.0 109.458 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.97 169.04 10.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.868 . . . . 0.0 109.415 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.481 ' NH1' ' CD2' ' A' ' 263' ' ' PHE . 0.0 OUTLIER -98.3 142.67 29.67 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 109.493 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -110.42 -55.21 2.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.177 -0.952 . . . . 0.0 109.413 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.536 ' HB3' ' CZ2' ' A' ' 259' ' ' TRP . 52.1 mm-40 -144.04 144.42 31.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -122.63 122.58 39.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.306 -0.871 . . . . 0.0 109.45 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . 0.536 ' CZ2' ' HB3' ' A' ' 257' ' ' GLU . 6.1 m-90 -124.82 -176.64 3.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 73.2 m -93.37 2.11 56.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.237 -0.914 . . . . 0.0 109.67 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.42 -24.62 7.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.426 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 317' ' ' VAL . 10.1 ptt180 -178.51 166.31 1.79 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.24 -0.912 . . . . 0.0 109.451 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.576 ' CZ ' ' HB ' ' A' ' 317' ' ' VAL . 47.3 p90 -133.37 151.27 51.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.408 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -97.82 150.75 20.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.333 -0.854 . . . . 0.0 109.469 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.464 HG11 ' CE1' ' A' ' 267' ' ' TYR . 2.1 t -130.88 164.67 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.334 -0.854 . . . . 0.0 109.468 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 253' ' ' ALA . 0.9 OUTLIER -133.52 95.22 3.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' TYR . . . . . 0.762 ' CE2' ' HB2' ' A' ' 328' ' ' ALA . 44.3 m-85 -91.13 140.85 29.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.334 -0.854 . . . . 0.0 109.317 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 251' ' ' VAL . 0.8 OUTLIER -149.88 157.58 43.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.925 . . . . 0.0 109.602 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.651 ' CG2' HG13 ' A' ' 251' ' ' VAL . 98.5 t -144.3 145.85 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.202 -0.936 . . . . 0.0 109.46 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 7.6 p -127.76 173.09 10.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.337 -0.852 . . . . 0.0 109.534 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 106.24 -55.11 0.55 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 274' ' ' ALA . 0.3 OUTLIER -154.53 104.79 2.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.254 -1.145 . . . . 0.0 109.367 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 272' ' ' SER . 2.4 t -42.06 -26.74 0.1 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 0.0 109.87 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 272' ' ' SER . . . -79.37 78.3 5.89 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.068 -1.02 . . . . 0.0 108.665 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.925 ' CZ3' HG23 ' A' ' 277' ' ' VAL . 7.8 p-90 -128.95 172.78 11.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.286 -0.884 . . . . 0.0 109.855 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 331' ' ' ALA . 1.7 m -132.15 102.25 5.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.488 -0.757 . . . . 0.0 108.983 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.925 HG23 ' CZ3' ' A' ' 275' ' ' TRP . 12.3 t -79.96 127.45 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.253 -0.905 . . . . 0.0 109.961 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . 0.488 ' HB3' ' OG1' ' A' ' 329' ' ' THR . 1.5 t30 -112.46 109.65 19.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.35 -0.844 . . . . 0.0 108.976 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 327' ' ' ALA . 22.2 mt -90.29 140.93 29.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.319 -0.863 . . . . 0.0 109.682 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -138.38 93.06 2.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.325 -0.86 . . . . 0.0 109.3 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.715 HD13 ' HB3' ' A' ' 285' ' ' GLN . 24.1 mt -59.83 170.2 1.22 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -0.94 . . . . 0.0 109.68 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -116.62 85.08 2.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.219 -0.926 . . . . 0.0 109.439 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 129.52 -145.43 16.4 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.448 ' O ' HG23 ' A' ' 286' ' ' THR . 0.7 OUTLIER -92.6 4.96 52.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.228 -1.16 . . . . 0.0 109.588 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.715 ' HB3' HD13 ' A' ' 281' ' ' LEU . 57.6 mt-30 -47.06 154.5 0.35 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -0.924 . . . . 0.0 109.458 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 284' ' ' SER . 30.8 p -145.61 174.67 10.98 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.256 -0.903 . . . . 0.0 109.532 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . . . . . . . . . 29.2 mt -124.17 152.36 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 109.408 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -141.55 11.96 2.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.181 -0.949 . . . . 0.0 109.699 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.733 ' HB3' ' OG1' ' A' ' 316' ' ' THR . . . -154.3 153.99 32.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.069 -1.019 . . . . 0.0 109.603 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 24.0 p -165.37 126.02 1.9 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.238 -0.914 . . . . 0.0 109.39 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.567 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 22.4 p90 -124.98 138.85 54.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.265 -0.897 . . . . 0.0 109.659 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.545 ' O ' ' HB2' ' A' ' 293' ' ' ALA . 1.4 t-20 71.98 33.96 1.56 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.885 . . . . 0.0 109.508 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 292' ' ' ASN . . . 172.3 157.76 0.1 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.484 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 37.5 m-20 -104.86 99.08 8.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.487 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.648 HG22 HG22 ' A' ' 304' ' ' VAL . 48.0 t -95.48 112.44 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.919 . . . . 0.0 109.469 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 1.4 p -142.45 176.18 9.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.154 -0.966 . . . . 0.0 109.591 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 116.09 -154.7 16.71 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . 0.438 ' O ' ' HD2' ' A' ' 302' ' ' ARG . 2.5 m -94.93 179.08 5.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -1.115 . . . . 0.0 109.43 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . -77.11 -41.76 21.23 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.79 -32.21 13.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.257 -1.143 . . . . 0.0 109.452 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.0 p -147.12 138.67 24.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.199 -0.938 . . . . 0.0 109.481 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 298' ' ' SER . 18.3 mmm180 -119.35 102.09 8.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.2 -0.938 . . . . 0.0 109.394 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 40.0 m -69.21 149.72 48.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.469 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.648 HG22 HG22 ' A' ' 295' ' ' VAL . 58.5 t -140.27 139.76 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.419 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 30.0 p -145.17 155.83 54.56 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.47 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.08 140.63 18.03 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.626 2.217 . . . . 0.0 110.479 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -120.44 26.08 9.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 109.503 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 74.43 55.43 5.58 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.14 -60.4 0.77 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -1.133 . . . . 0.0 109.467 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -162.24 -179.77 37.07 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -103.15 -2.68 26.95 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.318 -1.107 . . . . 0.0 109.571 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.484 HG22 ' N ' ' A' ' 313' ' ' PHE . 40.9 m -113.77 162.06 16.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 109.539 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 267' ' ' TYR . 3.0 p90 -176.99 155.65 1.22 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.381 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.567 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -125.54 166.84 18.1 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 16.9 m -136.89 167.45 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.237 -1.155 . . . . 0.0 109.515 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . 0.733 ' OG1' ' HB3' ' A' ' 289' ' ' ALA . 89.1 m -117.52 108.55 15.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -0.883 . . . . 0.0 109.483 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.576 ' HB ' ' CZ ' ' A' ' 263' ' ' PHE . 40.4 t -100.91 149.95 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.294 -0.879 . . . . 0.0 109.347 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . . . . . . . . . 7.2 mtp -99.84 135.19 41.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.92 . . . . 0.0 109.501 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 320' ' ' ASN . 17.9 mmtp -46.92 -69.4 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.533 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 319' ' ' LYS . 24.9 m-20 61.27 24.64 14.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.467 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 97.13 -28.27 14.7 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.79 148.57 25.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.294 -1.121 . . . . 0.0 109.495 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' SER . . . . . 0.427 ' O ' ' C ' ' A' ' 324' ' ' THR . 23.3 t -123.27 -37.19 2.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.245 -0.909 . . . . 0.0 109.456 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -41.89 117.51 0.96 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.472 -0.768 . . . . 0.0 109.826 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.53 HG22 ' HE2' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -52.86 164.35 0.7 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.229 -0.92 . . . . 0.0 109.416 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.503 ' HB3' HD23 ' A' ' 281' ' ' LEU . 33.3 Cg_endo -77.78 166.39 25.41 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.673 2.249 . . . . 0.0 110.69 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 279' ' ' LEU . . . -92.72 170.52 9.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.357 -0.839 . . . . 0.0 109.135 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.762 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -147.78 149.0 31.56 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.136 -0.978 . . . . 0.0 110.011 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . 0.488 ' OG1' ' HB3' ' A' ' 278' ' ' ASN . 40.2 p -140.17 128.0 21.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 109.352 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . 0.418 ' HB3' HG22 ' A' ' 251' ' ' VAL . 16.6 p -82.43 171.63 13.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 109.517 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . 0.455 ' HB2' ' HB ' ' A' ' 276' ' ' THR . . . -127.54 133.64 49.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.455 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -126.92 9.87 7.09 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 56.3 p . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.262 -1.14 . . . . 0.0 109.457 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 40.2 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.326 0.584 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . 91.29 -83.16 1.26 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 22.5 p -136.3 169.18 18.08 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.133 -1.216 . . . . 0.0 109.444 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.841 ' O ' HG13 ' A' ' 269' ' ' VAL . 60.5 p -151.06 174.59 13.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.208 -0.933 . . . . 0.0 109.6 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.574 HG13 ' CG2' ' A' ' 269' ' ' VAL . 0.8 OUTLIER -132.17 171.49 17.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.462 -0.774 . . . . 0.0 109.608 -179.168 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.98 119.24 3.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.349 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.767 ' HB2' ' CE1' ' A' ' 267' ' ' TYR . . . -111.56 149.16 31.82 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.247 -0.908 . . . . 0.0 109.491 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 23.8 m -151.07 130.37 12.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.481 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.524 ' HD3' HG23 ' A' ' 325' ' ' THR . 2.7 mtm-85 -77.88 137.95 38.65 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.446 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -107.49 -69.14 0.86 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.26 -0.9 . . . . 0.0 109.449 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -107.71 136.09 48.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.504 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -111.2 129.25 56.01 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.253 -0.905 . . . . 0.0 109.411 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -124.7 172.31 9.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.911 . . . . 0.0 109.453 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 57.2 m -88.99 4.34 48.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.895 . . . . 0.0 109.63 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -119.09 -26.5 5.93 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.169 -0.957 . . . . 0.0 109.48 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 317' ' ' VAL . 16.0 ptt180 -173.41 162.42 4.3 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.45 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.585 ' CZ ' ' HB ' ' A' ' 317' ' ' VAL . 34.0 p90 -124.75 144.75 50.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.282 -0.886 . . . . 0.0 109.508 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 -85.47 157.93 20.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.182 -0.949 . . . . 0.0 109.44 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.688 HG11 ' CE2' ' A' ' 267' ' ' TYR . 1.9 t -136.12 152.23 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 0.0 109.505 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 253' ' ' ALA . 10.1 m -126.78 91.26 3.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.428 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' TYR . . . . . 0.827 ' CE1' ' HB2' ' A' ' 328' ' ' ALA . 58.8 m-85 -91.34 144.29 25.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.404 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.607 ' HB3' HG23 ' A' ' 312' ' ' THR . 24.9 p -159.93 158.26 30.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.211 -0.93 . . . . 0.0 109.585 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.841 HG13 ' O ' ' A' ' 250' ' ' SER . 74.2 t -134.87 141.47 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.302 -0.873 . . . . 0.0 109.394 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 7.1 t -115.69 138.29 51.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 109.526 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . 0.467 ' O ' ' CB ' ' A' ' 272' ' ' SER . . . 123.74 -15.63 7.94 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 271' ' ' GLY . 0.2 OUTLIER 167.73 165.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -1.197 . . . . 0.0 109.432 -179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 84.0 p -104.46 -24.46 13.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.234 -0.916 . . . . 0.0 109.519 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.75 77.43 6.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 108.744 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.983 ' CE3' HG23 ' A' ' 277' ' ' VAL . 9.8 p-90 -130.33 158.26 40.3 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.362 -0.836 . . . . 0.0 109.786 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 1.3 m -111.1 95.66 5.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.344 -0.847 . . . . 0.0 109.095 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.983 HG23 ' CE3' ' A' ' 275' ' ' TRP . 42.4 t -80.08 128.99 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.915 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 30.0 m-20 -107.55 130.74 54.84 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.856 . . . . 0.0 108.886 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.498 HD12 HG21 ' A' ' 304' ' ' VAL . 60.8 mt -118.94 126.45 51.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.36 -0.838 . . . . 0.0 109.578 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -110.47 82.56 1.61 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.298 -0.876 . . . . 0.0 109.497 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.624 HD22 ' HB3' ' A' ' 326' ' ' PRO . 4.3 mm? -59.75 145.23 45.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.984 . . . . 0.0 109.414 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.453 ' O ' ' HG3' ' A' ' 285' ' ' GLN . 2.3 m-80 -96.04 170.39 9.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.215 -0.928 . . . . 0.0 109.525 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 282' ' ' ASN . . . 45.34 -151.41 0.96 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 2.8 p -101.61 48.32 0.89 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -1.189 . . . . 0.0 109.466 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 282' ' ' ASN . 64.8 mt-30 -68.81 164.06 22.76 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.455 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 21.0 p -150.35 145.33 26.06 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 109.461 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.412 ' CD1' HG22 ' A' ' 317' ' ' VAL . 33.2 mm -88.69 135.64 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 109.423 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.497 ' OE1' ' CG ' ' A' ' 318' ' ' MET . 0.6 OUTLIER -112.14 -18.45 12.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -143.15 157.24 44.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.202 -0.936 . . . . 0.0 109.477 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 314' ' ' GLY . 1.7 p -168.6 134.81 1.84 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.473 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.524 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 34.8 p90 -144.2 155.01 43.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.207 -0.933 . . . . 0.0 109.521 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.476 ' CB ' ' HA ' ' A' ' 313' ' ' PHE . 0.4 OUTLIER 72.66 6.5 5.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.228 -0.92 . . . . 0.0 109.589 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.544 ' HB3' ' CB ' ' A' ' 313' ' ' PHE . . . 177.69 170.19 0.65 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.228 -0.92 . . . . 0.0 109.518 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.653 ' O ' HG13 ' A' ' 304' ' ' VAL . 38.7 m-80 -117.87 166.25 12.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -0.898 . . . . 0.0 109.505 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 304' ' ' VAL . 86.1 t -138.93 116.51 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.274 -0.891 . . . . 0.0 109.468 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 13.6 p -135.62 -170.05 2.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.231 -0.918 . . . . 0.0 109.459 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.6 171.1 34.5 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.5 -176.16 3.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -1.144 . . . . 0.0 109.455 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 83.22 62.0 1.85 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 55.72 30.58 15.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -1.179 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 302' ' ' ARG . 0.8 OUTLIER -148.31 171.18 16.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.89 . . . . 0.0 109.526 -179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 301' ' ' THR . 0.1 OUTLIER -155.7 84.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.358 179.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.492 HG22 ' H ' ' A' ' 304' ' ' VAL . 5.1 m -63.18 169.28 3.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.357 -0.84 . . . . 0.0 109.809 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.819 HG22 HG22 ' A' ' 295' ' ' VAL . 54.9 t -155.62 130.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 109.368 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 10.1 p -132.0 150.41 76.03 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.166 -0.959 . . . . 0.0 109.499 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.92 -174.03 2.06 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.584 2.19 . . . . 0.0 110.41 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -149.45 18.73 0.94 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.257 -0.902 . . . . 0.0 109.461 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 79.24 51.05 5.48 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.4 t -135.02 -85.2 0.4 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -1.129 . . . . 0.0 109.427 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -126.78 175.34 17.98 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . 0.481 ' N ' ' ND2' ' A' ' 311' ' ' ASN . 0.8 OUTLIER -108.18 -1.2 20.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.273 -1.134 . . . . 0.0 109.612 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.607 HG23 ' HB3' ' A' ' 268' ' ' SER . 30.2 m -116.9 107.29 14.41 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.17 -0.957 . . . . 0.0 109.428 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.65 ' HZ ' HG11 ' A' ' 277' ' ' VAL . 39.0 p90 -117.47 149.08 41.18 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.524 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -112.96 160.15 13.28 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 11.2 m -143.19 146.28 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -1.152 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . . . . . . . . . 54.5 m -103.8 102.59 12.41 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.0 109.527 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.585 ' HB ' ' CZ ' ' A' ' 263' ' ' PHE . 60.6 t -90.4 132.72 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.23 -0.919 . . . . 0.0 109.482 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . 0.497 ' CG ' ' OE1' ' A' ' 288' ' ' GLN . 28.1 mmm -87.45 143.75 27.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 0.0 109.577 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' LYS . . . . . 0.401 ' HE3' ' HB3' ' A' ' 323' ' ' SER . 37.5 mmtm -57.11 -76.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -0.871 . . . . 0.0 109.497 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 54.15 23.88 4.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.25 -0.906 . . . . 0.0 109.446 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 101.83 32.61 4.99 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . . . . . . . . . 13.2 t -158.02 117.45 3.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -1.116 . . . . 0.0 109.432 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' SER . . . . . 0.401 ' HB3' ' HE3' ' A' ' 319' ' ' LYS . 0.7 OUTLIER -112.13 3.39 17.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.579 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' THR . . . . . . . . . . . . . 1.2 m -98.53 128.08 44.72 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.137 -0.977 . . . . 0.0 108.927 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.569 HG22 ' CE1' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -59.45 165.66 3.82 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.89 . . . . 0.0 109.528 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.624 ' HB3' HD22 ' A' ' 281' ' ' LEU . 34.1 Cg_endo -77.43 171.56 17.42 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.643 2.228 . . . . 0.0 110.675 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -103.82 132.56 49.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.263 -0.898 . . . . 0.0 109.289 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.827 ' HB2' ' CE1' ' A' ' 267' ' ' TYR . . . -107.12 148.72 28.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.655 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 278' ' ' ASN . 52.7 p -149.18 125.86 11.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.35 -0.843 . . . . 0.0 109.465 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . . . . . . . . . 40.6 t -88.12 130.32 35.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -0.927 . . . . 0.0 109.492 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -126.09 119.04 26.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.522 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -86.95 121.47 5.81 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.215 -1.168 . . . . 0.0 109.444 -179.917 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -113.99 165.31 12.04 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 30.1 p -162.15 153.39 18.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -1.119 . . . . 0.0 109.491 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.609 ' O ' HG13 ' A' ' 269' ' ' VAL . 0.0 OUTLIER -141.69 175.67 9.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 109.591 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.668 HG13 ' CG2' ' A' ' 269' ' ' VAL . 0.8 OUTLIER -130.47 107.66 14.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.401 -0.812 . . . . 0.0 109.588 -179.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 34.2 p -96.86 112.37 24.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.378 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.495 ' HB2' ' CE2' ' A' ' 267' ' ' TYR . . . -95.6 140.43 30.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.601 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 23.5 m -130.32 149.67 51.9 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.318 -0.864 . . . . 0.0 109.377 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -85.05 122.89 29.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.927 . . . . 0.0 109.491 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -103.42 -148.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . 0.426 ' HB3' ' CH2' ' A' ' 259' ' ' TRP . 0.5 OUTLIER -47.7 132.43 14.28 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.251 -0.906 . . . . 0.0 109.412 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -107.94 157.15 18.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.313 -0.867 . . . . 0.0 109.607 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . 0.467 ' HB2' ' O ' ' A' ' 262' ' ' ARG . 5.1 m-90 -136.25 -170.13 2.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 54.3 m -103.1 -9.54 19.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 109.484 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . 0.428 ' O ' ' HB3' ' A' ' 262' ' ' ARG . 13.1 p-10 -133.75 17.25 3.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.435 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' ARG . . . . . 0.546 ' N ' ' HG2' ' A' ' 319' ' ' LYS . 0.4 OUTLIER 175.95 166.44 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.177 -0.952 . . . . 0.0 109.492 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.714 ' CZ ' HG11 ' A' ' 317' ' ' VAL . 55.0 p90 -148.66 136.2 20.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.42 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -87.24 155.06 20.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.495 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . . . . . . . . . 1.8 t -137.8 137.51 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.295 -0.878 . . . . 0.0 109.468 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 19.8 m -105.91 91.69 3.84 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.299 -0.876 . . . . 0.0 109.457 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' TYR . . . . . 0.793 ' CZ ' HD21 ' A' ' 279' ' ' LEU . 27.2 m-85 -80.58 136.05 36.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -0.893 . . . . 0.0 109.463 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 251' ' ' VAL . 2.7 t -131.59 159.49 38.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.908 . . . . 0.0 109.541 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.668 ' CG2' HG13 ' A' ' 251' ' ' VAL . 96.0 t -152.44 97.36 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.908 . . . . 0.0 109.495 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.61 -168.29 2.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.342 -0.849 . . . . 0.0 109.533 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 88.09 -41.71 3.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 57.5 p -173.11 170.54 4.36 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.277 -1.131 . . . . 0.0 109.359 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -106.17 -34.0 7.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.396 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -79.76 77.45 6.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.174 -0.954 . . . . 0.0 108.638 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.671 ' CE3' HG23 ' A' ' 277' ' ' VAL . 17.2 p-90 -127.46 153.53 46.18 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.326 -0.859 . . . . 0.0 109.797 -179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 87.2 m -113.96 95.19 5.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.345 -0.847 . . . . 0.0 109.116 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.956 HG22 ' HA ' ' A' ' 330' ' ' CYS . 48.4 t -107.56 149.53 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.621 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 328' ' ' ALA . 3.7 m-20 -127.46 132.87 49.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -0.878 . . . . 0.0 109.404 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.793 HD21 ' CZ ' ' A' ' 267' ' ' TYR . 7.1 mt -85.05 155.95 21.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.479 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -137.07 84.43 2.06 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.618 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.801 HD13 ' O ' ' A' ' 285' ' ' GLN . 19.0 mt -59.99 172.41 0.78 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 109.458 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.456 ' O ' ' C ' ' A' ' 283' ' ' GLY . 12.1 m-80 -86.84 59.45 5.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 109.772 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 282' ' ' ASN . . . 37.7 43.0 1.12 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.415 ' O ' ' C ' ' A' ' 285' ' ' GLN . 73.7 m -158.94 -87.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.1 -1.235 . . . . 0.0 109.63 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.801 ' O ' HD13 ' A' ' 281' ' ' LEU . 0.0 OUTLIER -43.13 140.81 1.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 9.2 p -115.97 179.7 3.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 109.513 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.493 HD12 ' HB ' ' A' ' 315' ' ' VAL . 18.1 mm -102.3 149.36 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.209 -0.932 . . . . 0.0 109.543 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.23 -33.86 3.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.188 -0.945 . . . . 0.0 109.469 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.401 ' HB3' ' OG1' ' A' ' 316' ' ' THR . . . -151.48 169.21 22.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.488 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -160.16 140.56 11.76 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.394 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.56 ' CZ2' ' HA3' ' A' ' 314' ' ' GLY . 31.2 p90 -136.58 148.57 47.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.943 . . . . 0.0 109.507 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 291' ' ' TRP . 0.7 OUTLIER 73.77 7.71 4.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.494 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.496 ' HB3' ' CB ' ' A' ' 313' ' ' PHE . . . 176.96 149.85 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.456 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -106.77 136.38 46.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.453 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 0.651 HG22 HG22 ' A' ' 304' ' ' VAL . 17.5 t -115.15 136.43 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.414 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . . . . . . . . . 44.2 p -108.73 161.23 15.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -91.19 144.99 17.53 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 19.5 m -150.75 -172.22 4.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.199 -1.177 . . . . 0.0 109.458 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 300' ' ' SER . . . -68.15 106.76 1.82 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.404 ' C ' ' O ' ' A' ' 299' ' ' GLY . 0.4 OUTLIER 44.16 28.37 0.27 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.253 -1.145 . . . . 0.0 109.473 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 1.4 p -152.57 168.88 24.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.214 -0.929 . . . . 0.0 109.398 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . 0.425 ' HB3' ' CG1' ' A' ' 295' ' ' VAL . 0.0 OUTLIER -146.67 141.3 26.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.225 -0.922 . . . . 0.0 109.488 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.483 ' O ' HG13 ' A' ' 295' ' ' VAL . 1.7 m -92.61 169.13 10.75 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.273 -0.892 . . . . 0.0 109.441 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.651 HG22 HG22 ' A' ' 295' ' ' VAL . 61.9 t -155.95 122.24 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.892 . . . . 0.0 109.49 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 52.9 p -130.66 155.39 81.32 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.99 146.13 22.81 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.67 2.247 . . . . 0.0 110.437 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -112.7 -10.25 13.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 119.29 29.6 1.73 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.8 -30.35 6.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -1.146 . . . . 0.0 109.414 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . 151.79 -156.55 26.75 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 311' ' ' ASN . 0.8 OUTLIER -117.17 8.27 13.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.225 -1.162 . . . . 0.0 109.573 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 11.1 m -109.61 96.57 6.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.408 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.523 ' CZ ' HG11 ' A' ' 304' ' ' VAL . 47.3 p90 -117.66 144.33 45.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.56 ' HA3' ' CZ2' ' A' ' 291' ' ' TRP . . . -109.77 168.35 13.15 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' A' ' 287' ' ' ILE . 5.5 m -141.96 144.01 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.306 -1.114 . . . . 0.0 109.452 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 289' ' ' ALA . 7.5 m -94.06 92.54 7.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 109.494 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.714 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 16.4 t -83.63 153.43 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.456 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . 0.425 ' O ' ' CG ' ' A' ' 285' ' ' GLN . 29.6 mtp -113.43 144.42 42.83 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.541 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' LYS . . . . . 0.546 ' HG2' ' N ' ' A' ' 262' ' ' ARG . 21.9 mmtp -65.95 -73.68 0.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 0.0 109.473 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 319' ' ' LYS . 4.3 m-20 63.16 24.02 14.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.332 -0.855 . . . . 0.0 109.408 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 99.56 37.95 3.84 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . 0.472 ' O ' ' HD2' ' A' ' 319' ' ' LYS . 0.3 OUTLIER -159.76 -157.42 0.57 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.18 -1.188 . . . . 0.0 109.467 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' SER . . . . . 0.441 ' O ' ' C ' ' A' ' 324' ' ' THR . 0.0 OUTLIER 179.89 -47.01 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.275 -0.891 . . . . 0.0 109.438 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' THR . . . . . 0.441 ' C ' ' O ' ' A' ' 323' ' ' SER . 0.2 OUTLIER -40.16 125.08 1.97 Allowed 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.599 -0.688 . . . . 0.0 110.102 -179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.582 HG22 ' HE2' ' A' ' 263' ' ' PHE . 0.7 OUTLIER -64.46 167.0 9.51 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.381 179.751 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.497 ' HD2' ' HB ' ' A' ' 325' ' ' THR . 33.2 Cg_endo -76.26 163.37 32.66 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.522 2.148 . . . . 0.0 110.614 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -110.98 115.15 29.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.341 -0.849 . . . . 0.0 109.376 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.446 ' HB2' ' CD2' ' A' ' 279' ' ' LEU . . . -103.61 163.56 12.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.494 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . 0.596 ' C ' HG13 ' A' ' 277' ' ' VAL . 35.8 p -149.49 127.17 11.68 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.303 -0.873 . . . . 0.0 109.367 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . 0.956 ' HA ' HG22 ' A' ' 277' ' ' VAL . 42.8 t -86.43 125.4 33.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.356 -0.84 . . . . 0.0 109.505 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . . . . . . . . . . . -139.13 170.27 16.26 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.234 -0.916 . . . . 0.0 109.41 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 144.27 141.04 3.7 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.192 -1.181 . . . . 0.0 109.44 -179.992 . . . . . . . . 0 0 . 1 stop_ save_